
<html lang="en"     class="pb-page"  data-request-id="92ce12e6-3a2c-4736-bab3-ca4361c11b62"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.6b01181;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities" /></meta><meta name="dc.Creator" content="Zi-Long  Wang" /></meta><meta name="dc.Creator" content="Jia-Xin  Pan" /></meta><meta name="dc.Creator" content="Jing-Jing  Song" /></meta><meta name="dc.Creator" content="Hong-Hai  Tang" /></meta><meta name="dc.Creator" content="Hong-Ping  Yu" /></meta><meta name="dc.Creator" content="Xu-Hui  Li" /></meta><meta name="dc.Creator" content="Ning  Li" /></meta><meta name="dc.Creator" content="Ting  Zhang" /></meta><meta name="dc.Creator" content="Run  Zhang" /></meta><meta name="dc.Creator" content="Meng-Na  Zhang" /></meta><meta name="dc.Creator" content="Biao  Xu" /></meta><meta name="dc.Creator" content="Quan  Fang" /></meta><meta name="dc.Creator" content="Rui  Wang" /></meta><meta name="dc.Description" content="The opioid and neuropeptide FF pharmacophore-containing chimeric peptide 0 (BN-9) was recently developed and produced potent nontolerance forming analgesia. In this study, 11 analogues of 0 were de..." /></meta><meta name="Description" content="The opioid and neuropeptide FF pharmacophore-containing chimeric peptide 0 (BN-9) was recently developed and produced potent nontolerance forming analgesia. In this study, 11 analogues of 0 were de..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 11, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01181" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01181" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01181" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01181" /></link>
        
    
    

<title>Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01181" /></meta><meta property="og:title" content="Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0008.jpeg" /></meta><meta property="og:description" content="The opioid and neuropeptide FF pharmacophore-containing chimeric peptide 0 (BN-9) was recently developed and produced potent nontolerance forming analgesia. In this study, 11 analogues of 0 were designed and synthesized. An in vitro cAMP assay demonstrated that these analogues behaved as multifunctional agonists at both opioid and NPFF receptors. In mouse tail-flick test, most of the analogues produced potent nontolerance forming antinociception. Notably, 11 (DN-9) was 33-fold more potent than 0 at analgesic effects, which was mediated by μ- and κ-opioid receptors. In addition, 11 also produced powerful analgesic effects in the formalin pain and CFA-induced chronic inflammatory pain models. Strikingly, following its repeated administration for 6 days, 11 did not produce antinociceptive tolerance in the tail-flick test and CFA-induced pain model. The present work indicates that it is reasonable to design multifunctional peptide ligands for opioid and NPFF receptors in a single molecule producing effective nontolerance forming antinociception." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01181"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01181">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01181&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01181&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01181&amp;href=/doi/10.1021/acs.jmedchem.6b01181" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10198-10208</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01118" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01204" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zi-Long++Wang">Zi-Long Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia-Xin++Pan">Jia-Xin Pan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing-Jing++Song">Jing-Jing Song</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong-Hai++Tang">Hong-Hai Tang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong-Ping++Yu">Hong-Ping Yu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xu-Hui++Li">Xu-Hui Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Li">Ning Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ting++Zhang">Ting Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Run++Zhang">Run Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meng-Na++Zhang">Meng-Na Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Biao++Xu">Biao Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Quan++Fang">Quan Fang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rui++Wang">Rui Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Key Laboratory of Preclinical Study for New Drugs of Gansu Province, and Institute of Physiology, School of Basic Medical Sciences, Lanzhou University, 199 Donggang West Road, Lanzhou, 730000, PR China</span></div><div class="corresp-info"><strong>*</strong>For R.W.: phone, +86-9318912567; fax, 86-931-891-1255; E-mail, <a href="/cdn-cgi/l/email-protection#ec9b8d828b9e9985ac809699c2898899c28f82"><span class="__cf_email__" data-cfemail="dbacbab5bca9aeb29bb7a1aef5bebfaef5b8b5">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For Q.F.: phone, +86-9318915322; E-mail, <a href="/cdn-cgi/l/email-protection#680e09060f192804121d460d0c1d460b06"><span class="__cf_email__" data-cfemail="4127202f2630012d3b346f2425346f222f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01181&amp;href=/doi/10.1021%2Facs.jmedchem.6b01181" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10198–10208</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 31, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 August 2016</li><li><span class="item_label"><b>Published</b> online</span>11 November 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01181" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01181</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10198%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZi-Long%2BWang%252C%2BJia-Xin%2BPan%252C%2BJing-Jing%2BSong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D22%26contentID%3Dacs.jmedchem.6b01181%26title%3DStructure-Based%2BOptimization%2Bof%2BMultifunctional%2BAgonists%2Bfor%2BOpioid%2Band%2BNeuropeptide%2BFF%2BReceptors%2Bwith%2BPotent%2BNontolerance%2BForming%2BAnalgesic%2BActivities%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10208%26publicationDate%3DNovember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01181"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">884</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01181" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zi-Long&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jia-Xin&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Jing-Jing&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Hong-Hai&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Hong-Ping&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Xu-Hui&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Ting&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Run&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Meng-Na&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Biao&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Quan&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Rui&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10198-10208&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01181&quot;},&quot;abstract&quot;:&quot;The opioid and neuropeptide FF pharmacophore-containing chimeric peptide 0 (BN-9) was recently developed and produced potent nontolerance forming analgesia. In this study, 11 analogues of 0 were designed and synthesized. An in vitro cAMP assay demonstrated that these analogues behaved as multifunctional agonists at both opioid and NPFF receptors. In mouse tail-flick test, most of the analogues produced potent nontolerance forming antinociception. Notably, 11 (DN-9) was 33-fold more potent than 0 at analgesic effects, which was mediated by μ- and κ-opioid receptors. In addition, 11 also produced powerful analgesic effects in the formalin pain and CFA-induced chronic inflammatory pain models. Strikingly, following its repeated administration for 6 days, 11 did not produce antinociceptive tolerance in the tail-flick test and CFA-induced pain model. The present work indicates that it is reasonable to design multifunctional peptide ligands for opioid and NPFF receptors in a single molecule producing effective nont&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01181&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01181" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01181&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01181" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01181&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01181" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01181&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01181&amp;href=/doi/10.1021/acs.jmedchem.6b01181" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01181" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01181" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01181%26sid%3Dliteratum%253Aachs%26pmid%3D27798836%26genre%3Darticle%26aulast%3DWang%26date%3D2016%26atitle%3DStructure-Based%2BOptimization%2Bof%2BMultifunctional%2BAgonists%2Bfor%2BOpioid%2Band%2BNeuropeptide%2BFF%2BReceptors%2Bwith%2BPotent%2BNontolerance%2BForming%2BAnalgesic%2BActivities%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D22%26spage%3D10198%26epage%3D10208%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292245" title="Multifunctional">Multifunctional</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/jmcmar.2016.59.issue-22/20161123/jmcmar.2016.59.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The opioid and neuropeptide FF pharmacophore-containing chimeric peptide <b>0</b> (BN-9) was recently developed and produced potent nontolerance forming analgesia. In this study, 11 analogues of <b>0</b> were designed and synthesized. An in vitro cAMP assay demonstrated that these analogues behaved as multifunctional agonists at both opioid and NPFF receptors. In mouse tail-flick test, most of the analogues produced potent nontolerance forming antinociception. Notably, <b>11</b> (DN-9) was 33-fold more potent than <b>0</b> at analgesic effects, which was mediated by μ- and κ-opioid receptors. In addition, <b>11</b> also produced powerful analgesic effects in the formalin pain and CFA-induced chronic inflammatory pain models. Strikingly, following its repeated administration for 6 days, <b>11</b> did not produce antinociceptive tolerance in the tail-flick test and CFA-induced pain model. The present work indicates that it is reasonable to design multifunctional peptide ligands for opioid and NPFF receptors in a single molecule producing effective nontolerance forming antinociception.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pain is an unpleasant sensory and emotional experience and serves a protective role to warn us of potential injuries or diseases. However, chronic pain can significantly influence the individual’s quality of life, and millions of people are suffering from various pains worldwide.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The treatment of pain, especially chronic pain, is a major challenge in the clinic. Although opioid analgesics play important roles in the treatment of severe acute pain and chronic pain,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> currently available opioid analgesics have a number of unwanted side effects that hamper their clinical use, particularly in chronic pain management.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Therefore, the need to develop novel analgesics with enhanced efficacy and limited side effects is becoming more and more urgent.</div><div class="NLM_p">The generation of pain is very complex, and numerous neurotransmitters and inflammatory mediators participate in the pain pathway.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> The opioid system is one of the main systems engaged in pain perception.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The activation of opioid receptors can strongly inhibit pain transmission but is also the source of the undesirable effects of opioid analgesics.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Previous studies have revealed that some neurotransmitters could modulate opioid activities.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Therefore, to reduce or eliminate opioid-related side effects, developing compounds that target opioid receptors and some other receptors with modulatory effects on opioid activities might be a promising strategy.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a></div><div class="NLM_p">The successful examples of this strategy include bifunctional opioid compounds that target opioid receptors and the nociceptin receptor, neurokinin-1 receptor (NK-1), cannabinoid receptor 1 (CB<sub>1</sub>), cholecystokinin type 2 receptor (CCK-2), or metabotropic glutamate receptor 5 (mGluR5).<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21">(14-21)</a> Nociceptin is one of the major compounds for developing bifunctional opioid analgesics, and a number of bifunctional compounds have been developed.<a onclick="showRef(event, 'ref20 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref22 ref23 ref24">(20, 22-24)</a> Recently, Guillemyn et al. reported that a hybrid peptide behaved as an agonist at opioid receptors and an antagonist at the nociceptin receptor. This hybrid peptide permeates the BBB and produces potent antinociception after intravenous administration with limited respiratory depression.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Hruby and colleagues have developed a series of bifunctional peptides with both the opioid agonist and NK-1 antagonist pharmacophores, including TY005, TY027, NP30, and their analogues.<a onclick="showRef(event, 'ref15 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref15 ref25 ref26">(15, 25, 26)</a> These compounds exhibit potent analgesia in both acute and chronic pain models with limited tolerance. PK20 and [Ile<sup>9</sup>]PK20, two chimeric peptides with both opioid and neurotensin pharmacophores, produced potent antinociceptive effects and had limited motor coordination impairments.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Taken together, these bifunctional opioid compounds induce powerful analgesic effects with limited side effects such as a lack of antinociceptive tolerance, respiratory depression, and motor coordination impairments.</div><div class="NLM_p">Neuropeptide FF (NPFF) was identified as an important endogenous opioid-modulating peptide and causes complicated opioid-modulating actions.<a onclick="showRef(event, 'ref8 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref8 ref29 ref30 ref31">(8, 29-31)</a> NPFF blocks opioid-induced antinociception at the supraspinal level<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> but induces an opioid-like analgesia or potentiated morphine analgesia at the spinal level.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> In addition, previous studies demonstrated that the NPFF system was involved in opioid antinociceptive tolerance and dependence.<a onclick="showRef(event, 'ref29 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref29 ref36 ref37 ref38 ref39">(29, 36-39)</a> In view of these findings, we recently synthesized and developed a multifunctional agonist toward opioid and NPFF receptors, <b>0</b> (BN-9, Tyr-D.Ala-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>0</b> is a chimeric peptide containing the half structure of biphalin (Tyr-D.Ala-Gly-Phe-NH−) and the C-terminal of NPFF. Our data showed that <b>0</b> has potent nontolerance forming antinociception in mice. Thus, <b>0</b> may be used as a promising lead compound to develop analgesics with reduced or eliminated tolerance.</div><div class="NLM_p last">To further identify the structural and conformational requirements of <b>0</b> for opioid and NPFF receptors interaction, we synthesized 11 analogues of <b>0</b> in an effort to balance opioid and NPFF receptors activation and improve antinociceptive potencies in this study. In addition, the in vitro functional activities, antinociceptive activities, and tolerance developments of these analogues were evaluated and compared with <b>0</b>. Most strikingly, analogue <b>11</b> (DN-9) was identified as a mixed agonist for μ, κ, δ-opioid, NPFF<sub>1</sub>, and NPFF<sub>2</sub> receptors and exerted a potent analgesic effect without tolerance (ED<sub>50</sub> = 0.0163 nmol), which is approximately 33-fold more potent than <b>0</b> in the tail-flick assay. <b>11</b> also produced a dramatic pain reduction in the mouse models of formalin pain and complete Freund’s adjuvant (CFA)-induced chronic inflammatory pain. Moreover, the substitution modification from <b>0</b> to <b>11</b> improved the metabolic stability in the mouse brain homogenate.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The analogues in this work were based on <b>0</b>, which functions as a mixed agonist of opioid and NPFF receptors. Our design of peptides that simultaneously interact with opioid and NPFF receptors was based on reasonable overlapping pharmacophores of opioid and NPFF receptors ligands in a single molecule. Previous studies for the structure–activity relationships of opioid and NPFF peptides indicated that the N-terminus of opioid peptides was an opioid pharmacophore, whereas the C-terminus RFamide of NPFF and related peptides was a NPFF pharmacophore.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> As shown in the chemical structure of <b>0</b>, the N-terminal amino acids unique to biphalin and the C-terminal part of NPFF were fused in a single molecule.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">As a multifunctional ligand, the agonism and selectivity for each receptor may affect its in vivo pharmacological activities. Therefore, the identification of a proper balance between the activation of each opioid and NPFF receptors subtypes may be a key factor in developing multifunctional opioid–NPFF agonists with more potent analgesic effects and reduced side effects. In the current work, we synthesized a series of analogues of <b>0</b> with the following modifications: (1) selective replacement of Try<sup>1</sup>, D.Ala<sup>2</sup>, and Phe<sup>4</sup> by the corresponding amino acids to selectively decrease δ-opioid potency or improve μ-opioid potency (analogues <b>1</b>–<b>4</b>) based on the reported data obtained from the structure–activity relationships of opioid peptides.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Previous studies suggested that [NMe.Tyr<sup>1</sup>]-Leu-enkephalin maintained μ-opioid activity and was 5-fold less active at the δ-opioid receptor compared with its parent peptide;<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> therefore, analogue <b>1</b> ([NMe.Tyr<sup>1</sup>]-BN-9) was designed to selectively decrease activity at the δ-opioid receptor. Furthermore, analogues <b>2</b>–<b>4</b> were designed based on the successful modifications of enkephalins. Substitution of hydrophilic <span class="smallcaps smallerCapital">d</span>-amino acids at the Gly<sup>2</sup> position of enkephalin could increase the potency and selectivity for μ-opioid, and D.Ser and D.Met were used successfully in previous studies.<a onclick="showRef(event, 'ref41 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref41 ref45 ref46">(41, 45, 46)</a> The Gly<sup>3</sup> position in enkephalin is very intolerant to substitutions, and the substitution of Phe<sup>4</sup> with NMe.Phe was often used in the powerful and stable ligands for the μ-opioid receptor;<a onclick="showRef(event, 'ref41 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref41 ref47 ref48">(41, 47, 48)</a> (2) substitution of Gln<sup>5</sup> with Gly, Leu, Met, D.Leu, D.Met, and D.Ala (analogues <b>5</b>–<b>10</b>). Gln<sup>5</sup> of the parent peptide <b>0</b> is an overlapping position of the opioid and NPFF pharmacophores of the parent peptide and changes at the 5-position of Leu- or Met-enkephalin yield active, selective μ-opioid receptor ligands.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In addition, the Gln<sup>4</sup> position of NPFF can be replaced with Gly, Glu, or Asn without significantly decreasing the potency at NPFF receptors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Therefore, Gly, Leu, Met, D.Leu, D.Met, and D.Ala were used to replace the 5-position of analogue <b>0</b>; (3) analogue <b>11</b> was designed by combining successful chemical modifications to enhance μ-opioid potency via in vitro functional assay. The structures of the synthesized analogues of <b>0</b> are presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures of Multifunctional Peptide Analogues Synthesized in the Present Study</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">abbreviated names</th><th class="colsep0 rowsep0" align="center">sequences</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>0</b></td><td class="colsep0 rowsep0" align="left">BN-9<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">[NMe.Tyr<sup>1</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left"><b>NMe.Tyr</b>-D.Ala-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">[D.Ser<sup>2</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-<b>D.Ser</b>-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[D.Met<sup>2</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-<b>D.Met</b>-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">[NMe.Phe<sup>4</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-<b>NMe.Phe</b>-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">[Gly<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>Gly</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">[Leu<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>Leu</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">[Met<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>Met</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">[D.Met<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>D.Met</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">[D.Leu<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>D.Leu</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">[D.Ala<sup>5</sup>]-BN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-Phe-<b>D.Ala</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">DN-9</td><td class="colsep0 rowsep0" align="left">Tyr-D.Ala-Gly-<b>NMe.Phe-Gly</b>-Pro-Gln-Arg-Phe-NH<sub>2</sub></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data cited from our previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div></div></div><div class="NLM_p">All of these analogues were synthesized by manual solid-phase synthesis using standard <i>N</i>-fluorenylmethoxycarbonyl (Fmoc) chemistry. Synthesis of the analogues was conducted on Rink amide 4-methybenzhydrylamine (MBHA) resin. Hexafluorophosphate (HBTU), 1-hydroxybenzotriazole (HOBt), and <i>N</i>,<i>N</i>′-diisopropylethylamine (DIEA) were used as coupling agents. The established peptides were desalted by gel filtration, purified using semipreparative reversed-phase high pressure liquid chromatography (RP-HPLC), and characterized by RP-HPLC, magnetic deflection time-of-flight mass spectrometry (MD-TOF MS), and melting point (mp). The peptides with the purities that exceeded 95% as characterized by analytical RP-HPLC were used in the following studies. The detailed analytical properties of these analogues are provided in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Analytical Data for Multifunctional Peptide Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">RP-HPLC 10–80% in 30 min</th><th class="rowsep1 colsep0" colspan="2" align="center">RP-HPLC 10–100% in 30 min</th><th class="rowsep1 colsep0" colspan="2" align="center">MD-TOF-MS [M + H]<sup><b>+</b></sup></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>R</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (min)</th><th class="colsep0 rowsep0" align="center">purity<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>R</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (min)</th><th class="colsep0 rowsep0" align="center">purity<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">calcd</th><th class="colsep0 rowsep0" align="center">identified</th><th class="colsep0 rowsep0" align="center">mp (°C)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">13.945</td><td class="colsep0 rowsep0" align="center">99.50</td><td class="colsep0 rowsep0" align="center">12.842</td><td class="colsep0 rowsep0" align="center">99.76</td><td class="colsep0 rowsep0" align="center">1126.54</td><td class="colsep0 rowsep0" align="center">1126.57</td><td class="colsep0 rowsep0" align="center">147–149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b></td><td class="colsep0 rowsep0" align="center">13.485</td><td class="colsep0 rowsep0" align="center">98.27</td><td class="colsep0 rowsep0" align="center">12.435</td><td class="colsep0 rowsep0" align="center">98.05</td><td class="colsep0 rowsep0" align="center">1128.54</td><td class="colsep0 rowsep0" align="center">1128.58</td><td class="colsep0 rowsep0" align="center">146–148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3</b></td><td class="colsep0 rowsep0" align="center">15.004</td><td class="colsep0 rowsep0" align="center">98.92</td><td class="colsep0 rowsep0" align="center">13.655</td><td class="colsep0 rowsep0" align="center">99.13</td><td class="colsep0 rowsep0" align="center">1172.54</td><td class="colsep0 rowsep0" align="center">1172.59</td><td class="colsep0 rowsep0" align="center">145–147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4</b></td><td class="colsep0 rowsep0" align="center">13.499</td><td class="colsep0 rowsep0" align="center">95.65</td><td class="colsep0 rowsep0" align="center">14.739</td><td class="colsep0 rowsep0" align="center">95.39</td><td class="colsep0 rowsep0" align="center">1126.54</td><td class="colsep0 rowsep0" align="center">1126.58</td><td class="colsep0 rowsep0" align="center">146–148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5</b></td><td class="colsep0 rowsep0" align="center">14.808</td><td class="colsep0 rowsep0" align="center">96.06</td><td class="colsep0 rowsep0" align="center">13.542</td><td class="colsep0 rowsep0" align="center">96.07</td><td class="colsep0 rowsep0" align="center">1041.50</td><td class="colsep0 rowsep0" align="center">1041.53</td><td class="colsep0 rowsep0" align="center">145–146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6</b></td><td class="colsep0 rowsep0" align="center">15.590</td><td class="colsep0 rowsep0" align="center">99.15</td><td class="colsep0 rowsep0" align="center">14.086</td><td class="colsep0 rowsep0" align="center">99.02</td><td class="colsep0 rowsep0" align="center">1097.56</td><td class="colsep0 rowsep0" align="center">1097.59</td><td class="colsep0 rowsep0" align="center">144–146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7</b></td><td class="colsep0 rowsep0" align="center">16.085</td><td class="colsep0 rowsep0" align="center">99.33</td><td class="colsep0 rowsep0" align="center">14.512</td><td class="colsep0 rowsep0" align="center">99.24</td><td class="colsep0 rowsep0" align="center">1115.52</td><td class="colsep0 rowsep0" align="center">1115.55</td><td class="colsep0 rowsep0" align="center">144–145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>8</b></td><td class="colsep0 rowsep0" align="center">17.241</td><td class="colsep0 rowsep0" align="center">99.18</td><td class="colsep0 rowsep0" align="center">15.530</td><td class="colsep0 rowsep0" align="center">99.50</td><td class="colsep0 rowsep0" align="center">1115.52</td><td class="colsep0 rowsep0" align="center">1115.55</td><td class="colsep0 rowsep0" align="center">144–146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0" align="center">18.535</td><td class="colsep0 rowsep0" align="center">99.79</td><td class="colsep0 rowsep0" align="center">16.447</td><td class="colsep0 rowsep0" align="center">99.91</td><td class="colsep0 rowsep0" align="center">1197.56</td><td class="colsep0 rowsep0" align="center">1197.59</td><td class="colsep0 rowsep0" align="center">146–148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center">15.638</td><td class="colsep0 rowsep0" align="center">98.78</td><td class="colsep0 rowsep0" align="center">14.203</td><td class="colsep0 rowsep0" align="center">98.76</td><td class="colsep0 rowsep0" align="center">1055.52</td><td class="colsep0 rowsep0" align="center">1055.54</td><td class="colsep0 rowsep0" align="center">147–149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="center">14.850</td><td class="colsep0 rowsep0" align="center">97.49</td><td class="colsep0 rowsep0" align="center">13.613</td><td class="colsep0 rowsep0" align="center">97.43</td><td class="colsep0 rowsep0" align="center">1055.50</td><td class="colsep0 rowsep0" align="center">1055.54</td><td class="colsep0 rowsep0" align="center">147–149</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>t</i><sub>R</sub> with XBridge  BEH 130 Prep C<sub>18</sub> (4.6 mm × 250 mm, 5 μm). The gradients 10–80% and 10–100% indicate solvent gradients of Me<sub>3</sub>CN in water from 10 to 80% in 30 min and from 10 to 100% in 30 min, respectively.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Purity determination based on analytical RP-HPLC.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biological Results</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> In Vitro cAMP Functional Activities</h4><div class="NLM_p">To investigate the agonistic activities of the new analogues of <b>0</b> toward opioid and NPFF receptors in vitro, the inhibition of forskolin-stimulated cyclic adenosine monophosphate (cAMP) accumulation was evaluated in HEK-293A cells stably expressing opioid or NPFF receptors. The results of the functional activities at opioid receptors are summarized in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Most of the analogues exhibited concentration-dependent inhibition in forskolin-stimulated cAMP accumulation in the cell expressing μ-, κ-, and δ-opioid receptors.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Activities of Multifunctional Peptide Analogues at Opioid Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">μ-opioid receptor</th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">κ-opioid receptor</th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">δ-opioid receptor</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">log EC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char="±">log EC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char="±">log EC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>0</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.51 ± 0.15<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">308.2<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">92.4 ± 9.7<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.25 ± 0.25<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">563.6<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">105.6 ± 20.7<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.23 ± 0.06<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">586.7<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">82.2 ± 3.7<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.71 ± 0.23</td><td class="colsep0 rowsep0" align="char" char=".">196.2</td><td class="colsep0 rowsep0" align="char" char="±">86.7 ± 16.2</td><td class="colsep0 rowsep0" align="char" char="±">–5.59 ± 0.04</td><td class="colsep0 rowsep0" align="center">2586</td><td class="colsep0 rowsep0" align="char" char="±">73.6 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">70.0 ± 4.5<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.25 ± 0.25</td><td class="colsep0 rowsep0" align="char" char=".">562.7</td><td class="colsep0 rowsep0" align="char" char="±">97.1 ± 16.7</td><td class="colsep0 rowsep0" align="char" char="±">–5.83 ± 0.06</td><td class="colsep0 rowsep0" align="center">1466</td><td class="colsep0 rowsep0" align="char" char="±">96.9 ± 4.7</td><td class="colsep0 rowsep0" align="char" char="±">–6.93 ± 0.16</td><td class="colsep0 rowsep0" align="center">117.7</td><td class="colsep0 rowsep0" align="char" char="±">84.9 ± 5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.37 ± 0.19</td><td class="colsep0 rowsep0" align="char" char=".">423.6</td><td class="colsep0 rowsep0" align="char" char="±">89.4 ± 13.3</td><td class="colsep0 rowsep0" align="char" char="±">–5.90 ± 0.08</td><td class="colsep0 rowsep0" align="center">1263</td><td class="colsep0 rowsep0" align="char" char="±">91.5 ± 5.1</td><td class="colsep0 rowsep0" align="char" char="±">–6.94 ± 0.12</td><td class="colsep0 rowsep0" align="center">113.8</td><td class="colsep0 rowsep0" align="char" char="±">84.7 ± 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">–7.70 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">20.1</td><td class="colsep0 rowsep0" align="char" char="±">91.6 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">–7.51 ± 0.03</td><td class="colsep0 rowsep0" align="center">31.0</td><td class="colsep0 rowsep0" align="char" char="±">95.6 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">–6.81 ± 0.16</td><td class="colsep0 rowsep0" align="center">156.7</td><td class="colsep0 rowsep0" align="char" char="±">84.9 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">–7.55 ± 0.42</td><td class="colsep0 rowsep0" align="char" char=".">28.4</td><td class="colsep0 rowsep0" align="char" char="±">80.4 ± 8.6</td><td class="colsep0 rowsep0" align="char" char="±">–5.79 ± 0.06</td><td class="colsep0 rowsep0" align="center">1631</td><td class="colsep0 rowsep0" align="char" char="±">84.2 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="±">–6.05 ± 0.09</td><td class="colsep0 rowsep0" align="center">898.3</td><td class="colsep0 rowsep0" align="char" char="±">75.7 ± 3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.60 ± 0.23</td><td class="colsep0 rowsep0" align="char" char=".">250.2</td><td class="colsep0 rowsep0" align="char" char="±">98.9 ± 13.2</td><td class="colsep0 rowsep0" align="char" char="±">–6.92 ± 0.08</td><td class="colsep0 rowsep0" align="center">120.3</td><td class="colsep0 rowsep0" align="char" char="±">96.8 ± 4.4</td><td class="colsep0 rowsep0" align="char" char="±">–7.31 ± 0.14</td><td class="colsep0 rowsep0" align="center">49.3</td><td class="colsep0 rowsep0" align="char" char="±">79.1 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.90 ± 0.11</td><td class="colsep0 rowsep0" align="char" char=".">126.9</td><td class="colsep0 rowsep0" align="char" char="±">89.2 ± 5.4</td><td class="colsep0 rowsep0" align="char" char="±">–6.62 ± 0.16</td><td class="colsep0 rowsep0" align="center">239.8</td><td class="colsep0 rowsep0" align="char" char="±">69.6 ± 6.0</td><td class="colsep0 rowsep0" align="char" char="±">–7.41 ± 0.07</td><td class="colsep0 rowsep0" align="center">38.8</td><td class="colsep0 rowsep0" align="char" char="±">81.2 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.39 ± 0.10</td><td class="colsep0 rowsep0" align="char" char=".">409.0</td><td class="colsep0 rowsep0" align="char" char="±">89.7 ± 5.6</td><td class="colsep0 rowsep0" align="char" char="±">–5.61 ± 0.34</td><td class="colsep0 rowsep0" align="center">2457</td><td class="colsep0 rowsep0" align="char" char="±">60.8 ± 13.9</td><td class="colsep0 rowsep0" align="char" char="±">–6.92 ± 0.05</td><td class="colsep0 rowsep0" align="center">119.9</td><td class="colsep0 rowsep0" align="char" char="±">78.4 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.23 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">583.3</td><td class="colsep0 rowsep0" align="char" char="±">86.3 ± 5.5</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">59.1 ± 5.0<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">–7.25 ± 0.12</td><td class="colsep0 rowsep0" align="center">56.9</td><td class="colsep0 rowsep0" align="char" char="±">86.4 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.61 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">248.6</td><td class="colsep0 rowsep0" align="char" char="±">85.6 ± 4.3</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">46.6 ± 6.6<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.09 ± 0.19</td><td class="colsep0 rowsep0" align="center">810.2</td><td class="colsep0 rowsep0" align="char" char="±">85.3 ± 9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">–7.41 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">38.6</td><td class="colsep0 rowsep0" align="char" char="±">81.6 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">–5.83 ± 0.21</td><td class="colsep0 rowsep0" align="center">1488</td><td class="colsep0 rowsep0" align="char" char="±">95.7 ± 13.7</td><td class="colsep0 rowsep0" align="char" char="±">–6.24 ± 0.09</td><td class="colsep0 rowsep0" align="center">574.7</td><td class="colsep0 rowsep0" align="char" char="±">85.4 ± 4.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The log EC<sub>50</sub> ± standard error is expressed as logarithmic values determined from the nonlinear regression analysis of data collected from at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Values were cited from our previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">The top of the agonist concentration response curve was not obtained even at the highest test concentration of the peptide; an EC<sub>50</sub> value cannot be determined.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">In these instances, the percentage of agonist response is provided for the response at 10 μM peptide.</p></div></div></div><div class="NLM_p"><i>N</i>-Methylation of the Tyr in position 1 (analogue <b>1</b>) results in considerably reduced potency at the δ-opioid receptor, indicating the Tyr<sup>1</sup> plays an important role in activating the δ-opioid receptor. Our results are consistent with the previous structure–activities studies of opioid peptides.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The previous studies reported that the alkylation of the N<sup>α</sup> of Tyr<sup>1</sup> of enkephalins resulted in a loss of potency at the δ-opioid receptor.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> However, the substitution of D.Ala, D.Ser, or D.Met at the position 2 of enkephalins could increase stability and potency in both the guinea pig ileum (GPI) and mouse vas deferens (MVD) assays.<a onclick="showRef(event, 'ref41 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref41 ref45 ref46">(41, 45, 46)</a> In this study, the substitution of position 2 with D.Ser or D.Met (analogues <b>2</b> and <b>3</b>) exhibited a very similar in vitro profile toward μ-opioid receptor. However, the κ-opioid activities were decreased approximately 2-fold, and the δ-opioid activities increased approximately 4-fold. In addition, our data showed that analogue <b>4</b> from the <i>N</i>-methylation of the Phe in position 4 exhibited increased the potency for both μ- and κ-opioid receptors. This result is consistent with the previous report that NMe.Phe<sup>4</sup>-dermophin significant improved μ and δ potency.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> DAMGO (Tyr-D.Ala-Gly-NMe.Phe-Gly-ol), which has an NMe.Phe at position 4, is one of most potent μ-opioid receptor agonists.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Moreover, modification at the Gln<sup>5</sup> position of <b>0</b> was performed in an effort to alter opioid receptor selectivity and balance the activities between opioid and NPFF receptors subtypes. Interestingly, the replacement of Gln in position 5 with Gly (analogue <b>5</b>) significantly increased μ-opioid potency. The substitution of position 5 with other amino acids (analogues <b>7</b>–<b>10</b>) in this study did not alter agonistic activities at the μ-opioid receptor; however, the substitution of position 5 with both <span class="smallcaps smallerCapital">l</span>- and <span class="smallcaps smallerCapital">d</span>-types of Leu or Met (analogues <b>6</b>–<b>10</b>) significantly enhanced δ-opioid activity. In addition, the replacement of Gln<sup>5</sup> with a <span class="smallcaps smallerCapital">d</span>-type amino acid (analogues <b>8</b>–<b>10</b>) led to reduced κ-opioid potencies.</div><div class="NLM_p">Furthermore, on the basis of the successful chemical modifications at the 4 and 5 positions to enhance μ-opioid potency in the in vitro functional assay, analogue <b>11</b> with substitutions at Phe<sup>4</sup> and Gln<sup>5</sup> residues improved its potency at the μ-opioid receptor but a slight loss of κ-opioid activity was observed.</div><div class="NLM_p">The data of the functional activities of the analogues at NPFF receptors are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. For the NPFF<sub>1</sub> receptor, only analogue <b>6</b> had a significantly improved activity, with approximately 11-fold potency compared with <b>0</b>. Analogue <b>2</b> had a slight decrease in NPFF<sub>1</sub> receptor potency, and analogues <b>8</b>–<b>10</b> exhibited a dramatic decrease in NPFF<sub>1</sub> receptor activation. Analogues <b>8</b>–<b>10</b> are <span class="smallcaps smallerCapital">d</span>-type amino acid substitutions at the 5 position, indicating the configuration of amino acid at position 5 may be critical for the NPFF<sub>1</sub> receptor potency of these analogues. For the NPFF<sub>2</sub> receptor, analogue <b>4</b> had an increase, whereas analogue <b>11</b> exhibited a significant decrease in agonistic properties. The remaining analogues have the similar activities for the NPFF<sub>2</sub> receptor compared with <b>0</b>. Our results indicate the contribution of the N-terminal amino acids of NPFF and related peptides to bind and activate NPFF receptors, which is consistent with previous studies.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional Activities of Multifunctional Peptide Analogues at NPFF Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">NPFFR<sub>1</sub></th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">NPFFR<sub>2</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">log EC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char="±">log EC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub>(nM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>0</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.23 ± 0.18<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">591.0<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">59.9 ± 9.3<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.73 ± 0.36</td><td class="colsep0 rowsep0" align="center">184.6</td><td class="colsep0 rowsep0" align="char" char="±">58.4 ± 15.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.03 ± 0.23</td><td class="colsep0 rowsep0" align="center">927.7</td><td class="colsep0 rowsep0" align="char" char="±">72.4 ± 13.8</td><td class="colsep0 rowsep0" align="char" char="±">–6.88 ± 0.28</td><td class="colsep0 rowsep0" align="center">132.2</td><td class="colsep0 rowsep0" align="char" char="±">49.5 ± 9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">–5.50 ± 0.42</td><td class="colsep0 rowsep0" align="center">3195</td><td class="colsep0 rowsep0" align="char" char="±">82.3 ± 17.3</td><td class="colsep0 rowsep0" align="char" char="±">–6.61 ± 0.25</td><td class="colsep0 rowsep0" align="center">254.0</td><td class="colsep0 rowsep0" align="char" char="±">63.0 ± 8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.18 ± 0.39</td><td class="colsep0 rowsep0" align="center">661.3</td><td class="colsep0 rowsep0" align="char" char="±">73.5 ± 17.9</td><td class="colsep0 rowsep0" align="char" char="±">–7.38 ± 0.47</td><td class="colsep0 rowsep0" align="center">41.3</td><td class="colsep0 rowsep0" align="char" char="±">57.9 ± 16.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.54 ± 0.31</td><td class="colsep0 rowsep0" align="center">289.1</td><td class="colsep0 rowsep0" align="char" char="±">67.7 ± 7.2</td><td class="colsep0 rowsep0" align="char" char="±">–6.57 ± 0.19</td><td class="colsep0 rowsep0" align="center">271.7</td><td class="colsep0 rowsep0" align="char" char="±">54.5 ± 6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.06 ± 0.38</td><td class="colsep0 rowsep0" align="center">880.7</td><td class="colsep0 rowsep0" align="char" char="±">66.8 ± 11.0</td><td class="colsep0 rowsep0" align="char" char="±">–6.73 ± 0.45</td><td class="colsep0 rowsep0" align="center">184.8</td><td class="colsep0 rowsep0" align="char" char="±">56.2 ± 16.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">–7.27 ± 0.36</td><td class="colsep0 rowsep0" align="center">54.4</td><td class="colsep0 rowsep0" align="char" char="±">68.4 ± 9.4</td><td class="colsep0 rowsep0" align="char" char="±">–6.59 ± 0.31</td><td class="colsep0 rowsep0" align="center">258.7</td><td class="colsep0 rowsep0" align="char" char="±">57.3 ± 10.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.52 ± 0.30</td><td class="colsep0 rowsep0" align="center">301.3</td><td class="colsep0 rowsep0" align="char" char="±">69.2 ± 10.3</td><td class="colsep0 rowsep0" align="char" char="±">–7.06 ± 0.38</td><td class="colsep0 rowsep0" align="center">87.0</td><td class="colsep0 rowsep0" align="char" char="±">58.4 ± 11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">26.6 ± 4.6<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.50 ± 0.32</td><td class="colsep0 rowsep0" align="center">318.2</td><td class="colsep0 rowsep0" align="char" char="±">70.18 ± 12.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">30.7 ± 4.6<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">–6.19 ± 0.24</td><td class="colsep0 rowsep0" align="center">651.4</td><td class="colsep0 rowsep0" align="char" char="±">37.2 ± 6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="center"><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">15.1 ± 8.4<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">–5.30 ± 0.34</td><td class="colsep0 rowsep0" align="center">5012</td><td class="colsep0 rowsep0" align="char" char="±">45.9 ± 18.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">–6.01 ± 0.30</td><td class="colsep0 rowsep0" align="center">973.4</td><td class="colsep0 rowsep0" align="char" char="±">69.8 ± 8.6</td><td class="colsep0 rowsep0" align="char" char="±">–6.51 ± 0.14</td><td class="colsep0 rowsep0" align="center">310.8</td><td class="colsep0 rowsep0" align="char" char="±">73.3 ± 7.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The log EC<sub>50</sub> ± standard error is expressed as logarithmic values determined from the nonlinear regression analysis of data collected from at least three independent experiments performed in duplicate.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Values were cited from our previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">The top of the agonist concentration response curve was not obtained even at the highest test concentration of the peptide; an EC<sub>50</sub> value cannot be determined.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">In these instances, the percentage of agonist response is provided for the response at 10 μM of peptide.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Antinociception and Tolerance Studies in the Tail-Flick Test</h4><div class="NLM_p">The antinociception and tolerance for the acute pain of these analogues were determined using the mouse tail-flick test. All analogues were evaluated for antinociception after icv administration. To evaluate antinociceptive tolerance, mice were icv injected 3 × ED<sub>50</sub> doses of the related analogues once daily for 6 days. The difference between the antinociceptive responses to analogues at the same dose on days 1 and 6 was compared to determine whether tolerance was developed. These data are summarized in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Antinociception and Tolerance Evaluation after the icv Administration of Multifunctional Peptide Analogues via Mouse Tail-Flick Test</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> nmol/mouse (95% CI)</th><th class="colsep0 rowsep0" align="center" char=".">relative potency to <b>0</b></th><th class="colsep0 rowsep0" align="center">6 days tolerance</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>0</b></td><td class="colsep0 rowsep0" align="left">0.5330 (0.5007, 0.5675)</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">1.2980 (1.2000, 1.4050)</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.6062 (0.5255, 0.6993)</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left">tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.0314 (0.0289, 0.0341)</td><td class="colsep0 rowsep0" align="char" char=".">16.97</td><td class="colsep0 rowsep0" align="left">tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.3862 (0.3590, 0.4154)</td><td class="colsep0 rowsep0" align="char" char=".">1.38</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.4172 (0.3798, 0.4583)</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0.1865 (0.1509, 0.2304)</td><td class="colsep0 rowsep0" align="char" char=".">2.86</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.2967 (0.2637, 0.3338)</td><td class="colsep0 rowsep0" align="char" char=".">1.80</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.3986 (0.3716, 0.4275)</td><td class="colsep0 rowsep0" align="char" char=".">1.34</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.4367 (0.3865, 0.4934)</td><td class="colsep0 rowsep0" align="char" char=".">1.22</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.3361 (0.2864, 0.3944)</td><td class="colsep0 rowsep0" align="char" char=".">1.59</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.0163 (0.0145, 0.0182)</td><td class="colsep0 rowsep0" align="char" char=".">32.78</td><td class="colsep0 rowsep0" align="left">no tolerance</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">ED<sub>50</sub> was determined at the time of peak effect.</p></div></div></div><div class="NLM_p">In the present study, <b>0</b> produced potent nontolerance forming antinociception with an ED<sub>50</sub> value of 0.533 nmol after icv administration, which is similar to our recent data that <b>0</b> produced nontolerance antinociception with an ED<sub>50</sub> value of 0.39 nmol.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> All of the new analogues produced potent dose- and time-dependent antinociception with ED<sub>50</sub> values ranging from 0.0163 to 1.298 nmol (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf" class="ext-link">Figure S1</a>). Among these analogues, analogues <b>3</b> and <b>11</b> exhibited significant improved antinociceptive potencies that were approximately 17- and 33-fold more potent compared with the parent peptide <b>0</b>, respectively. The high antinociceptive potency of <b>11</b> might result from its high potency at the μ-opioid receptor in vitro. However, it is difficult to explain the high antinociceptive potency of <b>3</b>. Compared with <b>0</b>, <b>3</b> displayed increased potency at δ-opioid and NPFF<sub>2</sub> receptors, but the functional interaction between NPFF and δ-opioid systems in pain modulation are completely unknown to date. It appears that the antinociceptive potency of the multifunctional peptides depends on their potencies and selectivities at opioid and NPFF receptors, the details of which need further elaboration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antinociceptive effect of <b>11</b> in the mouse tail-flick test after central administration. (A) Antinociceptive dose– and time–response curve for <b>11</b> after icv administration. (B) AUC date calculated from 0 to 60 min in the dose– and time–response curves. (C) Antinociceptive tolerance evaluation of <b>11</b> after 6 days of repeated icv administration. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared with the saline group according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In cAMP assays, both analogues <b>2</b> and <b>3</b> activate both opioid and NPFF receptors. To our surprise, only analogues <b>2</b> and <b>3</b> developed antinociceptive tolerance after 6 days of repeated icv injections (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf" class="ext-link">Figure S2</a>). It is difficult to explain these exceptional cases. However, their functional selectivity at the μ-opioid receptor might result in the different pharmacological effects on antinociceptive tolerance. Previous studies have suggested that β-arrestin pathway signaling downstream of the μ-opioid receptor may contribute to the desensitization of the μ-opioid receptor and the development of opioid antinociceptive tolerance.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> In the future, the functional selectivities of these multifunctional peptides should be further investigated. Overall, these results indicate that it is reasonable to design multifunctional peptide ligands for opioid and NPFF receptors in a single molecule, producing effective nontolerance forming antinociception.</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Antinociceptive Profiles of <b>11</b> in the Tail-Flick Test</h4><div class="NLM_p">The dose- and time-related antinociceptive effects and tolerance evaluation of <b>11</b> are presented in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. <b>11</b> exhibited a strong and sustained antinociceptive effect for longer than 60 min that peaked at 20 min (<i>F</i><sub>3, 31</sub> = 531.7, <i>P</i> < 0.001). The antinociception of <b>11</b> in the tail-flick test was approximately 33-fold more potent compared with <b>0</b> with calculated ED<sub>50</sub> values of 0.0163 nmol for <b>11</b> and 0.533 nmol for <b>0</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). According to our previous data, the ED<sub>50</sub> value for morphine was 1.02 nmol after icv administration in the tail-flick test,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> indicating <b>11</b> has approximately 62-fold more potent antinociception compared with morphine in the tail-flick test. Combined with the cAMP assay data described above, the enhanced μ-opioid agonistic activity might contribute to the potent antinociception of <b>11</b>. In addition, another potential explanation for the enhanced antinociception might due to its high stability in resisting the enzymatic hydrolysis. Our data in the metabolic stability test revealed that <b>11</b> displayed a half-life of 86.29 ± 4.00 min in the brain membrane homogenate, which is approximately 2-fold longer compared with <b>0</b> based on our previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Furthermore, <b>11</b> exhibited similar potency of antinociception on days 1 and 6 after 6 days of repeated treatments (<i>P</i> > 0.05) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). Taken together, our results clearly indicate that <b>11</b> produces the most potent analgesic effect among these new analogues and has no antinociceptive tolerance after repeated administration in acute pain model.</div><div class="NLM_p">Furthermore, to investigate the roles of opioid and NPFF receptors in the central antinociception of <b>11</b>, the antagonists of opioid and NPFF receptors were used in the present study. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A, pretreatment with the nonselective opioid receptor antagonist naloxone (5 nmol, icv) 10 min prior to <b>11</b> completely inhibited its supraspinal antinociception, suggesting the involvement of opioid receptors in the central antinociception of <b>11</b> (<i>F</i><sub>3,28</sub> = 270.3, <i>P</i> < 0.001). To further identify the role of individual opioid receptor subtypes in this process, β-funaltrexamine (β-FNA), nor-binaltorphimine (nor-BNI), or naltrindole (NTI), the selective antagonists for μ-, κ-, and δ- receptors, respectively, were icv injected 4 h, 30 min, or 20 min, respectively, prior to treatment with <b>11</b>. Our data showed that the central antinociception of <b>11</b> was completely inhibited by pretreatment with the μ- and κ-opioid receptor antagonists β-FNA (10 nmol) and nor-BNI (10 nmol) (<i>F</i><sub>7,59</sub> = 194.1, <i>P</i> < 0.001; <i>P</i> < 0.001) but not by the δ-opioid receptor antagonist NTI (10 nmol, <i>P</i> > 0.05). These data strongly suggest that <b>11</b> produces supraspinal antinociception via μ- and κ-opioid receptors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of the involvement of opioid and NPFF receptors in the central antinociception of <b>11</b> in the mouse tail-flick test. (A) Effect of pretreatment with naloxone (5 nmol, icv) on the central antinociception of <b>11</b>. (B) Effect of icv administration of the selective opioid receptors antagonist β-FNA (10 nmol), nor-BNI (10 nmol), or naltrindole (10 nmol) on the central antinociception of <b>11</b>. (C) Effect of pretreatment with RF9 (10 nmol, icv) on the central antinociception of <b>11</b>. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared to the saline group, ###<i>P</i> < 0.001 indicates significant differences compared with the Saline + <b>11</b> group, according to one-way ANOVA, followed by Bonferroni’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, the possible role of the NPFF system in the antinociception of <b>11</b> was also investigated. Our results illustrated that the antinociception of <b>11</b> was significantly augmented by pretreatment with the nonselective NPFF receptors antagonist RF9 (10 nmol, icv) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C; <i>F</i><sub>3,30</sub> = 100.5, <i>P</i> < 0.001), which is similar to the property of its parent peptide <b>0</b>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Previous studies have indicated that NPFF caused antiopioid activities at the supraspinal level.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Given that <b>11</b> could activate both NPFF and opioid receptors, its NPFF moiety might exert antiopioid activities and partially reduce its opioid moiety-mediated antinociception after supraspinal administration. In the present study, pretreatment with RF9 prevented the antiopioid activities of the NPFF moiety and endogenous NPFF systems and might further potentiate the μ-opioid antinociception of <b>11</b> after icv administration. This result was consistent with above deduction and supports an antiopioid character of the NPFF system in the brain.</div><div class="NLM_p">The antinociceptive effects of <b>11</b> were further investigated after ip administration in the tail-flick test. Our results demonstrated that <b>11</b> produced dose-dependent antinociceptive effects after ip administration (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>; <i>F</i><sub>3,30</sub> = 34.328, <i>P</i> < 0.001). The ED<sub>50</sub> value was 26.57 (20.63, 34.24) mg/kg. The previous reports have demonstrated that the activation of peripheral opioid receptor could produce analgesic effects.<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53-55)</a> Thus, the antinociceptive effect of systemic administration of <b>11</b> might occur through the activation of peripheral opioid receptors. Another potential explanation is that <b>11</b> might cross the BBB after systemic administration and produce antinociception via central opioid receptors. The antinociceptive ED<sub>50</sub> value of systemic <b>11</b> injection was considerably reduced compared with central administration (approximately 38000-fold), which suggested that an improved ability of <b>11</b> to cross the BBB could significantly decrease the effective doses required for systemic administration. Thus, to create analogues of <b>11</b> with high metabolic stability and high BBB penetrability is one of our directions for future research.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antinociceptive effect of <b>11</b> in the mouse tail-flick test after systemic administration. (A) Antinociceptive dose– and time–response curve for <b>11</b> after ip administration. (B) AUC date calculated from 0 to 60 min based on the dose– and time–response curves. Each value represents the mean ± SEM. Group size is indicated in the figures. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 indicate significant differences compared with the saline group according to one-way ANOVA, followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Antinociceptive Activities of <b>11</b> in the Formalin Test</h4><div class="NLM_p">We then performed the formalin test for further investigation of the antinociceptive effects of <b>11</b>. The intraplantar injection of formalin results in a biphasic pain response. Phase I (0–5 min) is thought to be induced by the direct activation of nociceptors, whereas the subsequent phase II (15–30 min) is proposed to reflect the combined effects of nociceptor input and spinal cord sensitization.<a onclick="showRef(event, 'ref40 ref56'); return false;" href="javascript:void(0);" class="ref ref40 ref56">(40, 56)</a> As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, <b>11</b> dose-dependently inhibited both the phase I and phase II flinching behaviors induced by formalin administration (<i>F</i><sub>4,40</sub> = 36.0, <i>P</i> < 0.001; <i>F</i><sub>3,32</sub> = 35.7, <i>P</i> < 0.001, respectively). The reference ED<sub>50</sub> values of <b>11</b> were 18.80 (15.97, 22.12) and 103.4 (96.02, 111.30) pmol for phase I and phase II, respectively. Compared with the ED<sub>50</sub> values of <b>0</b> at 120 and 1140 pmol in the same model,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> our current data indicate that <b>11</b> has 6.4- and 11-fold increased potent analgesia compared to <b>0</b> in the formalin test.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antinociceptive effects of the icv injection of <b>11</b> in the mouse formalin test. Each value represents the mean ± SEM. Group size is indicated in the figure. *** <i>P</i> < 0.001 versus saline according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Antinociceptive Activities and Tolerance Evaluation of <b>11</b> in the Chronic Inflammatory Pain Test</h4><div class="NLM_p">The antinociceptive effect of <b>11</b> on chronic inflammatory pain was also evaluated in this study. CFA-induced hyperalgesia is a well-characterized model to study chronic inflammatory pain. Mice received a single intraplantar injection of CFA into the hind paw, and robust tactile hyperalgesia was induced over several days. In our present study, CFA injection into the hindpaw of mice dramatically reduced the mechanical thresholds on day 3. The icv injection of 3 nmol morphine markedly reduced the CFA-induced tactile hyperalgesia (<i>P</i> < 0.001). After icv injection, <b>11</b> dose-dependently reduced the CFA-induced mechanical allodynia with an ED<sub>50</sub> value of 3.92 (1.85, 8.29) pmol (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A, <i>F</i><sub>4,47</sub> = 16.1, <i>P</i> < 0.001). In addition, 30 pmol of <b>11</b> produced an antinociceptive effect equivalent to that of 3 nmol of morphine, demonstrating that <b>11</b> exhibits an approximately 100-fold more potent analgesic effect compared with morphine in the CFA-induced chronic inflammatory pain model.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antinociceptive effect of the icv injection of <b>11</b> on CFA-induced chronic inflammatory pain. (A) Antinociceptive dose– and time–response curves for <b>11</b> in the CFA-induced chronic inflammatory pain. (B) Antinociceptive tolerance evaluation of <b>11</b> and morphine after 6 days of repeated icv administration in CFA-induced chronic inflammatory pain. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared with the saline group according to one-way ANOVA followed by Bonferroni’s post-hoc test; ###<i>P</i> < 0.001 indicates significant differences compared with day 1 according to one-way ANOVA followed by Tukey’s HSD post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our aforementioned results suggest no tolerance to <b>11</b> antinociception developed in the mouse tail-flick test. However, in the clinic, antinociceptive tolerance most frequently develops during chronic pain management. To determine the tolerance potential, we therefore tested the effect of <b>11</b> on the CFA-induced chronic inflammatory pain following repeated administrations. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, a once daily icv injection of 3 nmol morphine for 6 consecutive days resulted in the development of progressive antinociceptive tolerance in CFA-induced mechanical allodynia (<i>F</i><sub>6,69</sub> = 13.0; <i>P</i> < 0.05, <i>P</i> < 0.001, <i>P</i> < 0.001 for 4, 5, and 6 days of repeated injection, respectively), with an approximately 75% analgesic effect loss on day 6 compared with day 1. The icv administration of 30 pmol of <b>11</b> exerted an equivalent analgesic effect to 3 nmol of morphine on day 1 after injection. However, the effect of <b>11</b> remained throughout the whole observation time from day 1 to day 6. No significant changes of mechanical allodynia caused by CFA were detected in control mice receiving repeated icv injections of normal saline. Taken together, <b>11</b> produces robust nontolerance forming antinociception in the CFA-induced chronic inflammatory pain model, suggesting that <b>11</b> might be a valuable therapeutic analgesic that lacks adverse effects in chronic inflammatory pain management.</div></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Motor Impairment Evaluation of <b>11</b> in the Rota-Rod Test</h4><div class="NLM_p">To eliminate the influence of locomotor function and coordination in the pain test, the potential effect of <b>11</b> on locomotor function and coordination was evaluated with the rota-rod test after both central and systemic administration. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B, compared with saline, both icv and ip administration of <b>11</b> at the highest doses used in the pain studies produced no significant changes in rota-rod performance. In our previous study, high doses of <b>0</b> produced significant inhibition on rota-rod performance at 10 min after icv administration. The present results suggest that <b>11</b> exhibits weaker side effects on motor impairment compared with <b>0</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of the icv (A) and ip (B) administrations of <b>11</b> on the motor performance of mice in the rota-rod test. Each value represents the mean ± SEM. Group size is indicated in the figure. No significant differences were observed according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Peptide <b>0</b>, a novel multifunctional agonist at opioid and NPFF receptors with potent, nontolerance forming antinociception, was characterized in our recent study.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We further developed and tested a series of new <b>0</b> analogues in an effort to balance the opioid and NPFF receptors activation and optimize its activities for pain modulation. In in vitro cAMP functional assays, these new analogues behaved as multifunctional agonists of opioid and NPFF receptors. In the mouse tail-flick test, all of these analogues produced potent dose- and time-dependent antinociception, and most of them had no antinociceptive tolerance. More importantly, among analogues, <b>11</b> exhibited the most potent antinociceptive effect (ED<sub>50</sub> = 16.3 pmol), which is a 33-fold increase compared with <b>0</b>. Furthermore, <b>11</b> also produced significant antinociception in the mouse tail-flick test after ip administration. Thus, analogue <b>11</b> was selected, and its antinociceptive effect was further evaluated in both acute and chronic pain models. In the formalin test, <b>11</b> produced a dramatic antinociceptive effect on formalin-induced pain in phase I and phase II, with ED<sub>50</sub> values of 18.80 and 103.4 pmol, respectively. Additionally, <b>11</b> produced a robust antiallodynic effect in CFA-induced chronic inflammatory pain with an ED<sub>50</sub> value of 3.92 pmol. Notably, <b>11</b> also did not produce antinociceptive tolerance after repeated administration in the chronic inflammatory pain model. Taken together, analogue <b>11</b>, a multifunctional agonist of opioid and NPFF receptors, exhibits robust nontolerance forming analgesia in both acute and chronic pain models. Further pharmacological and pharmacokinetic investigations of <b>11</b> are ongoing in our lab.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Materials</h3><div class="NLM_p last">[<sup>3</sup>H] cAMP (50 Ci/mmol) was purchased from PerkinElmer, Boston, MA. Naloxone, β-FNA, nor-BNI, NTI, protein kinase A (PKA), forskolin, and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma-Aldrich (St Louis, MO, USA). All amino acids and coupling reagents were purchased from GL Biochem Ltd. (Shanghai, China). Rink amide MBHA resins were purchased from Nankai Hecheng Science & Technology Co., Ltd. (Tianjin, China). Sephadex G-25 was purchased from Amersham, Pharmacia Biotech (China) Ltd. (Shanghai, China). The organic solvents were purchased from J&K Scientific Ltd. (Beijing, China). Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum, G418, penicillin, and streptomycin were purchased from Invitrogen (Carlsbad, CA).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis and Characterization of Peptides</h3><div class="NLM_p">The peptides were synthesized by manual solid-phase synthesis using standard <i>N</i>-fluorenylmethoxycarbonyl (Fmoc) chemistry based on a previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Briefly, the appropriate amino acid Fmoc-AA-OH (2.5 equiv) was coupled to Rink amide MBHA resin (0.43 mmol/g) in dimethylformamide (DMF) using HBTU (2.5 equiv) and HOBt (2.5 equiv) in the presence of DIEA (5 equiv). The resin was washed with DMF. The Fmoc protecting group was removed by treatment with 1% piperidine and 1% 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in DMF and washed with DMF; then, the next amino acid was coupled using the same procedure. After completion of the coupling cycle, the resin was also washed with several portions of DMF, CH<sub>2</sub>Cl<sub>2</sub>, and MeOH before it was dried in a vacuum for at least 3 h. The final peptide was cleaved from the resin by treatment with a solution of TFA:triethylsilane:H<sub>2</sub>O = 95:2.5:2.5 for 2 h at room temperature. The resin was filtered off and washed with TFA. The filtrate was collected in a flask and evaporated using the vacuum-rotary evaporator at 37 °C. Cold diethyl ether was used to precipitate the product, which was extracted by 10% acetic acid in water and lyophilized. Fractions containing the purified peptides were pooled and lyophilized.</div><div class="NLM_p last">The established peptides were desalted by gel filtration and then purified using semipreparative reversed-phase high-pressure liquid chromatography (RP-HPLC). The purified peptides were characterized by high-resolution mass spectroscopy, melting points, and analytical RP-HPLC. Mass spectra were determined with an electrospray ionization mass spectrometer (ESI-Q-TOFmaXis-4G, Bruker Daltonics). Melting points were measured on a Micro melting point apparatus (AII-E, China). The purities of the peptides were verified by analytical RP-HPLC, with a Waters Delta 600 instrument equipped with an XBridge TM BEH 130 Prep C<sub>18</sub> (4.6 mm × 250 mm, 5 μm). Absorbance was monitored at λ = 220 nm. The solvents for analytical RP-HPLC were as follows: A, 0.1% trifluoroacetic acid (TFA) in acetonitrile; B, 0.1% TFA in water. The column was eluted at a flow rate of 1 mL/min with a linear gradient of A/B = 10:90 to A/B = 80:10 for 30 min or a gradient of A/B = 10:90 to A/B = 100:0 for 30 min. The retention time was reported as <i>t</i><sub>R</sub> (min). The final purities of the peptides were greater than 95%. The detailed analytical properties of these analogues are provided in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Animals</h3><div class="NLM_p last">Male adult Kunming mice, which were provided by the Experimental Animal Center of Lanzhou University, were used in the present study. Animals were housed in an animal room that was maintained at 22 ± 2 °C with a 12 h light/12 h dark cycle and were given free access to food and water. All animals were used only once in the present study. The animal experimentation protocols were approved by the Ethics Committee of Lanzhou University and performed in accordance with the European Community guidelines for the use of experimental animals (2010/63/EU).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Measurements of cAMP Accumulation</h3><div class="NLM_p last">In vitro cAMP assays were performed as described in our previous reports.<a onclick="showRef(event, 'ref40 ref57'); return false;" href="javascript:void(0);" class="ref ref40 ref57">(40, 57)</a> HEK-293A cells, which stably express the μ-, κ-, or δ-opioid receptors or NPFF<sub>1</sub> or NPFF<sub>2</sub> receptors, were cultured in DMEM with 10% fetal bovine serum, 400 mg/mL G418, 100 IU/mL penicillin, and 100 mg/mL streptomycin (Invitrogen). Cells were maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. Before the cAMP assay, HEK-293A cells were seeded in 24-well microtiter plates and cultured for 24 h. Then, cells were incubated at 37 °C in serum-free medium containing 1 mM IBMX, vehicle, or various concentrations of drugs and 5 μM forskolin for 30 min. After incubation, cells were lysed, and cyclic adenosine monophosphate (cAMP) levels were assessed by a competition PKA binding assay. The concentrations of cAMP in lysates were calculated using the standard curve that was constructed using cAMP standard.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Tail-Flick Test and Tolerance Development</h3><div class="NLM_p">The radiant heat tail-flick test was used to assess the acute antinociceptive effects. Various doses of drugs were injected icv according to our previous report.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Briefly, a stainless steel guide cannula was implanted at 3.0 mm posterior, 1.0 mm lateral to the bregma and 3.0 mm ventrally from the surface of skull at least 4 days before use. As described in our previous studies,<a onclick="showRef(event, 'ref40 ref58'); return false;" href="javascript:void(0);" class="ref ref40 ref58">(40, 58)</a> mice were gently restrained by hand, and the tail was placed on the radiant heat source at 3 cm from the distal end. The tail-flick latency was the time required for the mouse flick its tail off the heat source. Here, 10 s was used as the cutoff time to avoid tissue damage. Tail-flick latency was determined both before and after drug injection. Data are expressed as the maximum possible effect (MPE) calculated as MPE (%) = 100 × [(postdrug response – baseline response)/(cutoff response – baseline response)]. The raw data from each animal were converted to area under the curve (AUC).</div><div class="NLM_p last">Mice received repeated icv injections of drugs for 6 days to evaluate the development of antinociceptive tolerance. The antinociceptive effects were tested on the first and sixth days using the methods described above. The differences of MPE (%) values at maximum antinociception on day 1 and day 6 were used to assess the degree of tolerance.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Metabolic Stability</h3><div class="NLM_p last">The metabolic stability analysis was performed using mouse brain homogenate as described in our previous reports.<a onclick="showRef(event, 'ref40 ref59'); return false;" href="javascript:void(0);" class="ref ref40 ref59">(40, 59)</a> Briefly, 10 of μL peptide stock solution (10 μM) was added to 190 μL of mouse brain homogenate and then incubated at 37 °C. Then, 20 μL of the mixture was withdrawn at 0, 5, 10, 15, 30, 60, 120, and 240 min and immediately followed by the addition of 90 μL of acetonitrile. After maintaining on ice for 5 min, 90 μL of 0.5% acetic acid was added to prevent further enzymatic breakdown. The aliquots were centrifuged at 13000<i>g</i> for 15 min, and the supernatants were collected for HPLC analysis. Linear regression was used to calculate the metabolic half-life of <b>11</b> incubated in the brain homogenates.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Formalin-Induced Nociceptive Behavioral Test</h3><div class="NLM_p last">The formalin test was conducted following our previous protocol.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The animals were acclimatized in a transparent acrylic observation chamber with a mirror positioned below the floor for a period of 15 min. Mice were icv administered saline or <b>11</b> 5 min later followed by an intraplantar injection of 20 μL of 5% formalin. After injection, mice were immediately placed back in the observation chamber, and the time spent licking, shaking, and biting the injected paw at 0–5 min and 15–30 min was measured with a stopwatch. The times observed were converted to % MPE as follows: % MPE = 100 × [(control time – postdrug time)/control time].</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> CFA-Induced Chronic Inflammatory Pain Model</h3><div class="NLM_p last">The CFA model was used to evaluate the antinociception and tolerance of <b>11</b> in chronic inflammatory pain. On the first day of the experiment, the basal threshold for mechanical stimulation was measured 5 times at 5 min intervals with an electric von Frey (IITC Life Science). Then, 20 μL of CFA was given via intraplantar injection into the right hind paw. Three days after CFA injection, mechanical allodynia was tested using the method described. Then, mice received an icv injection of saline, morphine, or <b>11</b>, and the mechanical response was measured at 15, 30, 45, 60, 75, and 90 min. Each time point was measured 3 times at 2 min intervals. To investigate the antinociceptive tolerance of morphine and <b>11</b> in chronic inflammatory pain, mice were icv injected with morphine or <b>11</b> once daily for 6 consecutive days after 3 days of the intraplantar injection of CFA. The mechanical response was measured at maximum antinociception time (15 min after drug injection) on each test day.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Rota-Rod Test</h3><div class="NLM_p last">Motor impairment was measured on a rota-rod apparatus as described in our previous report.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Briefly, mice were trained to stay on the rod (16 rpm) for 2 days in three consecutive sessions prior to drug administration. The cut off time was 300 s, and the animals that did not remain on the rod for the 180 s were eliminated from experiments. On the third day, the animals received icv or ip saline or <b>11</b> injections, and the tests were performed at 10, 20, and 30 min after administration. The latency to fall off the rod was recorded at each time point.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Data Analysis</h3><div class="NLM_p last">All data were provided as the means ± SEM. The EC<sub>50</sub> values for cAMP assays and the ED<sub>50</sub> values for the antinociception were calculated using Graphpad Prism 5. The data obtained from the dose–response curve or antagonism assays were analyzed with one-way ANOVA followed by Dunnett’s or Bonferroni’s post-hoc test, respectively. The data obtained from tolerance development assays were analyzed with one-way ANOVA followed by Tukey’s HSD test. <i>P</i>-Values less than 0.05 were considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01181">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01181" class="ext-link">10.1021/acs.jmedchem.6b01181</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Details of the antinociceptive dose– and time–response curve and tolerance evaluation for the icv administration of the new analogues of <b>0</b> in the mouse tail-flick test; antinociceptive tolerance evalution of morphine and <b>0</b> analogues after 6 days of repeated icv administration in the mouse tail-flick test (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf">jm6b01181_si_001.pdf (142.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01181" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Quan Fang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea8c8b848d9baa86909fc48f8e9fc48984"><span class="__cf_email__" data-cfemail="f79196999086b79b8d82d9929382d99499">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rui Wang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e295838c8590978ba28e9897cc878697cc818c"><span class="__cf_email__" data-cfemail="86f1e7e8e1f4f3efc6eafcf3a8e3e2f3a8e5e8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zi-Long Wang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-Xin Pan</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing-Jing Song</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong-Hai Tang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong-Ping Yu</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xu-Hui Li</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Li</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting Zhang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Run Zhang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meng-Na Zhang</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Biao Xu</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory of Preclinical
Study for New Drugs of Gansu Province, and Institute of Physiology,
School of Basic Medical Sciences, Lanzhou
University, 199 Donggang
West Road, Lanzhou, 730000, PR China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.L. Wang, J. X. Pan, H .H.Tang, H. P. Yu, X. H. Li, T. Zhang, R. Zhang, M. N. Zhang, B. Xu, and N. Li performed the research. Q. Fang and R. Wang designed the research study. J. J. Song contributed essential reagents or tools. Z. L. Wang, J. X. Pan, and Q. Fang analyzed the data. Z. L. Wang and Q. Fang wrote the paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d211e3000-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by grants from the National Natural Science Foundation of China (nos. 81273355, 81473095), the Program for New Century Excellent Talents in University (NCET-13-0257), the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R27), and the Fundamental Research Funds for the Central Universities (lzujbky-2016-58).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations Used</h2><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">β-FNA</td><td class="NLM_def"><p class="first last">beta-funaltrexamine</p></td></tr><tr><td class="NLM_term">BN-9</td><td class="NLM_def"><p class="first last">Tyr-D.Ala-Gly-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CB<sub>1</sub></td><td class="NLM_def"><p class="first last">cannabinoid receptor 1</p></td></tr><tr><td class="NLM_term">CCK-2</td><td class="NLM_def"><p class="first last">cholecystokinin type 2 receptor</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DN-9</td><td class="NLM_def"><p class="first last">Tyr-D.Ala-Gly-NMe.Phe-Gly-Pro-Gln-Arg-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">EN-9</td><td class="NLM_def"><p class="first last">Tyr-Pro-Phe-Phe-Gln-Pro-Gln-Arg-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">effective concentration 50% of maximum response</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">effective dose 50% of maximum response</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">9-fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">IBMX</td><td class="NLM_def"><p class="first last">3-isobutyl-1-methylxanthine</p></td></tr><tr><td class="NLM_term">icv</td><td class="NLM_def"><p class="first last">intracerebroventricularly</p></td></tr><tr><td class="NLM_term">GPI</td><td class="NLM_def"><p class="first last">guinea pig ileum</p></td></tr><tr><td class="NLM_term">MBHA</td><td class="NLM_def"><p class="first last">4-methybenzhydrylamine</p></td></tr><tr><td class="NLM_term">MD-TOF MS</td><td class="NLM_def"><p class="first last">magnetic deflection time-of-flight mass spectrometry</p></td></tr><tr><td class="NLM_term">mGluR5</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor 5</p></td></tr><tr><td class="NLM_term">mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">%MPE</td><td class="NLM_def"><p class="first last">the percent maximum possible effect</p></td></tr><tr><td class="NLM_term">MVD</td><td class="NLM_def"><p class="first last">mouse vas deferens</p></td></tr><tr><td class="NLM_term">nor-BNI</td><td class="NLM_def"><p class="first last">nor-binaltorphimine</p></td></tr><tr><td class="NLM_term">NK1</td><td class="NLM_def"><p class="first last">neurokinin-1 receptor</p></td></tr><tr><td class="NLM_term">NPFF</td><td class="NLM_def"><p class="first last">Phe-Leu-Phe-Glu-Pro-Gln-Arg-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">NTI</td><td class="NLM_def"><p class="first last">naltrindole</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">RF9</td><td class="NLM_def"><p class="first last">1- adamantanecarbonyl-Arg-Phe-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed-phase high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Breivik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventafridda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallacher, D.</span><span> </span><span class="NLM_article-title">Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment</span> <span class="citation_source-journal">Eur. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.ejpain.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.ejpain.2005.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16095934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BD287ntVWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=287-333&author=H.+Breivikauthor=B.+Collettauthor=V.+Ventafriddaauthor=R.+Cohenauthor=D.+Gallacher&title=Survey+of+chronic+pain+in+Europe%3A+prevalence%2C+impact+on+daily+life%2C+and+treatment&doi=10.1016%2Fj.ejpain.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment</span></div><div class="casAuthors">Breivik Harald; Collett Beverly; Ventafridda Vittorio; Cohen Rob; Gallacher Derek</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pain (London, England)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-333</span>
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    </div><div class="casAbstract">UNLABELLED:  This large scale computer-assisted telephone survey was undertaken to explore the prevalence, severity, treatment and impact of chronic pain in 15 European countries and Israel.  Screening interviews identified respondents aged 18 years with chronic pain for in-depth interviews. 19% of 46,394 respondents willing to participate (refusal rate 46%) had suffered pain for 6 months, had experienced pain in the last month and several times during the last week.  Their pain intensity was 5 on a 10-point Numeric Rating Scale (NRS) (1 = no pain, 10 = worst pain imaginable) during last episode of pain.  In-depth interviews with 4839 respondents with chronic pain (about 300 per country) showed: 66% had moderate pain (NRS = 5-7), 34% had severe pain (NRS = 8-10), 46% had constant pain, 54% had intermittent pain. 59% had suffered with pain for two to 15 years, 21% had been diagnosed with depression because of their pain, 61% were less able or unable to work outside the home, 19% had lost their job and 13% had changed jobs because of their pain. 60% visited their doctor about their pain 2-9 times in the last six months.  Only 2% were currently treated by a pain management specialist.  One-third of the chronic pain sufferers were currently not being treated.  Two-thirds used non-medication treatments, e.g,. massage (30%), physical therapy (21%), acupuncture (13%).  Almost half were taking non-prescription analgesics; 'over the counter' (OTC) NSAIDs (55%), paracetamol (43%), weak opioids (13%).  Two-thirds were taking prescription medicines: NSAIDs (44%), weak opioids (23%), paracetamol (18%), COX-2 inhibitors (1-36%), and strong opioids (5%).  Forty percent had inadequate management of their pain.  Interesting differences between countries were observed, possibly reflecting differences in cultural background and local traditions in managing chronic pain.  CONCLUSIONS:  Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives.  Very few were managed by pain specialists and nearly half received inadequate pain management.  Although differences were observed between the 16 countries, we have documented that chronic pain is a major health care problem in Europe that needs to be taken more seriously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpPXuM7ASCakGy1nwu7K2mfW6udTcc2ebP7MhR4kGkNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ntVWitQ%253D%253D&md5=bf092661c57858a462857ac057d03c48</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBreivik%26aufirst%3DH.%26aulast%3DCollett%26aufirst%3DB.%26aulast%3DVentafridda%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DGallacher%26aufirst%3DD.%26atitle%3DSurvey%2520of%2520chronic%2520pain%2520in%2520Europe%253A%2520prevalence%252C%2520impact%2520on%2520daily%2520life%252C%2520and%2520treatment%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2006%26volume%3D10%26spage%3D287%26epage%3D333%26doi%3D10.1016%2Fj.ejpain.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">McCarberg, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R.</span><span> </span><span class="NLM_article-title">Consequences of neuropathic pain: quality-of-life issues and associated costs</span> <span class="citation_source-journal">Am. J. Manage. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">S263</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=S263-268&author=B.+H.+McCarbergauthor=R.+Billington&title=Consequences+of+neuropathic+pain%3A+quality-of-life+issues+and+associated+costs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarberg%26aufirst%3DB.%2BH.%26aulast%3DBillington%26aufirst%3DR.%26atitle%3DConsequences%2520of%2520neuropathic%2520pain%253A%2520quality-of-life%2520issues%2520and%2520associated%2520costs%26jtitle%3DAm.%2520J.%2520Manage.%2520Care%26date%3D2006%26volume%3D12%26spage%3DS263%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Inturrisi, C. E.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of opioids for pain</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1097/00002508-200207001-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1097%2F00002508-200207001-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=12479250" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=S3-13&author=C.+E.+Inturrisi&title=Clinical+pharmacology+of+opioids+for+pain&doi=10.1097%2F00002508-200207001-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00002508-200207001-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200207001-00002%26sid%3Dliteratum%253Aachs%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26atitle%3DClinical%2520pharmacology%2520of%2520opioids%2520for%2520pain%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2002%26volume%3D18%26spage%3DS3%26epage%3D13%26doi%3D10.1097%2F00002508-200207001-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zollner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, C.</span><span> </span><span class="NLM_article-title">Opioids</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=31-63&author=C.+Zollnerauthor=C.+Stein&title=Opioids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZollner%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DC.%26atitle%3DOpioids%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2007%26spage%3D31%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ji, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. J.</span><span> </span><span class="NLM_article-title">Emerging targets in neuroinflammation-driven chronic pain</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/nrd4334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2Fnrd4334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=533-548&author=R.+R.+Jiauthor=Z.+Z.+Xuauthor=Y.+J.+Gao&title=Emerging+targets+in+neuroinflammation-driven+chronic+pain&doi=10.1038%2Fnrd4334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4334%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26aulast%3DXu%26aufirst%3DZ.%2BZ.%26aulast%3DGao%26aufirst%3DY.%2BJ.%26atitle%3DEmerging%2520targets%2520in%2520neuroinflammation-driven%2520chronic%2520pain%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D533%26epage%3D548%26doi%3D10.1038%2Fnrd4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basbaum, A. I.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of nociception</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1038/35093019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2F35093019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11557989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVyjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2001&pages=203-210&author=D.+Juliusauthor=A.+I.+Basbaum&title=Molecular+mechanisms+of+nociception&doi=10.1038%2F35093019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of nociception</span></div><div class="casAuthors">Julius, David; Basbaum, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue">6852</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with refs.  The sensation of pain alerts us to real or impending injury and triggers appropriate protective responses.  Unfortunately, pain often outlives its usefulness as a warning system and instead becomes chronic and debilitating.  This transition to a chronic phase involves changes within the spinal cord and brain, but there is also remarkable modulation where pain messages are initiated - at the level of the primary sensory neuron.  Efforts to det. how these neurons detect pain-producing stimuli of a thermal, mech. or chem. nature have revealed new signaling mechanisms and brought us closer to understanding the mol. events that facilitate transitions from acute to persistent pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UN0IIQBxV7Vg90H21EOLACvtfcHk0liYYJMYDBBoBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVyjsr0%253D&md5=fae43aea6b2fb0691d651811972393cd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F35093019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35093019%26sid%3Dliteratum%253Aachs%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DMolecular%2520mechanisms%2520of%2520nociception%26jtitle%3DNature%26date%3D2001%26volume%3D413%26spage%3D203%26epage%3D210%26doi%3D10.1038%2F35093019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Basbaum, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of pain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1016/j.cell.2009.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.cell.2009.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19837031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWht7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=267-284&author=A.+I.+Basbaumauthor=D.+M.+Bautistaauthor=G.+Scherrerauthor=D.+Julius&title=Cellular+and+molecular+mechanisms+of+pain&doi=10.1016%2Fj.cell.2009.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of pain</span></div><div class="casAuthors">Basbaum, Allan I.; Bautista, Diana M.; Scherrer, Gregory; Julius, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-284</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The nervous system detects and interprets a wide range of thermal and mech. stimuli, as well as environmental and endogenous chem. irritants.  When intense, these stimuli generate acute pain, and in the setting of persistent injury, both peripheral and central nervous system components of the pain transmission pathway exhibit tremendous plasticity, enhancing pain signals and producing hypersensitivity.  When plasticity facilitates protective reflexes, it can be beneficial, but when the changes persist, a chronic pain condition may result.  Genetic, electrophysiol., and pharmacol. studies are elucidating the mol. mechanisms that underlie detection, coding, and modulation of noxious stimuli that generate pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNLc2p-hLJLVg90H21EOLACvtfcHk0liYYJMYDBBoBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWht7zI&md5=afa43d19ea22a39b27952a2962df504b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DJulius%26aufirst%3DD.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520pain%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D267%26epage%3D284%26doi%3D10.1016%2Fj.cell.2009.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Opioid-modulating peptides: mechanisms of action</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.2174/1568026053544515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F1568026053544515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=15857316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=341-355&author=C.+Mollereauauthor=M.+Roumyauthor=J.+M.+Zajac&title=Opioid-modulating+peptides%3A+mechanisms+of+action&doi=10.2174%2F1568026053544515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-modulating peptides: mechanisms of action</span></div><div class="casAuthors">Mollereau, Catherine; Roumy, Michel; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Opioids are involved in the physiol. control of numerous functions of the central nervous system, particularly nociception.  It appears that some endogenous neuropeptides, called anti-opioids, participate in an homeostatic system tending to reduce the effects of opioids.  Neuropeptide FF (NPFF) and cholecystokinin (CCK) possess these properties and, paradoxically, the opioid peptides nociceptin and dynorphin display some anti-opioid activity.  All these peptides exhibit complex properties as they are able to both counteract and potentiate opioid activity, acting rather as modulators of opioid functions.  The purpose of this review is to highlight that 2 different mechanisms are clearly involved in the control of opioid functions by opioid-modulating peptides: a circuitry-induced mechanism for nociceptin and dynorphin, and a cellular anti-opioid mechanism for NPFF and CCK.  The knowledge of these mechanisms has potential therapeutic interest in the control of opioid functions, notably for alleviating pain and(or) for the treatment of opioid abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZw2fMuWKMaLVg90H21EOLACvtfcHk0ljWUdvHoWMt5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaqu70%253D&md5=f4a866b30e48dd49e4599405b8f1dab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568026053544515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053544515%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DRoumy%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DOpioid-modulating%2520peptides%253A%2520mechanisms%2520of%2520action%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D341%26epage%3D355%26doi%3D10.2174%2F1568026053544515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Welch, S. P.</span><span> </span><span class="NLM_article-title">Interaction of the cannabinoid and opioid systems in the modulation of nociception</span> <span class="citation_source-journal">Int. Rev. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1080/09540260902782794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1080%2F09540260902782794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19367508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BD1M3nsl2qsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=143-151&author=S.+P.+Welch&title=Interaction+of+the+cannabinoid+and+opioid+systems+in+the+modulation+of+nociception&doi=10.1080%2F09540260902782794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the cannabinoid and opioid systems in the modulation of nociception</span></div><div class="casAuthors">Welch Sandra P</div><div class="citationInfo"><span class="NLM_cas:title">International review of psychiatry (Abingdon, England)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cannabinoids and opioids produce antinociceptive synergy.  Cannabinoids such as Delta-9-tetrahydrocannabinol (THC) release endogenous opioids and endocannabinoids such as anandamide (AEA) also alter endogenous opioid tone.  Opioids and cannabinoids bind distinct receptors that co-localize in areas of the brain involved with the processing of pain signals.  Therefore, it is logical to look at interactions of these two systems in the modulation of both acute and chronic pain.  These drugs are often co-abused.  In addition, the lack of continued effectiveness of opioids due to tolerance development limits the use of such drugs.  The cost to society and patients in terms of dollars, loss of productivity, as well as quality of life, is staggering.  This review summarizes the data indicating that with cannabinoid/opioid therapy one may be able to produce long-term antinociceptive effects at doses devoid of substantial side effects, while preventing the neuronal biochemical changes that accompany tolerance.  The clinical utility of modulators of the endocannabinoid system as a potential mimic for THC-like drugs in analgesia and tolerance-sparing effects of opioids is a critical future direction also addressed in the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxqa50ZJHHcIxhnOQkIHOxfW6udTcc2ea4857AC05gmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3nsl2qsw%253D%253D&md5=5c9c0f1480176202e3de9dd1bdc954fa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F09540260902782794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09540260902782794%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DS.%2BP.%26atitle%3DInteraction%2520of%2520the%2520cannabinoid%2520and%2520opioid%2520systems%2520in%2520the%2520modulation%2520of%2520nociception%26jtitle%3DInt.%2520Rev.%2520Psychiatry%26date%3D2009%26volume%3D21%26spage%3D143%26epage%3D151%26doi%3D10.1080%2F09540260902782794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Bi- or multifunctional opioid peptide drugs</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span><span class="refDoi"> DOI: 10.1016/j.lfs.2009.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.lfs.2009.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19285088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlChs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=598-603&author=P.+W.+Schiller&title=Bi-+or+multifunctional+opioid+peptide+drugs&doi=10.1016%2Fj.lfs.2009.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bi- or multifunctional opioid peptide drugs</span></div><div class="casAuthors">Schiller, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">598-603</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Strategies for the design of bi- or multifunctional drugs are reviewed.  A distinction is made between bifunctional drugs interacting in a monovalent fashion with two targets and ligands contg. two distinct pharmacophores binding in a bivalent mode to the two binding sites in a receptor heterodimer.  Arguments are presented to indicate that some of the so-called "bivalent" ligands reported in the literature are unlikely to simultaneously interact with two binding sites.  Aspects related to the development of bi- or multifunctional drugs are illustrated with examples from the field of opioid analgesics.  The drug-like properties of the tetrapeptide Dmt1[DALDA] with triple action as a μ opioid agonist, norepinephrine uptake inhibitor and releaser of endogenous opioid peptides to produce potent spinal analgesia are reviewed.  Rationales for the development of opioid peptides with mixed agonist/antagonist profiles as analgesics with reduced side effects are presented.  Progress in the development of mixed μ opioid agonist/δ opioid antagonists with low propensity to produce tolerance and phys. dependence is reviewed.  Efforts to develop bifunctional peptides contg. a μ opioid agonist and a cholecystokinin antagonist or an NK1 receptor antagonist as analgesics expected to produce less tolerance and dependence are also reviewed.  A strategy to improve the drug-like properties of bifunctional opioid peptide analgesics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51QVXgJVx6LVg90H21EOLACvtfcHk0ljWUdvHoWMt5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlChs7o%253D&md5=6bb5b32b59f9d2bbd12763c1c32cd641</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2009.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2009.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DBi-%2520or%2520multifunctional%2520opioid%2520peptide%2520drugs%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D598%26epage%3D603%26doi%3D10.1016%2Fj.lfs.2009.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span> </span><span class="NLM_article-title">Hybrid opioid/non-opioid ligands in pain research</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7435</span><span class="NLM_x">–</span> <span class="NLM_lpage">7450</span><span class="refDoi"> DOI: 10.2174/138161281942140105165646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F138161281942140105165646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23448481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7435-7450&author=P.+Kleczkowskaauthor=A.+W.+Lipkowskiauthor=D.+Tourweauthor=S.+Ballet&title=Hybrid+opioid%2Fnon-opioid+ligands+in+pain+research&doi=10.2174%2F138161281942140105165646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid Opioid/Non-Opioid Ligands in Pain Research</span></div><div class="casAuthors">Kleczkowska, Patrycja; Lipkowski, Andrzej W.; Tourwe, Dirk; Ballet, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">7435-7450</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To address the different types of pain (e.g. acute, chronic, neuropathic) different classes of medications, mainly non-steroidal anti-inflammatory drugs and narcotics (opioids), are used.  More specifically, the alleviation or treatment of moderate to severe pain states commonly invokes the use of opioids.  Unfortunately, their chronic administration induces various undesirable side effects, such as for example phys. dependence and tolerance.  One strategy to overcome these major side effects and to prolong the antinociceptive efficiency of the applied drugs involves the creation of multifunctional compds. which contain hybridized structures.  Combination of opioid agonist and antagonist pharmacophores in a single chem. entity has been considered and extensively investigated, but opioids have also been combined with other bioactive neurotransmitters and peptide hormones that are involved in pain perception (e.g. substance P, neurotensin, cholecystokinin, cannabinoids, melanocortin ligands, etc.).  Such novel chimeras (also called designed multiple ligands or twin/triplet drugs), may interact independently with their resp. receptors and potentially result in more effective antinociceptive properties.  The designed multiple ligands presented in this work include opioid-non-opioid peptide dimer analogs, mixed peptidic- non-peptidic bifunctional ligands and dual non-peptidic dimers.  The main focus herein is placed on the design and biol. evaluation of these multiple opioid compds., rather than the synthetic approach and prepn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRD8bJ077blrVg90H21EOLACvtfcHk0livxQ4A_i_HZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFyrsg%253D%253D&md5=ffb0df5135c1b9461124b86d47c86531</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161281942140105165646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161281942140105165646%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DBallet%26aufirst%3DS.%26atitle%3DHybrid%2520opioid%252Fnon-opioid%2520ligands%2520in%2520pain%2520research%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D7435%26epage%3D7450%26doi%3D10.2174%2F138161281942140105165646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Turnaturi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinucci, L.</span><span> </span><span class="NLM_article-title">Multitarget opioid ligands in pain relief: New players in an old game</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.ejmech.2015.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26656913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=211-228&author=R.+Turnaturiauthor=G.+Aricoauthor=G.+Ronsisvalleauthor=C.+Parentiauthor=L.+Pasquinucci&title=Multitarget+opioid+ligands+in+pain+relief%3A+New+players+in+an+old+game&doi=10.1016%2Fj.ejmech.2015.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget opioid ligands in pain relief: New players in an old game</span></div><div class="casAuthors">Turnaturi, Rita; Arico, Giuseppina; Ronsisvalle, Giuseppe; Parenti, Carmela; Pasquinucci, Lorella</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-228</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Still nowadays pain is one of the most common disabling conditions and yet it remains too often unsolved.  Analgesic opioid drugs, and mainly MOR agonists such as morphine, are broadly employed for pain management.  MOR activation, however, has been seen to cause not only analgesia but also undesired side effects.  A potential pain treatment option is represented by the simultaneous targeting of different opioid receptors.  In fact, ligands possessing multitarget capabilities led to an improved pharmacol. fingerprint.  This review focuses on the examn. of multitarget opioid ligands which have been distinguished in peptide and non-peptide and further listed as bivalent and bifunctional ligands.  Moreover, the potential of these compds., both as analgesic drugs and pharmacol. tools to explore heteromer receptors, has been stressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1KgfVHTj67Vg90H21EOLACvtfcHk0livxQ4A_i_HZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmsrrN&md5=49fa91877cdaa733f7ec58d5e80a3869</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DArico%26aufirst%3DG.%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DPasquinucci%26aufirst%3DL.%26atitle%3DMultitarget%2520opioid%2520ligands%2520in%2520pain%2520relief%253A%2520New%2520players%2520in%2520an%2520old%2520game%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D211%26epage%3D228%26doi%3D10.1016%2Fj.ejmech.2015.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bihel, F.</span><span> </span><span class="NLM_article-title">Opioid adjuvant strategy: improving opioid effectiveness</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.4155/fmc.15.186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.4155%2Ffmc.15.186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26898358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339-354&author=F.+Bihel&title=Opioid+adjuvant+strategy%3A+improving+opioid+effectiveness&doi=10.4155%2Ffmc.15.186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid adjuvant strategy: improving opioid effectiveness</span></div><div class="casAuthors">Bihel, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-354</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Opioid analgesics continue to be the mainstay of pharmacol. treatment of moderate to severe pain.  Many patients, particularly those suffering from chronic pain, require chronic high-dose analgesic therapy.  Achieving clin. efficacy and tolerability of such treatment regimens is hampered by the appearance of opioid-induced side effects such as tolerance, hyperalgesia and withdrawal syndrome.  Among the therapeutic options to improve the opioid effectiveness, this current review focuses on strategies combining opioids to other drugs that can modulate opioid-mediated effects.  We will discuss about exptl. evidences reported for several potential opioid adjuvants, including N-methyl-D-aspartate receptor antagonists, 5-HT7 agonists, sigma-1 antagonists, I2-R ligands, cholecystokinin antagonists, neuropeptide FF-R antagonists and toll-like receptor 4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJF8bC0s0lxbVg90H21EOLACvtfcHk0livxQ4A_i_HZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjs70%253D&md5=13f51430ab11eb649db0afda5676dea0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.186%26sid%3Dliteratum%253Aachs%26aulast%3DBihel%26aufirst%3DF.%26atitle%3DOpioid%2520adjuvant%2520strategy%253A%2520improving%2520opioid%2520effectiveness%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D339%26epage%3D354%26doi%3D10.4155%2Ffmc.15.186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Salat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1036985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1517%2F13543784.2015.1036985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=837-844&author=K.+Salatauthor=A.+Jakubowskaauthor=K.+Kulig&title=Cebranopadol%3A+a+first-in-class+potent+analgesic+agent+with+agonistic+activity+at+nociceptin%2Forphanin+FQ+and+opioid+receptors&doi=10.1517%2F13543784.2015.1036985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1036985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1036985%26sid%3Dliteratum%253Aachs%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DJakubowska%26aufirst%3DA.%26aulast%3DKulig%26aufirst%3DK.%26atitle%3DCebranopadol%253A%2520a%2520first-in-class%2520potent%2520analgesic%2520agent%2520with%2520agonistic%2520activity%2520at%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D837%26epage%3D844%26doi%3D10.1517%2F13543784.2015.1036985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00824.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1111%2Fj.1476-5381.2010.00824.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20977451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2ms7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=986-1001&author=T.+M.+Largent-Milnesauthor=T.+Yamamotoauthor=P.+Nairauthor=J.+W.+Moultonauthor=V.+J.+Hrubyauthor=J.+Laiauthor=F.+Porrecaauthor=T.+W.+Vanderah&title=Spinal+or+systemic+TY005%2C+a+peptidic+opioid+agonist%2Fneurokinin+1+antagonist%2C+attenuates+pain+with+reduced+tolerance&doi=10.1111%2Fj.1476-5381.2010.00824.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance</span></div><div class="casAuthors">Largent-Milnes, T. M.; Yamamoto, T.; Nair, P.; Moulton, J. W.; Hruby, V. J.; Lai, J.; Porreca, F.; Vanderah, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">986-1001</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The use of opioids in treating pain is limited due to significant side effects including somnolence, constipation, analgesic tolerance, addiction and respiratory depression.  Pre-clin. studies have shown that neurokinin 1 (NK1) receptor antagonists block opioid-induced antinociceptive tolerance and may inhibit opioid-induced rewarding behaviors.  Here, we have characterized a bifunctional peptide with both opioid agonist and NK1 antagonist pharmacophores in a rodent model of neuropathic pain.  Rats were evaluated for behavioral responses to both tactile and thermal stimuli in either an uninjured, sham- or nerve-injured state.  TY005 (Tyr-DAla-Gly-Phe-Met-Pro-Leu-Trp-O-3,5-Bn(CF3)2) was delivered spinally or systemically to assess the antinociceptive effects after acute exposure.  Motor skills were evaluated using the rotarod test to det. potential sedative effects.  Spinal TY005 was given chronically to sham- or nerve-injured animals to det. the development of tolerance.  Bolus injections of TY005 produced dose-dependent antinociception in non-injured animals and alleviated nerve injury-induced thermal and tactile hypersensitivities (i.e. antihyperalgesia) more effectively than morphine.  Sedative effects were not evident from the rotarod test at doses that were antihyperalgesic, nor at doses 3-fold higher.  Repeated administration of TY005 did not lead to the development of antihyperalgesic tolerance or alter sensory thresholds.  Collectively, the data suggest that opioid agonist/NK1 antagonist bifunctional peptides represent a promising novel approach to the management of chronic pain without the development of tolerance, reducing the need for escalation of doses and unwanted side effects assocd. with opiates alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIZV-rESBFrVg90H21EOLACvtfcHk0ljyL8bsBQczWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2ms7jN&md5=5ea51d658f8678e93d8e19a5f20802c1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00824.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00824.x%26sid%3Dliteratum%253Aachs%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DMoulton%26aufirst%3DJ.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DSpinal%2520or%2520systemic%2520TY005%252C%2520a%2520peptidic%2520opioid%2520agonist%252Fneurokinin%25201%2520antagonist%252C%2520attenuates%2520pain%2520with%2520reduced%2520tolerance%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D986%26epage%3D1001%26doi%3D10.1111%2Fj.1476-5381.2010.00824.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Le Naour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekkirala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyuzhny, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span><span class="refDoi"> DOI: 10.1021/jm4005219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5505-5513&author=M.+Le+Naourauthor=E.+Akgunauthor=A.+Yekkiralaauthor=M.+M.+Lunzerauthor=M.+D.+Powersauthor=A.+E.+Kalyuzhnyauthor=P.+S.+Portoghese&title=Bivalent+ligands+that+target+mu+opioid+%28MOP%29+and+cannabinoid1+%28CB1%29+receptors+are+potent+analgesics+devoid+of+tolerance&doi=10.1021%2Fjm4005219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm4005219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005219%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNaour%26aufirst%3DM.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DYekkirala%26aufirst%3DA.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DPowers%26aufirst%3DM.%2BD.%26aulast%3DKalyuzhny%26aufirst%3DA.%2BE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DBivalent%2520ligands%2520that%2520target%2520mu%2520opioid%2520%2528MOP%2529%2520and%2520cannabinoid1%2520%2528CB1%2529%2520receptors%2520are%2520potent%2520analgesics%2520devoid%2520of%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5505%26epage%3D5513%26doi%3D10.1021%2Fjm4005219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnatt, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Hage, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dever, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimers: binding affinity versus functional activities</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1039/c3md00080j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1039%2Fc3md00080j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23682308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=847-851&author=Y.+Yuanauthor=C.+K.+Arnattauthor=N.+El-Hageauthor=S.+M.+Deverauthor=J.+C.+Jacobauthor=D.+E.+Selleyauthor=K.+F.+Hauserauthor=Y.+Zhang&title=A+bivalent+ligand+targeting+the+putative+mu+opioid+receptor+and+chemokine+receptor+CCR5+heterodimers%3A+binding+affinity+versus+functional+activities&doi=10.1039%2Fc3md00080j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities</span></div><div class="casAuthors">Yuan, Yunyun; Arnatt, Christopher K.; El-Hage, Nazira; Dever, Seth M.; Jacob, Joanna C.; Selley, Dana E.; Hauser, Kurt F.; Zhang, Yan</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">847-851</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Opioid substitution and antiretroviral therapies have steadily increased the life spans of AIDS patients with opioid addiction, while the adverse drug-drug interactions and persistence of HIV-assocd. neurocognitive disorders still require new strategies to target opioid abuse and HIV-1 comorbidities.  A bivalent ligand 1 with a 21-atom spacer was thus synthesized and explicitly characterized as a novel pharmacol. probe to study the underlying mechanism of opioid-enhanced NeuroAIDS.  The steric hindrance generated from the spacer affected the binding affinity and Ca2+ flux inhibition functional activity of bivalent ligand 1 at the chemokine receptor CCR5 more profoundly than it did at the mu opioid receptor (MOR).  However, the CCR5 radioligand binding affinity and the Ca2+ flux inhibition function of the ligand seemed not necessarily to correlate with its antiviral activity given that it was at least two times more potent than maraviroc alone in reducing Tat expression upon HIV-1 infection in human astrocytes.  Furthermore, the ligand was also about two times more potent than the simple mixt. of maraviroc and naltrexone in the same viral entry inhibition assay.  Therefore bivalent ligand 1 seemed to function more effectively by targeting specifically the putative MOR-CCR5 heterodimer in the viral invasion process.  The results reported here suggest that a properly designed bivalent ligand may serve as a useful chem. probe to study the potential MOR-CCR5 interaction during the progression of NeuroAIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc2twZlWfnf7Vg90H21EOLACvtfcHk0ljyL8bsBQczWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu7g%253D&md5=74444181b5c9d456600a745c066f67d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3md00080j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00080j%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DArnatt%26aufirst%3DC.%2BK.%26aulast%3DEl-Hage%26aufirst%3DN.%26aulast%3DDever%26aufirst%3DS.%2BM.%26aulast%3DJacob%26aufirst%3DJ.%2BC.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DHauser%26aufirst%3DK.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DA%2520bivalent%2520ligand%2520targeting%2520the%2520putative%2520mu%2520opioid%2520receptor%2520and%2520chemokine%2520receptor%2520CCR5%2520heterodimers%253A%2520binding%2520affinity%2520versus%2520functional%2520activities%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D847%26epage%3D851%26doi%3D10.1039%2Fc3md00080j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Harikumar, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Modulation of cell surface expression of nonactivated cholecystokinin receptors using bivalent ligand-induced internalization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span><span class="refDoi"> DOI: 10.1021/jm100135g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100135g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2836-2842&author=K.+G.+Harikumarauthor=E.+Akgunauthor=P.+S.+Portogheseauthor=L.+J.+Miller&title=Modulation+of+cell+surface+expression+of+nonactivated+cholecystokinin+receptors+using+bivalent+ligand-induced+internalization&doi=10.1021%2Fjm100135g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100135g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100135g%26sid%3Dliteratum%253Aachs%26aulast%3DHarikumar%26aufirst%3DK.%2BG.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DModulation%2520of%2520cell%2520surface%2520expression%2520of%2520nonactivated%2520cholecystokinin%2520receptors%2520using%2520bivalent%2520ligand-induced%2520internalization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2836%26epage%3D2842%26doi%3D10.1021%2Fjm100135g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javed, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeester, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">11595</span><span class="NLM_x">–</span> <span class="NLM_lpage">11599</span><span class="refDoi"> DOI: 10.1073/pnas.1305461110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.1305461110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23798416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Gls73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11595-11599&author=E.+Akgunauthor=M.+I.+Javedauthor=M.+M.+Lunzerauthor=B.+A.+Smeesterauthor=A.+J.+Beitzauthor=P.+S.+Portoghese&title=Ligands+that+interact+with+putative+MOR-mGluR5+heteromer+in+mice+with+inflammatory+pain+produce+potent+antinociception&doi=10.1073%2Fpnas.1305461110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception</span></div><div class="casAuthors">Akgun, Eyup; Javed, Muhammad I.; Lunzer, Mary M.; Smeester, Branden A.; Beitz, Al J.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11595-11599, S11595/1-S11595/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The low effectiveness of morphine and related mu opioid analgesics for the treatment of chronic inflammatory pain is a result of opioid-induced release of proinflammatory cytokines and glutamate that lower the pain threshold.  In this regard, the use of opioids with metabotropic glutamate-5 receptor (mGluR5) antagonist has been reported to increase the efficacy of morphine and prevent the establishment of adverse effects during chronic use.  Given the presence of opioid receptors (MORs) and mGluR5 in glia and neurons, together with reports that suggest coexpressed MOR/mGluR5 receptors in cultured cells assoc. as a heteromer, the possibility that such a heteromer could be a target in vivo was addressed by the design and synthesis of a series of bivalent ligands that contain mu opioid agonist and mGluR5 antagonist pharmacophores linked through spacers of varying length (10-24 atoms).  The series was evaluated for antinociception using the tail-flick and von Frey assays in mice pretreated with lipopolysaccharide (LPS) or in mice with bone cancer.  In LPS-pretreated mice, MMG22, I (22-atom spacer), was the most potent member of the series (intrathecal ED50 ∼ 9 fmol per mouse), whereas in untreated mice its ED50 was more than three orders of magnitude higher.  As members of the series with shorter or longer spacers have ≥500-fold higher ED50s in LPS-treated mice, the exceptional potency of MMG22 may be a result of the optimal bridging of protomers in a putative MOR-mGluR5 heteromer.  The finding that MMG22 possesses a >106 therapeutic ratio suggests that it may be an excellent candidate for treatment of chronic, intractable pain via spinal administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sHkH4sok2bVg90H21EOLACvtfcHk0lhuH2YTlK79lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Gls73N&md5=ced95f48600b2217e402a5cf794f0784</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305461110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305461110%26sid%3Dliteratum%253Aachs%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DJaved%26aufirst%3DM.%2BI.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DSmeester%26aufirst%3DB.%2BA.%26aulast%3DBeitz%26aufirst%3DA.%2BJ.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DLigands%2520that%2520interact%2520with%2520putative%2520MOR-mGluR5%2520heteromer%2520in%2520mice%2520with%2520inflammatory%2520pain%2520produce%2520potent%2520antinociception%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11595%26epage%3D11599%26doi%3D10.1073%2Fpnas.1305461110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Guillemyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyniewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojewska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mika, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arranz-Gibert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megarbane, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span> </span><span class="NLM_article-title">Bifunctional peptide-based opioid agonist-nociceptin antagonist ligands for dual treatment of acute and neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3792</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3777-3792&author=K.+Guillemynauthor=J.+Starnowskaauthor=C.+Lagardauthor=J.+Dyniewiczauthor=E.+Rojewskaauthor=J.+Mikaauthor=N.+N.+Chungauthor=V.+Utardauthor=P.+Kossonauthor=A.+W.+Lipkowskiauthor=L.+Chevillardauthor=P.+Arranz-Gibertauthor=M.+Teixidoauthor=B.+Megarbaneauthor=D.+Tourweauthor=F.+Simoninauthor=B.+Przewlockaauthor=P.+W.+Schillerauthor=S.+Ballet&title=Bifunctional+peptide-based+opioid+agonist-nociceptin+antagonist+ligands+for+dual+treatment+of+acute+and+neuropathic+pain&doi=10.1021%2Facs.jmedchem.5b01976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain</span></div><div class="casAuthors">Guillemyn, Karel; Starnowska, Joanna; Lagard, Camille; Dyniewicz, Jolanta; Rojewska, Ewelina; Mika, Joanna; Chung, Nga N.; Utard, Valerie; Kosson, Piotr; Lipkowski, Andrzej W.; Chevillard, Lucie; Arranz-Gibert, Pol; Teixido, Meritxell; Megarbane, Bruno; Tourwe, Dirk; Simonin, Frederic; Przewlocka, Barbara; Schiller, Peter W.; Ballet, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3777-3792</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the opioid pharmacophore H-Dmt-D-Arg-Aba-β-Ala-NH2 (7) was linked to peptide ligands for the nociceptin receptor.  Combination of 7 and NOP ligands (e.g., H-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2) led to binding affinities in the low nanomolar domain.  In vitro, the hybrids behaved as agonists at the opioid receptors and antagonists at the nociceptin receptor.  I.v. administration of hybrid 13a (H-Dmt-D-Arg-Aba-β-Ala-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2) to mice resulted in potent and long lasting antinociception in the tail-flick test, indicating that 13a was able to permeate the BBB.  This was further supported by a cell-based BBB model.  All hybrids alleviated allodynia and hyperalgesia in neuropathic pain models.  Esp. with respect to hyperalgesia, they showed to be more effective than the parent compds.  Hybrid 13a did not result in significant respiratory depression, in contrast to an equipotent analgesic dose of morphine.  These hybrids hence represent a promising avenue toward analgesics for the dual treatment of acute and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMjKi5JZ8AVbVg90H21EOLACvtfcHk0lhuH2YTlK79lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOntL4%253D&md5=fa45a9594bfe7d25d9729aabf85d3b85</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01976%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DStarnowska%26aufirst%3DJ.%26aulast%3DLagard%26aufirst%3DC.%26aulast%3DDyniewicz%26aufirst%3DJ.%26aulast%3DRojewska%26aufirst%3DE.%26aulast%3DMika%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DUtard%26aufirst%3DV.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DChevillard%26aufirst%3DL.%26aulast%3DArranz-Gibert%26aufirst%3DP.%26aulast%3DTeixido%26aufirst%3DM.%26aulast%3DMegarbane%26aufirst%3DB.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DSimonin%26aufirst%3DF.%26aulast%3DPrzewlocka%26aufirst%3DB.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBallet%26aufirst%3DS.%26atitle%3DBifunctional%2520peptide-based%2520opioid%2520agonist-nociceptin%2520antagonist%2520ligands%2520for%2520dual%2520treatment%2520of%2520acute%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3777%26epage%3D3792%26doi%3D10.1021%2Facs.jmedchem.5b01976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnes, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1016/S0024-3205(03)00390-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2FS0024-3205%2803%2900390-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=699-704&author=V.+J.+Hrubyauthor=R.+S.+Agnesauthor=P.+Davisauthor=S.+W.+Maauthor=Y.+S.+Leeauthor=T.+W.+Vanderahauthor=J.+Laiauthor=F.+Porreca&title=Design+of+novel+peptide+ligands+which+have+opioid+agonist+activity+and+CCK+antagonist+activity+for+the+treatment+of+pain&doi=10.1016%2FS0024-3205%2803%2900390-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900390-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900390-4%26sid%3Dliteratum%253Aachs%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DAgnes%26aufirst%3DR.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DDesign%2520of%2520novel%2520peptide%2520ligands%2520which%2520have%2520opioid%2520agonist%2520activity%2520and%2520CCK%2520antagonist%2520activity%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D699%26epage%3D704%26doi%3D10.1016%2FS0024-3205%2803%2900390-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orduna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/mu receptor agonists in the sciatic nerve ligation chronic pain model in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1124/jpet.111.184663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1124%2Fjpet.111.184663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21859931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=687-693&author=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=J.+Ordunaauthor=J.+Montenegroauthor=F.+Jiangauthor=N.+T.+Zaveriauthor=L.+Toll&title=Differential+effects+of+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+agonists+in+acute+versus+chronic+pain%3A+studies+with+bifunctional+NOP%2Fmu+receptor+agonists+in+the+sciatic+nerve+ligation+chronic+pain+model+in+mice&doi=10.1124%2Fjpet.111.184663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice</span></div><div class="casAuthors">Khroyan, Taline V.; Polgar, Willma E.; Orduna, Juan; Montenegro, Jose; Jiang, Faming; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150) and 1-(1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidinl-4-yl)-indolin-2-one (SR16835) are moderately selective nociceptin/orphanin FQ (NOP) receptor agonists.  In the [35S]guanosine 5'-O-(3-thiotriphosphate) assay in vitro, SR14150 is a partial agonist at both the NOP and μ-opioid receptors, whereas SR16835 is a full agonist at the NOP receptor and has low efficacy at μ receptors.  These compds. were tested for antinociceptive and antiallodynic activity, using mice in chronic pain, subsequent to spinal nerve ligation (SNL) surgery.  When administered s.c. to mice after SNL surgery, SR14150 but not SR16835 increased tail-flick latency, which was blocked by the opioid antagonist naloxone, but not by the NOP receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).  In contrast, both SR14150 and SR16835 had antiallodynic activity when mech. allodynia was measured with von Frey monofilaments.  This effect was completely blocked by SB-612111 but not by naloxone.  On the other hand, morphine antinociception and antiallodynia were both blocked by naloxone and potentiated by SB-612111.  These results indicate that, in mice, circuitry mediating antinociceptive activity in acute and chronic pain states is different.  It is possible that during a chronic pain state, an up-regulated NOP system in the spinal cord leads to NOP receptor-mediated antiallodynia, which is blocked by NOP antagonists.  However, supraspinal up-regulation could lead to an attenuation of morphine antinociception and antiallodynia, which can be alleviated by an NOP receptor antagonist.  Thus, although neither NOP agonists nor antagonists are effective as analgesics in acute pain, they may have efficacy as analgesics, either alone or in combination with morphine, for treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0K9DfQCAq7Vg90H21EOLACvtfcHk0lgp93jaUDmXfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL&md5=d5e03c7d72ac9feab468aa8cdc8ba89d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184663%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DOrduna%26aufirst%3DJ.%26aulast%3DMontenegro%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDifferential%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520agonists%2520in%2520acute%2520versus%2520chronic%2520pain%253A%2520studies%2520with%2520bifunctional%2520NOP%252Fmu%2520receptor%2520agonists%2520in%2520the%2520sciatic%2520nerve%2520ligation%2520chronic%2520pain%2520model%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D687%26epage%3D693%26doi%3D10.1124%2Fjpet.111.184663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3308</span><span class="NLM_x">–</span> <span class="NLM_lpage">3313</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmcl.2013.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3308-3313&author=N.+T.+Zaveriauthor=F.+Jiangauthor=C.+Olsenauthor=W.+E.+Polgarauthor=L.+Toll&title=Designing+bifunctional+NOP+receptor-mu+opioid+receptor+ligands+from+NOP+receptor-selective+scaffolds.+Part+I&doi=10.1016%2Fj.bmcl.2013.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDesigning%2520bifunctional%2520NOP%2520receptor-mu%2520opioid%2520receptor%2520ligands%2520from%2520NOP%2520receptor-selective%2520scaffolds.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3308%26epage%3D3313%26doi%3D10.1016%2Fj.bmcl.2013.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Blair Journigan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2508</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmc.2014.02.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2508-2516&author=V.+Blair+Journiganauthor=W.+E.+Polgarauthor=T.+V.+Khroyanauthor=N.+T.+Zaveri&title=Designing+bifunctional+NOP+receptor-mu+opioid+receptor+ligands+from+NOP-receptor+selective+scaffolds.+Part+II&doi=10.1016%2Fj.bmc.2014.02.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%2BJournigan%26aufirst%3DV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DDesigning%2520bifunctional%2520NOP%2520receptor-mu%2520opioid%2520receptor%2520ligands%2520from%2520NOP-receptor%2520selective%2520scaffolds.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2508%26epage%3D2516%26doi%3D10.1016%2Fj.bmc.2014.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7337</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmc.2009.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19762245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ais7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7337-7343&author=T.+Yamamotoauthor=P.+Nairauthor=S.+W.+Maauthor=P.+Davisauthor=H.+I.+Yamamuraauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=The+biological+activity+and+metabolic+stability+of+peptidic+bifunctional+compounds+that+are+opioid+receptor+agonists+and+neurokinin-1+receptor+antagonists+with+a+cystine+moiety&doi=10.1016%2Fj.bmc.2009.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety</span></div><div class="casAuthors">Yamamoto, Takashi; Nair, Padma; Ma, Shou-wu; Davis, Peg; Yamamura, Henry I.; Vanderah, Todd W.; Porreca, Frank; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7337-7343</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to improve metabolic stability, a ring structure with a cystine moiety was introduced into TY027 (Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-[3',5'-(CF3)2Bzl]), which is a lead compd. of our developing bifunctional peptide possessing opioid agonist and NK1 antagonist activities.  TY038 (Tyr-cyclo[D-Cys-Gly-Phe-Met-Pro-D-Cys]-Trp-NH-[3',5'-(CF3)2Bzl]) was found as a highly selective δ opioid agonist over μ receptor in conventional tissue-based assays, together with an effective NK1 antagonist activity and good metabolic stability with more than 24 h half life in rat plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparHxQyFibhbVg90H21EOLACvtfcHk0lgp93jaUDmXfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ais7nL&md5=61567a71476cf64f45d354d7be6cec53</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DThe%2520biological%2520activity%2520and%2520metabolic%2520stability%2520of%2520peptidic%2520bifunctional%2520compounds%2520that%2520are%2520opioid%2520receptor%2520agonists%2520and%2520neurokinin-1%2520receptor%2520antagonists%2520with%2520a%2520cystine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7337%26epage%3D7343%26doi%3D10.1016%2Fj.bmc.2009.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratilova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4975</span><span class="NLM_x">–</span> <span class="NLM_lpage">4978</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmcl.2013.06.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4975-4978&author=P.+Nairauthor=T.+Yamamotoauthor=T.+M.+Largent-Milnesauthor=S.+Cowellauthor=V.+Kulkarniauthor=S.+Moyeauthor=E.+Navratilovaauthor=P.+Davisauthor=S.+W.+Maauthor=T.+W.+Vanderahauthor=J.+Laiauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Truncation+of+the+peptide+sequence+in+bifunctional+ligands+with+mu+and+delta+opioid+receptor+agonist+and+neurokinin+1+receptor+antagonist+activities&doi=10.1016%2Fj.bmcl.2013.06.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DP.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DCowell%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DMoye%26aufirst%3DS.%26aulast%3DNavratilova%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DTruncation%2520of%2520the%2520peptide%2520sequence%2520in%2520bifunctional%2520ligands%2520with%2520mu%2520and%2520delta%2520opioid%2520receptor%2520agonist%2520and%2520neurokinin%25201%2520receptor%2520antagonist%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4975%26epage%3D4978%26doi%3D10.1016%2Fj.bmcl.2013.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojnik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowicka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujalska-Zadrozny, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span> </span><span class="NLM_article-title">Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile(9)]PK20 in an acute pain treatment in rodents</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1648</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/j.brainres.2016.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.brainres.2016.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1648&publication_year=2016&pages=172-180&author=P.+Kleczkowskaauthor=E.+Hermansauthor=P.+Kossonauthor=A.+Kowalczykauthor=A.+Lesniakauthor=K.+Pawlikauthor=E.+Bojnikauthor=S.+Benyheauthor=B.+Nowickaauthor=M.+Bujalska-Zadroznyauthor=A.+Misickaauthor=A.+W.+Lipkowski&title=Antinociceptive+effect+induced+by+a+combination+of+opioid+and+neurotensin+moieties+vs.+their+hybrid+peptide+%5BIle%289%29%5DPK20+in+an+acute+pain+treatment+in+rodents&doi=10.1016%2Fj.brainres.2016.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile9]PK20 in an acute pain treatment in rodents</span></div><div class="casAuthors">Kleczkowska, Patrycja; Hermans, Emmanuel; Kosson, Piotr; Kowalczyk, Agnieszka; Lesniak, Anna; Pawlik, Karolina; Bojnik, Engin; Benyhe, Sandor; Nowicka, Barbara; Bujalska-Zadrozny, Magdalena; Misicka, Aleksandra; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1648</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">172-180</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hybrid compds. are suggested to be a more effective remedy for treatment of various diseases than combination therapy, since the attenuation or total disappearance of side effects, typically induced by a single moiety, can be obsd.  This is of great importance, esp. when we consider problems resulting from the use of opioid analgesics.  However, although it seems that such compds. can be valuable therapeutic tools, the lack of conviction among the public as to the appropriateness of their use still remains; therefore patients are commonly treated with polypharmacy.  Thus, in the presented paper we show a comparison of the antinociceptive effect between a novel opioid-neurotensin chimera called [Ile9]PK20 and a mixt. of its structural elements, delivered intrathecally and systemically.  Addnl., motor coordination was assessed in the rotarod test.  The results clearly indicate that spinal administration of the examd. compds., resulted in a long-lasting, dose- and time-dependent antinociceptive effect.  Although the mixt. of both pharmacophores was found to be more active than [Ile9]PK20, motor impairments surfaced as a side effect.  This in turn illustrates the advantageous use of hybrid structures over drug cocktails.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpYBf-wrNJbVg90H21EOLACvtfcHk0ljq2TNarbsnyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgsLfO&md5=73edaf5ea34e262e8adb6f3108823844</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2016.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2016.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DHermans%26aufirst%3DE.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DLesniak%26aufirst%3DA.%26aulast%3DPawlik%26aufirst%3DK.%26aulast%3DBojnik%26aufirst%3DE.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DNowicka%26aufirst%3DB.%26aulast%3DBujalska-Zadrozny%26aufirst%3DM.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DAntinociceptive%2520effect%2520induced%2520by%2520a%2520combination%2520of%2520opioid%2520and%2520neurotensin%2520moieties%2520vs.%2520their%2520hybrid%2520peptide%2520%255BIle%25289%2529%255DPK20%2520in%2520an%2520acute%2520pain%2520treatment%2520in%2520rodents%26jtitle%3DBrain%2520Res.%26date%3D2016%26volume%3D1648%26spage%3D172%26epage%3D180%26doi%3D10.1016%2Fj.brainres.2016.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span> </span><span class="NLM_article-title">PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1186/1744-8069-6-86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1186%2F1744-8069-6-86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=86&author=P.+Kleczkowskaauthor=P.+Kossonauthor=S.+Balletauthor=I.+Van+den+Eyndeauthor=Y.+Tsudaauthor=D.+Tourweauthor=A.+W.+Lipkowski&title=PK20%2C+a+new+opioid-neurotensin+hybrid+peptide+that+exhibits+central+and+peripheral+antinociceptive+effects&doi=10.1186%2F1744-8069-6-86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects</span></div><div class="casAuthors">Kleczkowska, Patrycja; Kosson, Piotr; Ballet, Steven; Van den Eynde, Isabelle; Tsuda, Yuko; Tourwe, Dirk; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>CODEN:
                <span class="NLM_cas:coden">MPOAC5</span>;
        ISSN:<span class="NLM_cas:issn">1744-8069</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The clin. treatment of various types of pain relies upon the use of opioid analgesics.  However most of them produce, in addn. to the analgesic effect, several side effects such as the development of dependence and addiction as well as sedation, dysphoria, and constipation.  One soln. to these problems are chimeric compds. in which the opioid pharmacophore is hybridized with another type of compd. to increase antinociceptive effects.  Neurotensin-induced antinociception is not mediated through the opioid system.  Therefore, hybridizing neurotensin with opioid elements may result in a potent synergistic antinociceptor.  Results: Using the known structure-activity relationships of neurotensin we have synthesized a new chimeric opioid-neurotensin compd. PK20 which is characterized by a very strong antinociceptive potency.  The observation that the opioid antagonist naltrexone did not completely reverse the antinociceptive effect, indicates the partial involvement of the nonopioid component in PK20 in the produced analgesia.  Conclusions: The opioid-neurotensin hybrid analog PK20, in which opioid and neurotensin pharmacophores overlap partially, expresses high antinociceptive tail-flick effects after central as well as peripheral applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoYplSz0cuXLVg90H21EOLACvtfcHk0ljq2TNarbsnyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrvM&md5=cf7bc30203a46b1087061d84a028259e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-6-86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-6-86%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DI.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DPK20%252C%2520a%2520new%2520opioid-neurotensin%2520hybrid%2520peptide%2520that%2520exhibits%2520central%2520and%2520peripheral%2520antinociceptive%2520effects%26jtitle%3DMol.%2520Pain%26date%3D2010%26volume%3D6%26spage%3D86%26doi%3D10.1186%2F1744-8069-6-86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mouledous, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Opioid-modulating properties of the neuropeptide FF system</span> <span class="citation_source-journal">Biofactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1002/biof.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fbiof.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20803521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1eitrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=423-429&author=L.+Mouledousauthor=C.+Mollereauauthor=J.+M.+Zajac&title=Opioid-modulating+properties+of+the+neuropeptide+FF+system&doi=10.1002%2Fbiof.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-modulating properties of the neuropeptide FF system</span></div><div class="casAuthors">Mouledous, Lionel; Mollereau, Catherine; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">BioFactors</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-429</span>CODEN:
                <span class="NLM_cas:coden">BIFAEU</span>;
        ISSN:<span class="NLM_cas:issn">1872-8081</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Opioid receptors are involved in the control of pain perception in the central nervous system together with endogenous neuropeptides, termed opioid-modulating peptides, participating in a homeostatic system.  Neuropeptide FF (NPFF) and related peptides possess anti-opioid properties, the cellular mechanisms of which are still unclear.  The purpose of this review is to detail the phenomenon of cross-talk taking place between opioid and NPFF systems at the in vivo pharmacol. level and to propose cellular and mol. models of functioning.  A better knowledge of the mechanisms underlying opioid-modulating properties of NPFF has potential therapeutic interest for the control of opioid functions, notably for alleviating pain and/or for the treatment of opioid abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoMvNllQW4rVg90H21EOLACvtfcHk0ljq2TNarbsnyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1eitrbM&md5=c489980c318bc15aae70b2f1285ee281</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbiof.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbiof.116%26sid%3Dliteratum%253Aachs%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DOpioid-modulating%2520properties%2520of%2520the%2520neuropeptide%2520FF%2520system%26jtitle%3DBiofactors%26date%3D2010%26volume%3D36%26spage%3D423%26epage%3D429%26doi%3D10.1002%2Fbiof.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Yang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iadarola, M. J.</span><span> </span><span class="NLM_article-title">Modulatory role of neuropeptide FF system in nociception and opiate analgesia</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.npep.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.npep.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=17854890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=1-18&author=H.+Y.+Yangauthor=T.+Taoauthor=M.+J.+Iadarola&title=Modulatory+role+of+neuropeptide+FF+system+in+nociception+and+opiate+analgesia&doi=10.1016%2Fj.npep.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulatory role of neuropeptide FF system in nociception and opiate analgesia</span></div><div class="casAuthors">Yang, Hsiu-Ying T.; Tao, Tao; Iadarola, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tetra-peptide FMRF-NH2 is a cardioexcitatory peptide in the clam.  Using the antibody against this peptide, FMRF-NH2-like immunoreactive material was detected in mammalian CNS.  Subsequently, mammalian FMRF-NH2 immunoreactive peptides were isolated from bovine brain and characterized to be FLFQPQRF-NH2 (NPFF) and AGEGLSSPFWSLAAPQRF-NH2 (NPAF).  The genes encoding NPFF precursor proteins and NPFF receptors 1 and 2 are expressed in all vertebrate species examd. to date and are highly conserved.  Among many biol. roles suggested for the NPFF system, the possible modulatory role of NPFF in nociception and opiate analgesia has been most widely investigated.  Pharmacol., NPFF-related peptides were found to exhibit analgesia and also potentiate the analgesic activity of opiates when administered intrathecally but attenuate the opiate induced analgesia when administered intracerebroventricularly.  RF-NH2 peptides including NPFF-related peptides were found to delay the rate of acid sensing ion channels (ASIC) desensitization resulting in enhancing acid gated currents, raising the possibility that NPFF also may have a pain modulatory role through ASIC.  The genes for NPFF as well as NPFF-R2, preferred receptor for NPFF, are highly unevenly expressed in the rat CNS with the highest levels localized to the superficial layers of the dorsal spinal cord.  These two genes are also present in the dorsal root ganglia (DRG), though at low levels in normal rats.  NPFF and NPFF-R2 mRNAs were found to be coordinately up-regulated in spinal cord and DRG of rats with peripheral inflammation.  In addn., NPFF-R2 immunoreactivity in the primary afferents was increased by peripheral inflammation.  The findings from the early studies on the analgesic and morphine modulating activities suggested a role for NPFF in pain modulation and this possibility is further supported by the distribution of NPFF and its receptor and the regulation of the NPFF system in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ3E7lCwQWnLVg90H21EOLACvtfcHk0liEpFtkpUrUOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVylsrg%253D&md5=ef433f74a8ebc21e349e22e1f960680b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DTao%26aufirst%3DT.%26aulast%3DIadarola%26aufirst%3DM.%2BJ.%26atitle%3DModulatory%2520role%2520of%2520neuropeptide%2520FF%2520system%2520in%2520nociception%2520and%2520opiate%2520analgesia%26jtitle%3DNeuropeptides%26date%3D2008%26volume%3D42%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.npep.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Quillet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bihel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhabazi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilien, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, F.</span><span> </span><span class="NLM_article-title">RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.pharmthera.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=84-132&author=R.+Quilletauthor=S.+Ayachiauthor=F.+Bihelauthor=K.+Elhabaziauthor=B.+Ilienauthor=F.+Simonin&title=RF-amide+neuropeptides+and+their+receptors+in+Mammals%3A+Pharmacological+properties%2C+drug+development+and+main+physiological+functions&doi=10.1016%2Fj.pharmthera.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions</span></div><div class="casAuthors">Quillet, Raphaelle; Ayachi, Safia; Bihel, Frederic; Elhabazi, Khadija; Ilien, Brigitte; Simonin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-132</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  RF-amide neuropeptides, with their typical Arg-Phe-NH2 signature at their carboxyl C-termini, belong to a lineage of peptides that spans almost the entire life tree.  Throughout evolution, RF-amide peptides and their receptors preserved fundamental roles in reprodn. and feeding, both in Vertebrates and Invertebrates.  The scope of this review is to summarize the current knowledge on the RF-amide systems in Mammals from historical aspects to therapeutic opportunities.  Taking advantage of the most recent findings in the field, special focus will be given on mol. and pharmacol. properties of RF-amide peptides and their receptors as well as on their implication in the control of different physiol. functions including feeding, reprodn. and pain.  Recent progress on the development of drugs that target RF-amide receptors will also be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNuBEfA0vxh7Vg90H21EOLACvtfcHk0liEpFtkpUrUOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCgt7g%253D&md5=47630823d26f5794a3a7b669c06ae18e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DQuillet%26aufirst%3DR.%26aulast%3DAyachi%26aufirst%3DS.%26aulast%3DBihel%26aufirst%3DF.%26aulast%3DElhabazi%26aufirst%3DK.%26aulast%3DIlien%26aufirst%3DB.%26aulast%3DSimonin%26aufirst%3DF.%26atitle%3DRF-amide%2520neuropeptides%2520and%2520their%2520receptors%2520in%2520Mammals%253A%2520Pharmacological%2520properties%252C%2520drug%2520development%2520and%2520main%2520physiological%2520functions%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D160%26spage%3D84%26epage%3D132%26doi%3D10.1016%2Fj.pharmthera.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.2174/092986611794654012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F092986611794654012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21121889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=403-409&author=Q.+Fangauthor=T.+N.+Jiangauthor=N.+Liauthor=Z.+L.+Hanauthor=R.+Wang&title=Central+administration+of+neuropeptide+FF+and+related+peptides+attenuate+systemic+morphine+analgesia+in+mice&doi=10.2174%2F092986611794654012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice</span></div><div class="casAuthors">Fang, Quan; Jiang, Tian-nan; Li, Ning; Han, Zheng-lan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-409</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) belongs to an opioid-modulating peptide family.  NPFF has been reported to play important roles in the control of pain and analgesia through interactions with the opioid system.  However, very few studies examd. the effect of supraspinal NPFF system on analgesia induced by opiates administered at the peripheral level.  In the present study, intracerebroventricular (i.c.v.) injection of NPFF (1, 3 and 10 nmol) dose-dependently inhibited systemic morphine (0.12 mg, i.p.) analgesia in the mouse tail flick test.  Similarly, i.c.v. administration of dNPA and NPVF, two agonists highly selective for NPFF2 and NPFF1 receptors, resp., decreased analgesia induced by i.p. morphine in mice.  Furthermore, these anti-opioid activities of NPFF and related peptides were blocked by pretreatment with the NPFF receptors selective antagonist RF 9 (10 nmol, i.c.v.).  These results demonstrate that activation of central NPFF1 and NPFF2 receptors has the similar anti-opioid actions on the antinociceptive effect of systemic morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQRM265cpFbVg90H21EOLACvtfcHk0liYJQ65r6_l1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlSnurs%253D&md5=52f5901722a3f7a8779a012d477058dc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F092986611794654012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986611794654012%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DT.%2BN.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DCentral%2520administration%2520of%2520neuropeptide%2520FF%2520and%2520related%2520peptides%2520attenuate%2520systemic%2520morphine%2520analgesia%2520in%2520mice%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2011%26volume%3D18%26spage%3D403%26epage%3D409%26doi%3D10.2174%2F092986611794654012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratta, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majane, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, E.</span><span> </span><span class="NLM_article-title">Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">7757</span><span class="NLM_x">–</span> <span class="NLM_lpage">7761</span><span class="refDoi"> DOI: 10.1073/pnas.82.22.7757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.82.22.7757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=3865193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL28XhsFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=7757-7761&author=H.+Y.+Yangauthor=W.+Frattaauthor=E.+A.+Majaneauthor=E.+Costa&title=Isolation%2C+sequencing%2C+synthesis%2C+and+pharmacological+characterization+of+two+brain+neuropeptides+that+modulate+the+action+of+morphine&doi=10.1073%2Fpnas.82.22.7757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine</span></div><div class="casAuthors">Yang, H. Y. T.; Fratta, W.; Majane, E. A.; Costa, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7757-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Two peptides that crossreact with an antiserum raised against Phe-Met-Arg-Phe-NH2 were purified from bovine brain ext.  Their structures were Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2  [99588-52-0] and Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2  [99566-27-5].  The sequences were detd. by gas-phase sequencing, except for the COOH-terminal phenylalaninamides.  These were assigned on the basis of the reactivity of the peptides with the anti-Phe-Met-Arg-Phe-NH2 antiserum, which appears to recognize the detd. -Arg-Phe-NH2.  Both peptides were synthesized, and the synthetic peptides have the same HPLC retention times as the endogenous Phe-Met-Arg-Phe-NH2 immunoreactive peptides, thus confirming the assignment of phenylalaninamide to the COOH-terminal positions.  Both of the synthetic peptides decreased tail-flick latency in rats, and the octapeptide was more active than the octadecapeptide.  The octapeptide also attenuated the prolongation of the tail-flick latency induced by morphine  [57-27-2].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrSLMcu4RF7Vg90H21EOLACvtfcHk0liYJQ65r6_l1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsFamuw%253D%253D&md5=545596b16b26ea9f5e6612bc1f4b306b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.22.7757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.22.7757%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DFratta%26aufirst%3DW.%26aulast%3DMajane%26aufirst%3DE.%2BA.%26aulast%3DCosta%26aufirst%3DE.%26atitle%3DIsolation%252C%2520sequencing%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520two%2520brain%2520neuropeptides%2520that%2520modulate%2520the%2520action%2520of%2520morphine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D7757%26epage%3D7761%26doi%3D10.1073%2Fpnas.82.22.7757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gouarderes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamandas, K.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/0014-2999(93)90095-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2893%2990095-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=8102975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1993&pages=73-81&author=C.+Gouarderesauthor=M.+Sutakauthor=J.+M.+Zajacauthor=K.+Jhamandas&title=Antinociceptive+effects+of+intrathecally+administered+F8Famide+and+FMRFamide+in+the+rat&doi=10.1016%2F0014-2999%2893%2990095-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat</span></div><div class="casAuthors">Gouarderes, Christine; Sutak, Maaja; Zajac, Jean Marie; Jhamandas, Khem</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of intrathecal injections of F8Famide (Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2, 0.05-17.5 nmol) and FMRFamide (Phe-Met-Arg-Phe-NH2, 0.002-25 nmol), known as anti-opioid agents, were investigated by using noxious thermal (tail flick) and mech. (paw pressure) tests in the rat.  Both peptides produced significant long-lasting (24-48 h) analgesia in both tests without causing detectable motor dysfunction.  Pretreatment with systemic naloxone (5.5 μmol/kg i.p.) attenuated the initial antinociceptive effects (first hour) induced by both peptides (8.8 nmol) in the tail flick test and only by FMRFamide in the paw pressure test.  A subeffective dose of F8Famide (0.05 nmol) enhanced both the intensity and the duration of spinal morphine (6.6 nmol) analgesia in both tests.  In contrast, a subanalgesic dose of FMRFamide (0.002 nmol) decreased the intensity and enhanced the duration of the effect of morphine.  These results show that, besides acting as antinociceptive agents in the spinal cord, F8Famide and FMRFamide could differentially modulate spinal opioid functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf1qTi_F38LVg90H21EOLACvtfcHk0liYJQ65r6_l1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFaguro%253D&md5=fd912d83d08e5853d0e304e1ae9e9084</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990095-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990095-Y%26sid%3Dliteratum%253Aachs%26aulast%3DGouarderes%26aufirst%3DC.%26aulast%3DSutak%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26aulast%3DJhamandas%26aufirst%3DK.%26atitle%3DAntinociceptive%2520effects%2520of%2520intrathecally%2520administered%2520F8Famide%2520and%2520FMRFamide%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D237%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0014-2999%2893%2990095-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kontinen, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span> </span><span class="NLM_article-title">Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">977</span><span class="refDoi"> DOI: 10.1016/0196-9781(95)00068-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0196-9781%2895%2900068-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=7479344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK2MXntFSnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=973-977&author=V.+K.+Kontinenauthor=E.+A.+Kalso&title=Differential+modulation+of+alpha+2-adrenergic+and+mu-opioid+spinal+antinociception+by+neuropeptide+FF&doi=10.1016%2F0196-9781%2895%2900068-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Differential modulation of α2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF</span></div><div class="casAuthors">Kontinen, Vesa K.; Kalso, Eija A.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Tarrytown, New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">973-7</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) has been found to act as an antiopioid peptide.  However, intrathecal NPFF has recently been shown to potentiate the antinociceptive effects of intrathecal morphine and to produce antinociception on its own.  The aim of this study was to find out whether pretreatment with NPFF causes a comparable potentiation of dexmedetomidine-induced antinociception.  NPFF (0.05-10.0 nmol) produced no antinociceptive effects in the rat tail flick test.  NPFF potentiated the antinociceptive effect of intrathecal morphine (7.8 nmol).  This potentiation was prevented by intrathecal naltrindole (28 nmol), which did not attenuate the antinociceptive effect of morphine.  Dexmedetomidine (1.6-6.4 nmol) produced a dose-dependent antinociceptive effect, which was not potentiated by NPFF.  Activation of the endogenous β-opioid system due to the antiopioid effect of intrathecal NPFF is proposed as an explanation to the reported differential action of NPFF on the μ-opioid and the α2-adrenergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXB-DrpZNe-7Vg90H21EOLACvtfcHk0ljdypYgOpjxDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFSnsr0%253D&md5=ea5d38d9c81d68eec6337cfdca8e3b53</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2895%2900068-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252895%252900068-U%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BK.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26atitle%3DDifferential%2520modulation%2520of%2520alpha%25202-adrenergic%2520and%2520mu-opioid%2520spinal%2520antinociception%2520by%2520neuropeptide%2520FF%26jtitle%3DPeptides%26date%3D1995%26volume%3D16%26spage%3D973%26epage%3D977%26doi%3D10.1016%2F0196-9781%2895%2900068-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Simonin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laulin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laboureyras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamandas, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacTavish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matifas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonnet, G.</span><span> </span><span class="NLM_article-title">RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1073/pnas.0502090103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.0502090103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16407169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=466-471&author=F.+Simoninauthor=M.+Schmittauthor=J.+P.+Laulinauthor=E.+Laboureyrasauthor=J.+H.+Jhamandasauthor=D.+MacTavishauthor=A.+Matifasauthor=C.+Mollereauauthor=P.+Laurentauthor=M.+Parmentierauthor=B.+L.+Kiefferauthor=J.+J.+Bourguignonauthor=G.+Simonnet&title=RF9%2C+a+potent+and+selective+neuropeptide+FF+receptor+antagonist%2C+prevents+opioid-induced+tolerance+associated+with+hyperalgesia&doi=10.1073%2Fpnas.0502090103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia</span></div><div class="casAuthors">Simonin, Frederic; Schmitt, Martine; Laulin, Jean-Paul; Laboureyras, Emilie; Jhamandas, Jack H.; MacTavish, David; Matifas, Audrey; Mollereau, Catherine; Laurent, Patrick; Parmentier, Marc; Kieffer, Brigitte L.; Bourguignon, Jean-Jacques; Simonnet, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) has been proposed to play a role in pain modulation, opioid tolerance, and several other physiol. processes.  However, pharmacol. agents that would help define physiol. roles for this peptide are still missing.  Here we report the discovery of a potent and selective NPFF receptor antagonist, RF9, that can be administered systemically.  This compd. does not show any effects by itself but can block efficiently the increase in blood pressure and heart rate evoked by NPFF.  When chronically coinjected with heroin, RF9 completely blocks the delayed and long-lasting paradoxical opioid-induced hyperalgesia and prevents the development of assocd. tolerance.  Our data indicate that NPFF receptors are part of a bona fide antiopioid system and that selective antagonists of these receptors could represent useful therapeutic agents for improving the efficacy of opioids in chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mP_bY_LIv7Vg90H21EOLACvtfcHk0ljdypYgOpjxDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVSksQ%253D%253D&md5=16892ae9708b76e0bd11860c3e444879</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502090103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502090103%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DF.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DLaulin%26aufirst%3DJ.%2BP.%26aulast%3DLaboureyras%26aufirst%3DE.%26aulast%3DJhamandas%26aufirst%3DJ.%2BH.%26aulast%3DMacTavish%26aufirst%3DD.%26aulast%3DMatifas%26aufirst%3DA.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DP.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DBourguignon%26aufirst%3DJ.%2BJ.%26aulast%3DSimonnet%26aufirst%3DG.%26atitle%3DRF9%252C%2520a%2520potent%2520and%2520selective%2520neuropeptide%2520FF%2520receptor%2520antagonist%252C%2520prevents%2520opioid-induced%2520tolerance%2520associated%2520with%2520hyperalgesia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D466%26epage%3D471%26doi%3D10.1073%2Fpnas.0502090103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pineda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Galiano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Garrido, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Pino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijcks, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomenrohr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Noort, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tena-Sempere, M.</span><span> </span><span class="NLM_article-title">Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1902</span><span class="NLM_x">–</span> <span class="NLM_lpage">1913</span><span class="refDoi"> DOI: 10.1210/en.2009-1259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1210%2Fen.2009-1259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20160130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1CmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=1902-1913&author=R.+Pinedaauthor=D.+Garcia-Galianoauthor=M.+A.+Sanchez-Garridoauthor=M.+Romeroauthor=F.+Ruiz-Pinoauthor=E.+Aguilarauthor=F.+A.+Dijcksauthor=M.+Blomenrohrauthor=L.+Pinillaauthor=P.+I.+van+Noortauthor=M.+Tena-Sempere&title=Characterization+of+the+potent+gonadotropin-releasing+activity+of+RF9%2C+a+selective+antagonist+of+RF-amide-related+peptides+and+neuropeptide+FF+receptors%3A+physiological+and+pharmacological+implications&doi=10.1210%2Fen.2009-1259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications</span></div><div class="casAuthors">Pineda, R.; Garcia-Galiano, D.; Sanchez-Garrido, M. A.; Romero, M.; Ruiz-Pino, F.; Aguilar, E.; Dijcks, F. A.; Blomenrohr, M.; Pinilla, L.; van Noort, P. I.; Tena-Sempere, M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1902-1913</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Identification of RF-amide-related peptides (RFRP), as putative mammalian orthologs of the avian gonadotropin-inhibitory hormone, has drawn considerable interest on its potential effects and mechanisms of action in the control of gonadotropin secretion in higher vertebrates.  Yet, these analyses have so far relied mostly on indirect approaches, while direct assessment of their physiol. roles has been hampered by the lack of suitable antagonists.  RF9 was recently reported as a selective and potent antagonist of the receptors for RFRP (RFRPR) and the related neuropeptides, neuropeptide FF (NPFF) and neuropeptide AF (NPFF receptor).  We show here that RF9 possesses very strong gonadotropin-releasing activities in vivo.  Central administration of RF9 evoked a dose-dependent increase of LH and FSH levels in adult male and female rats.  Similarly, male and female mice responded to intracerebroventricular injection of RF9 with robust LH secretory bursts.  In rats, administration of RF9 further augmented the gonadotropin-releasing effects of kisspeptin, and its stimulatory effects were detected despite the prevailing suppression of gonadotropin secretion by testosterone or estradiol.  In fact, blockade of estrogen receptor-α partially attenuated gonadotropin responses to RF9.  Finally, systemic administration of RF9 modestly stimulated LH secretion in vivo, although no direct effects in terms of gonadotropin secretion were detected at the pituitary in vitro.  Although, these data are the first to disclose the potent gonadotropin-releasing activity of RF9, a selective antagonist of RFRP (and NPFF) receptors.  Our findings support a putative role of the RFRP/gonadotropin-inhibitory hormone system in the central control of gonadotropin secretion in mammals and have interesting implications concerning the potential therapeutic indications and pharmacol. effects of RF9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocbncTm_LSjrVg90H21EOLACvtfcHk0ljdypYgOpjxDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1CmurY%253D&md5=472c43660da33a416ecee90042b9aca2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fen.2009-1259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2009-1259%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%26aufirst%3DR.%26aulast%3DGarcia-Galiano%26aufirst%3DD.%26aulast%3DSanchez-Garrido%26aufirst%3DM.%2BA.%26aulast%3DRomero%26aufirst%3DM.%26aulast%3DRuiz-Pino%26aufirst%3DF.%26aulast%3DAguilar%26aufirst%3DE.%26aulast%3DDijcks%26aufirst%3DF.%2BA.%26aulast%3DBlomenrohr%26aufirst%3DM.%26aulast%3DPinilla%26aufirst%3DL.%26aulast%3Dvan%2BNoort%26aufirst%3DP.%2BI.%26aulast%3DTena-Sempere%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520potent%2520gonadotropin-releasing%2520activity%2520of%2520RF9%252C%2520a%2520selective%2520antagonist%2520of%2520RF-amide-related%2520peptides%2520and%2520neuropeptide%2520FF%2520receptors%253A%2520physiological%2520and%2520pharmacological%2520implications%26jtitle%3DEndocrinology%26date%3D2010%26volume%3D151%26spage%3D1902%26epage%3D1913%26doi%3D10.1210%2Fen.2009-1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Marchand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betourne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marty, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daumas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frances, B.</span><span> </span><span class="NLM_article-title">A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span><span class="refDoi"> DOI: 10.1016/j.peptides.2005.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.peptides.2005.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16494968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=964-972&author=S.+Marchandauthor=A.+Betourneauthor=V.+Martyauthor=S.+Daumasauthor=H.+Halleyauthor=J.+M.+Lassalleauthor=J.+M.+Zajacauthor=B.+Frances&title=A+neuropeptide+FF+agonist+blocks+the+acquisition+of+conditioned+place+preference+to+morphine+in+C57Bl%2F6J+mice&doi=10.1016%2Fj.peptides.2005.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice</span></div><div class="casAuthors">Marchand, Stephane; Betourne, Alexandre; Marty, Virginie; Daumas, Stephanie; Halley, Helene; Lassalle, Jean-Michel; Zajac, Jean-Marie; Frances, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-972</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neuropeptide FF behaves as an opioid-modulating peptide that seems to be involved in morphine tolerance and phys. dependence.  Nevertheless, the effects of neuropeptide FF agonists on the rewarding properties of morphine remain unknown.  C57BL6 mice were conditioned in an unbiased balanced paradigm of conditioned place preference to study the effect of i.c.v. injections of 1DMe ([D-Tyr1,(NMe)Phe3]-neuropeptide FF), a stable agonist of the neuropeptide FF system, on the acquisition of place conditioning by morphine or alc. (ethanol).  Morphine (10 mg/kg, i.p.) or ethanol (2 g/kg, i.p.) induced a significant place preference.  Injection of 1DMe (1-20 nmol), given 10 min before the i.p. injection of the reinforcing drug during conditioning, inhibited the rewarding effect of morphine but had no effect on the rewarding effect of ethanol.  However, a single injection of 1DMe given just before place preference testing was unable to inhibit the rewarding effects of morphine.  By itself, 1DMe was inactive but an aversive effect of this agonist could be evidenced if the exptl. procedure was biased.  These results suggest that neuropeptide FF, injected during conditioning, should influence the development of rewarding effects of morphine and reinforce the hypothesis of strong inhibitory interactions between neuropeptide FF and opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWobhvneEwrLVg90H21EOLACvtfcHk0lilCFqwRR3paA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVeitb4%253D&md5=b1ef3824383885ae0c952de0e9c574b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DS.%26aulast%3DBetourne%26aufirst%3DA.%26aulast%3DMarty%26aufirst%3DV.%26aulast%3DDaumas%26aufirst%3DS.%26aulast%3DHalley%26aufirst%3DH.%26aulast%3DLassalle%26aufirst%3DJ.%2BM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26aulast%3DFrances%26aufirst%3DB.%26atitle%3DA%2520neuropeptide%2520FF%2520agonist%2520blocks%2520the%2520acquisition%2520of%2520conditioned%2520place%2520preference%2520to%2520morphine%2520in%2520C57Bl%252F6J%2520mice%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D964%26epage%3D972%26doi%3D10.1016%2Fj.peptides.2005.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.bbr.2013.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bbr.2013.03.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2013&pages=51-56&author=Z.+L.+Hanauthor=Z.+L.+Wangauthor=H.+Z.+Tangauthor=N.+Liauthor=Q.+Fangauthor=X.+H.+Liauthor=X.+L.+Yangauthor=X.+Y.+Zhangauthor=R.+Wang&title=Neuropeptide+FF+attenuates+the+acquisition+and+the+expression+of+conditioned+place+aversion+to+endomorphin-2+in+mice&doi=10.1016%2Fj.bbr.2013.03.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DTang%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DNeuropeptide%2520FF%2520attenuates%2520the%2520acquisition%2520and%2520the%2520expression%2520of%2520conditioned%2520place%2520aversion%2520to%2520endomorphin-2%2520in%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D248%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.bbr.2013.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1880</span><span class="refDoi"> DOI: 10.1111/bph.13489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1111%2Fbph.13489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=27018797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmtlenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=1864-1880&author=N.+Liauthor=Z.+L.+Hanauthor=Z.+L.+Wangauthor=Y.+H.+Xingauthor=Y.+L.+Sunauthor=X.+H.+Liauthor=J.+J.+Songauthor=T.+Zhangauthor=R.+Zhangauthor=M.+N.+Zhangauthor=B.+Xuauthor=Q.+Fangauthor=R.+Wang&title=BN-9%2C+a+chimeric+peptide+with+mixed+opioid+and+neuropeptide+FF+receptor+agonistic+properties%2C+produces+nontolerance-forming+antinociception+in+mice&doi=10.1111%2Fbph.13489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice</span></div><div class="casAuthors">Li, Ning; Han, Zheng-lan; Wang, Zi-long; Xing, Yan-hong; Sun, Yu-long; Li, Xu-hui; Song, Jing-jing; Zhang, Ting; Zhang, Run; Zhang, Meng-na; Xu, Biao; Fang, Quan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1864-1880</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Neuropeptide FF (NPFF) behaves as an endogenous opioid-modulating peptide.  In the present study, the opioid and NPFF pharmacophore-contg. chimeric peptide BN-9 was synthesized and pharmacol. characterized.  Exptl. Approach : Agonist activities of BN-9 at opioid and NPFF receptors were characterized in in vitro cAMP assays.  Antinociceptive activities of BN-9 were evaluated in the mouse tail-flick and formalin tests.  Furthermore, its side effects were investigated in rotarod, antinociceptive tolerance, reward and gastrointestinal transit tests.  Key Results : BN-9 acted as a novel multifunctional agonist at μ, δ, κ, NPFF1 and NPFF2 receptors in cAMP assays.  In the tail-flick test, BN-9 produced dose-related antinociception and was approx. equipotent to morphine; this antinociception was blocked by μ and κ receptor antagonists, but not by the δ receptor antagonist.  In the formalin test, supraspinal administration of BN-9 produced significant analgesia.  Notably, repeated administration of BN-9 produced analgesia without loss of potency over 8 days.  In contrast, repeated i.c.v. co-administration of BN-9 with the NPFF receptor antagonist RF9 produced significant antinociceptive tolerance.  Furthermore, i.c.v.  BN-9 induced conditioned place preference.  When given by the same routes, BN-9 had a more than eightfold higher ED50 value for gastrointestinal transit inhibition compared with the ED50 values for antinociception.  Conclusions and Implications : BN-9 produced a robust, nontolerance-forming analgesia with limited inhibition of gastrointestinal transit.  As BN-9 is able to activate both opioid and NPFF systems, this provides an interesting approach for the development of novel analgesics with minimal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpicXFgT8DcO7Vg90H21EOLACvtfcHk0lilCFqwRR3paA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmtlenu7Y%253D&md5=90dce7f015555e141e30a0e82d8bdfd7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fbph.13489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13489%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DXing%26aufirst%3DY.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%2BN.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DBN-9%252C%2520a%2520chimeric%2520peptide%2520with%2520mixed%2520opioid%2520and%2520neuropeptide%2520FF%2520receptor%2520agonistic%2520properties%252C%2520produces%2520nontolerance-forming%2520antinociception%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D1864%26epage%3D1880%26doi%3D10.1111%2Fbph.13489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrig, C. A.</span><span> </span><span class="NLM_article-title">Recent developments in the design of receptor specific opioid peptides</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1002/med.2610090306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fmed.2610090306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=2547125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=343-401&author=V.+J.+Hrubyauthor=C.+A.+Gehrig&title=Recent+developments+in+the+design+of+receptor+specific+opioid+peptides&doi=10.1002%2Fmed.2610090306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of receptor-specific opioid peptides</span></div><div class="casAuthors">Hruby, Victor; Gehrig, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-401</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 179 refs., describing the design of peptides with specificity for the μ-, δ-, and κ-opioid receptors.  Opioid antagonists of a peptide nature are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYb3tCrcYC7Vg90H21EOLACvtfcHk0liOBl5Z3OxA2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSiurc%253D&md5=a8feef3e6753c2bb9c25d33176bda87a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610090306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610090306%26sid%3Dliteratum%253Aachs%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DGehrig%26aufirst%3DC.%2BA.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520receptor%2520specific%2520opioid%2520peptides%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1989%26volume%3D9%26spage%3D343%26epage%3D401%26doi%3D10.1002%2Fmed.2610090306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Liu, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1002/med.20222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fmed.20222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=536-580&author=W.+X.+Liuauthor=R.+Wang&title=Endomorphins%3A+potential+roles+and+therapeutic+indications+in+the+development+of+opioid+peptide+analgesic+drugs&doi=10.1002%2Fmed.20222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs</span></div><div class="casAuthors">Liu, Wei X.; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">536-580</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The application of endomorphins as clin. available analgesic drugs has been impeded by their relatively poor receptor selectivity compared with alkaloid analgesics, rapid degrdn. in vivo, inefficient to penetrate the blood-brain barrier (BBB), and undesirable or toxic effects, such as acute tolerance and phys. dependence, respiratory depression, and inhibition of gastrointestinal motility.  Extensive studies have been performed so far striving to conquer these problems.  In this article we review and discuss conformational and topog. modifications of the peptide amide bond and amino acid side groups to attain the most appropriate receptor binding affinity and high receptor selectivity; diverse strategies such as insertion of unnatural amino acids, covalent or noncovalent constraints as well as cyclization of linear peptides to enhance the enzymic stability; designing of peptidomimetic ligands, glycopeptides, and N-terminal amidinationed analogs (such as incorporating guanidine into endomorphins) to penetrate the BBB.  Also, several pertinent examples of bivalent and/or multivalent (such as mixed μ-agonist/δ-antagonist profile) compds. are discussed based on the existing literature and current data intending to give an insight into the development of opioid peptides expressing low tendency to produce acute tolerance and phys. dependence. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 32, No. 3, 536-580, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHdETrlLSOH7Vg90H21EOLACvtfcHk0liOBl5Z3OxA2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWnsr8%253D&md5=5a5183b1c9059cc3ea55ed9154cc6907</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fmed.20222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20222%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEndomorphins%253A%2520potential%2520roles%2520and%2520therapeutic%2520indications%2520in%2520the%2520development%2520of%2520opioid%2520peptide%2520analgesic%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D536%26epage%3D580%26doi%3D10.1002%2Fmed.20222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Vyas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheve, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.peptides.2005.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.peptides.2005.07.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=990-996&author=N.+Vyasauthor=C.+Mollereauauthor=G.+Cheveauthor=C.+R.+McCurdy&title=Structure-activity+relationships+of+neuropeptide+FF+and+related+peptidic+and+non-peptidic+derivatives&doi=10.1016%2Fj.peptides.2005.07.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DVyas%26aufirst%3DN.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DCheve%26aufirst%3DG.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DStructure-activity%2520relationships%2520of%2520neuropeptide%2520FF%2520and%2520related%2520peptidic%2520and%2520non-peptidic%2520derivatives%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D990%26epage%3D996%26doi%3D10.1016%2Fj.peptides.2005.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Summers, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, R. J.</span><span> </span><span class="NLM_article-title">The interaction of N alpha-alkylenkephalins with opiate receptors. Tissue-dependent shifts in the opiate activity of methionine-enkephalin following N alpha-alkylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1981&pages=4951-4956&author=M.+C.+Summersauthor=R.+J.+Hayes&title=The+interaction+of+N+alpha-alkylenkephalins+with+opiate+receptors.+Tissue-dependent+shifts+in+the+opiate+activity+of+methionine-enkephalin+following+N+alpha-alkylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DM.%2BC.%26aulast%3DHayes%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520interaction%2520of%2520N%2520alpha-alkylenkephalins%2520with%2520opiate%2520receptors.%2520Tissue-dependent%2520shifts%2520in%2520the%2520opiate%2520activity%2520of%2520methionine-enkephalin%2520following%2520N%2520alpha-alkylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26volume%3D256%26spage%3D4951%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Audigier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gout, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cros, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0014-2999(80)90114-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2880%2990114-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=6247160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL3cXktF2ksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1980&pages=35-46&author=Y.+Audigierauthor=H.+Mazarguilauthor=R.+Goutauthor=J.+Cros&title=Structure-activity+relationships+of+enkephalin+analogs+at+opiate+and+enkephalin+receptors%3A+correlation+with+analgesia&doi=10.1016%2F0014-2999%2880%2990114-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors:  correlation with analgesia</span></div><div class="casAuthors">Audigier, Y.; Mazarguil, H.; Gout, R.; Cros, J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The influences of physico-chem. parameters (chem. structure and lipophilicity), biochem. properties (catabolism, affinity for etorphine binding sites and (D-Ala)2-Leu5-enkephalinamide binding sites), and biol. activities in isolated organs (guinea pig ileum and mouse vas deferens) on the regulation of analgesia induced after intracerebroventricular injection of various enkephalin analogs were detd.  The selectivity of these metabolically stable analogs for μ- and δ-receptors, present in guinea pig ileum and mouse vas deferens, resp., depended on the C-terminal amino acid and also on the nature of the 2nd D-amino acid.  A strong correlation existed between activity in guinea pig ileum and affinity for etorphine binding sites, suggesting that these sites in rat brain have properties identical to those of μ-receptors characterized in guinea pig ileum.  Similarly, the affinity for (D-Ala)2-Leu5-enkephalinamide binding sites in mouse brain correlated with the activity in mouse vas deferens and suggested that central δ-receptors are not different from peripheral δ-receptors.  Considering morphine-like drugs and enkephalin analogs contg. the same C-terminal amino acid as the enkephalins, there was a good correlation between activity on μ-receptors (affinity for etorphine binding sites and activity in guinea pig ileum) and the antinociceptive activity.  This supports the hypothesis that μ-receptors are strongly involved in the analgesic effect.  However, when proline was the C-terminal amino acid, the antinociceptive activity was enhanced without any concomitant increase in the affinity.  This activity enhancement was the same for each analog and a similar correlation (identical to what was found with other opioid peptides and opiates) could still be established.  The reason for such a potentiation of the activity remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6jjF8XqMzt7Vg90H21EOLACvtfcHk0liOBl5Z3OxA2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktF2ksr8%253D&md5=554ff23f80e7c142e4c077c11f36b8a3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2880%2990114-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252880%252990114-4%26sid%3Dliteratum%253Aachs%26aulast%3DAudigier%26aufirst%3DY.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DGout%26aufirst%3DR.%26aulast%3DCros%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationships%2520of%2520enkephalin%2520analogs%2520at%2520opiate%2520and%2520enkephalin%2520receptors%253A%2520correlation%2520with%2520analgesia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1980%26volume%3D63%26spage%3D35%26epage%3D46%26doi%3D10.1016%2F0014-2999%2880%2990114-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shaw, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, M. J.</span><span> </span><span class="NLM_article-title">In vitro profile of some opioid pentapeptide analogues</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1016/0014-2999(78)90109-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2878%2990109-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaE1cXlsFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1978&pages=313-317&author=J.+S.+Shawauthor=M.+J.+Turnbull&title=In+vitro+profile+of+some+opioid+pentapeptide+analogues&doi=10.1016%2F0014-2999%2878%2990109-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro profile of some opioid pentapeptide analogs</span></div><div class="casAuthors">Shaw, John S.; Turnbull, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-17</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The opiate agonist potency of 13 synthetic enkephalin pentapeptides was examd. on the elec.-stimulated guinea pig ileum and mouse vas deferens prepns. in comparison with Met-enkephalin  [58569-55-4], Leu-enkephalin  [58822-25-6], β-endorphin  [60617-12-1], and normorphine  [466-97-7].  Their antagonism by naloxone was also assessed on each prepn.  The findings are compatible with, and are discussed in the context of, the presence of at least 2 populations of receptors in these prepns..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUD_wveHlrgLVg90H21EOLACvtfcHk0lj3g9z_tBcZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlsFOksb8%253D&md5=f8ec859f9a2298f9b67969a0dba05338</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990109-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990109-7%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DTurnbull%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vitro%2520profile%2520of%2520some%2520opioid%2520pentapeptide%2520analogues%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D49%26spage%3D313%26epage%3D317%26doi%3D10.1016%2F0014-2999%2878%2990109-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Wuster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, R.</span><span> </span><span class="NLM_article-title">The preference of putative pro-enkephalins for different types of opiate receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90226-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0024-3205%2881%2990226-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=1219-1227&author=M.+Wusterauthor=P.+Rubiniauthor=R.+Schulz&title=The+preference+of+putative+pro-enkephalins+for+different+types+of+opiate+receptors&doi=10.1016%2F0024-3205%2881%2990226-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990226-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990226-5%26sid%3Dliteratum%253Aachs%26aulast%3DWuster%26aufirst%3DM.%26aulast%3DRubini%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DR.%26atitle%3DThe%2520preference%2520of%2520putative%2520pro-enkephalins%2520for%2520different%2520types%2520of%2520opiate%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D29%26spage%3D1219%26epage%3D1227%26doi%3D10.1016%2F0024-3205%2881%2990226-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Handa, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. F.</span><span> </span><span class="NLM_article-title">Analogues of beta-LPH61–64 possessing selective agonist activity at mu-opiate receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span><span class="refDoi"> DOI: 10.1016/0014-2999(81)90364-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2881%2990364-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=6263640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL3MXksFGhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1981&pages=531-540&author=B.+K.+Handaauthor=A.+C.+Laneauthor=J.+A.+Lordauthor=B.+A.+Morganauthor=M.+J.+Ranceauthor=C.+F.+Smith&title=Analogues+of+beta-LPH61%E2%80%9364+possessing+selective+agonist+activity+at+mu-opiate+receptors&doi=10.1016%2F0014-2999%2881%2990364-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of β-LPH61-64 possessing selective agonist activity at μ-opiate receptors</span></div><div class="casAuthors">Handa, Balraj K.; Lane, Anthony C.; Lord, John A. H.; Morgan, Barry A.; Rance, Michael J.; Smith, Colin F. C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-40</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Peptides based on the stabilized tetrapeptide HTyr-D-Ala-Gly-MePheOH were synthesized (M. et al. 1977) and shown to have substantial opioid activity both in vitro and in vivo.  The selectivity of these compds. for different receptor populations was investigated using both isolated tissue assays and binding studies.  Results suggest that the compds. are potent agonists at μ-receptors with little or no affinity for the δ-receptor population.  One of the compds., RX 783006 (Tyr-D-Ala-Gly-MePhe-NH(CH2)2OH)  [78123-71-4], was tritiated to high specific radioactivity and may prove to be a useful probe in the elucidation of the function of the heterogeneous opiate receptor population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp14h_RQou3fLVg90H21EOLACvtfcHk0lj3g9z_tBcZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFGhtbY%253D&md5=6dc5006ca4ee4e384466f421cd23425d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2881%2990364-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252881%252990364-2%26sid%3Dliteratum%253Aachs%26aulast%3DHanda%26aufirst%3DB.%2BK.%26aulast%3DLane%26aufirst%3DA.%2BC.%26aulast%3DLord%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DRance%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BF.%26atitle%3DAnalogues%2520of%2520beta-LPH61%25E2%2580%259364%2520possessing%2520selective%2520agonist%2520activity%2520at%2520mu-opiate%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D70%26spage%3D531%26epage%3D540%26doi%3D10.1016%2F0014-2999%2881%2990364-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouarderes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tafani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of neuropeptide FF: role of C-terminal regions</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1016/S0196-9781(01)00468-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2FS0196-9781%2801%2900468-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11514031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=1471-1478&author=H.+Mazarguilauthor=C.+Gouarderesauthor=J.+A.+Tafaniauthor=D.+Marcusauthor=M.+Kotaniauthor=C.+Mollereauauthor=M.+Roumyauthor=J.+M.+Zajac&title=Structure-activity+relationships+of+neuropeptide+FF%3A+role+of+C-terminal+regions&doi=10.1016%2FS0196-9781%2801%2900468-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of neuropeptide FF: role of C-terminal regions</span></div><div class="casAuthors">Mazarguil, H.; Gouarderes, C.; Tafani, J.-A. M.; Marcus, D.; Kotani, M.; Mollereau, C.; Roumy, M.; Zajac, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1471-1478</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A structure-activity study was carried out to det. the importance of the C-terminal amino acids of the octapeptide Neuropeptide FF (NPFF) in binding and agonistic activity.  Affinities of NPFF analogs were tested toward NPFF receptors of the rat spinal cord and the human NPFF2 receptors transfected in CHO cells.  The activities of these analogs were evaluated by their ability to both inhibit adenylate cyclase in NPFF2 receptor transfected CHO cells and to reverse the effect of nociceptin on acutely dissocd. rat dorsal raphe neurons.  The substitutions of Phenylalanine8 by a tyrosine, phenylglycine or homophenylalanine were deleterious for high affinity.  Similarly, the replacement of Arginine7 by a lysine or D-Arginine induces a loss in affinity.  The pharmacol. characterization showed that the presence of the amidated Phe8 and Arg7 residues are also extremely crit. for activation of anti-opioid effects on dorsal raphe neurons.  The sequence of the C-terminal dipeptide seems also to be responsible for the high affinity and the activity on human NPFF2 receptors.  The results support the view that a code messaging the mol. interaction toward NPFF-receptors is expressed in the C-terminal region of these peptides but the N-terminal segment is important to gain very high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqJrQWywXEbVg90H21EOLACvtfcHk0lj3g9z_tBcZJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksLc%253D&md5=a5527ccb1b91887b8f821a9af783cada</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900468-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900468-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DGouarderes%26aufirst%3DC.%26aulast%3DTafani%26aufirst%3DJ.%2BA.%26aulast%3DMarcus%26aufirst%3DD.%26aulast%3DKotani%26aufirst%3DM.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DRoumy%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationships%2520of%2520neuropeptide%2520FF%253A%2520role%2520of%2520C-terminal%2520regions%26jtitle%3DPeptides%26date%3D2001%26volume%3D22%26spage%3D1471%26epage%3D1478%26doi%3D10.1016%2FS0196-9781%2801%2900468-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Gicquel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desprat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devillers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3477</span><span class="NLM_x">–</span> <span class="NLM_lpage">3481</span><span class="refDoi"> DOI: 10.1021/jm00047a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00047a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3477-3481&author=S.+Gicquelauthor=H.+Mazarguilauthor=C.+Despratauthor=M.+Allardauthor=J.+P.+Devillersauthor=G.+Simonnetauthor=J.+M.+Zajac&title=Structure-activity+study+of+neuropeptide+FF%3A+contribution+of+N-terminal+regions+to+affinity+and+activity&doi=10.1021%2Fjm00047a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Study of Neuropeptide FF: Contribution of N-Terminal Regions to Affinity and Activity</span></div><div class="casAuthors">Gicquel, Sophie; Mazarguil, Honore; Desprat, Corinne; Allard, Michele; Devillers, Jean-Philippe; Simonnet, Guy; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3477-81</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Twenty neuropeptide FF (NPFF) analogs having various lengths were synthesized by solid-phase peptide synthesis to gain more information on the role of N-terminal residues for the NPFF receptor affinity.  The affinities were evaluated in the rat spinal cord membrane prepns., and the biol. activities were measured on morphine analgesia in the mouse tail-flick test.  Shortening of the NPFF sequence from the N-terminus produced only a moderate decrease in affinity until NPFF(4-8) was reached.  In the same way, NPFF(3-8) significantly decreased morphine analgesia, while NPFF(4-8) had no significant effect at a dose of 22 nmol.  The introduction in the N-terminal part of NPFF of a D-enantiomer at positions 2 and 1 or the presence of an N-Me group on position 3 did not modify affinity and activity.  Substitution of proline5 by the D-isomer decreased the affinity of NPFF analogs whatever their length, and [Tyr1,D-Pro5]NPFF(1-8) was 2.5-fold less potent than [Tyr1]NPFF(1-8) in reversing morphine-induced analgesia.  In contrast, the presence of a glycine residue in position 5 did not influence the affinity toward NPFF receptors.  Data provide evidence that the N-terminal segment of neuropeptide FF is responsible for high-affinity binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr890at16DLTLVg90H21EOLACvtfcHk0lhVOx_vvEiYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKitrs%253D&md5=215b2957aa0393eeb0d0d935150de4a5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm00047a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00047a005%26sid%3Dliteratum%253Aachs%26aulast%3DGicquel%26aufirst%3DS.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DDesprat%26aufirst%3DC.%26aulast%3DAllard%26aufirst%3DM.%26aulast%3DDevillers%26aufirst%3DJ.%2BP.%26aulast%3DSimonnet%26aufirst%3DG.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520study%2520of%2520neuropeptide%2520FF%253A%2520contribution%2520of%2520N-terminal%2520regions%2520to%2520affinity%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3477%26epage%3D3481%26doi%3D10.1021%2Fjm00047a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Raehal, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span> </span><span class="NLM_article-title">Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1124/pr.111.004598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1124%2Fpr.111.004598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21873412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1001-1019&author=K.+M.+Raehalauthor=C.+L.+Schmidauthor=C.+E.+Groerauthor=L.+M.+Bohn&title=Functional+selectivity+at+the+mu-opioid+receptor%3A+implications+for+understanding+opioid+analgesia+and+tolerance&doi=10.1124%2Fpr.111.004598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance</span></div><div class="casAuthors">Raehal, Kirsten M.; Schmid, Cullen L.; Groer, Chad E.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1001-1019</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Opioids are the most effective analgesic drugs for the management of moderate or severe pain, yet their clin. use is often limited because of the onset of adverse side effects.  Drugs in this class produce most of their physiol. effects through activation of the μ opioid receptor; however, an increasing no. of studies demonstrate that different opioids, while presumably acting at this single receptor, can activate distinct downstream responses, a phenomenon termed functional selectivity.  Functional selectivity of receptor-mediated events can manifest as a function of the drug used, the cellular or neuronal environment examd., or the signaling or behavioral measure recorded.  This review summarizes both in vitro and in vivo work demonstrating functional selectivity at the μ opioid receptor in terms of G protein coupling, receptor phosphorylation, interactions with β-arrestins, receptor desensitization, internalization and signaling, and details on how these differences may relate to the progression of analgesic tolerance after their extended use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2I02i0h7f87Vg90H21EOLACvtfcHk0lhVOx_vvEiYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ksb0%253D&md5=ad63762316c6f136fbbd3155d0364199</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004598%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DSchmid%26aufirst%3DC.%2BL.%26aulast%3DGroer%26aufirst%3DC.%2BE.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DFunctional%2520selectivity%2520at%2520the%2520mu-opioid%2520receptor%253A%2520implications%2520for%2520understanding%2520opioid%2520analgesia%2520and%2520tolerance%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1001%26epage%3D1019%26doi%3D10.1124%2Fpr.111.004598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/35047086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2F35047086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11130073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=720-723&author=L.+M.+Bohnauthor=R.+R.+Gainetdinovauthor=F.+T.+Linauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=Mu-opioid+receptor+desensitization+by+beta-arrestin-2+determines+morphine+tolerance+but+not+dependence&doi=10.1038%2F35047086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence</span></div><div class="casAuthors">Bohn, Laura M.; Gainetdinov, Raul R.; Lin, Fang-Tsyr; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">720-723</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence.  The development of opiate tolerance occurs on continued use of the drug such that the amt. of drug required to elicit pain relief must be increased to compensate for diminished responsiveness.  In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors.  In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called β-arrestins.  Using a knockout mouse lacking β-arrestin-2 (βarr2-/-), we have assessed the contribution of desensitization of the μ-opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of phys. dependence.  Here we show that in mice lacking β-arrestin-2, desensitization of the μ-opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance.  However, the deletion of β-arrestin-2 does not prevent the chronic morphine-induced up-regulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become phys. dependent on the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOyilKuNxt7Vg90H21EOLACvtfcHk0lhVOx_vvEiYJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D&md5=6c54b96c15fec1c9620d1fd90d24a1eb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2F35047086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047086%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DMu-opioid%2520receptor%2520desensitization%2520by%2520beta-arrestin-2%2520determines%2520morphine%2520tolerance%2520but%2520not%2520dependence%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D720%26epage%3D723%26doi%3D10.1038%2F35047086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolle, R. E.</span><span> </span><span class="NLM_article-title">Peripherally restricted opioid agonists as novel analgesic agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.2174/1381612043453036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F1381612043453036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=15032700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=743-757&author=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Peripherally+restricted+opioid+agonists+as+novel+analgesic+agents&doi=10.2174%2F1381612043453036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally restricted opioid agonists as novel analgesic agents</span></div><div class="casAuthors">DeHaven-Hudkins, D. L.; Dolle, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mediation of antinociception via opioid receptors located in the periphery is a viable strategy to produce analgesia without the occurrence of side effects assocd. with stimulation of opioid receptors located in the central nervous system.  Peripheral opioid receptors are particularly important in inflammatory pain states and in the responses to pruritogenic stimuli, and have been implicated in the transmission of visceral pain.  Medicinal chem. approaches to achieve peripheralization of opioid agonists have started with a centrally acting opioid agonist as a template, and introduced features of lipophilicity, hydrophilicity, or combined lipophilicity and hydrophilicity to achieve amphiphilicity.  Quaternarization of centrally acting opioid agonists or identification of compds. that serve as substrates for the mdr transporter to achieve transport out of the brain has also been employed.  The in vivo assays used to identify peripherally selective compds. have measured a variety of behavioral and pharmacokinetic endpoints, with varying degrees of predictability.  This review focuses on a discussion of these methods, as well as a review of those compds. where sufficient data exist to support a claim of peripheralization in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooc-Vny_w6QrVg90H21EOLACvtfcHk0liXj_g6_KmN_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFOktbc%253D&md5=f3168a79c9798ca1fed846744baa1a41</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F1381612043453036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043453036%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DPeripherally%2520restricted%2520opioid%2520agonists%2520as%2520novel%2520analgesic%2520agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D743%26epage%3D757%26doi%3D10.2174%2F1381612043453036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Smith, H. S.</span><span> </span><span class="NLM_article-title">Peripherally-acting opioids</span> <span class="citation_source-journal">Pain Physician</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=S121-S132&author=H.+S.+Smith&title=Peripherally-acting+opioids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DH.%2BS.%26atitle%3DPeripherally-acting%2520opioids%26jtitle%3DPain%2520Physician%26date%3D2008%26volume%3D11%26spage%3DS121%26epage%3DS132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Stein, C.</span><span> </span><span class="NLM_article-title">Targeting pain and inflammation by peripherally acting opioids</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="refDoi"> DOI: 10.3389/fphar.2013.00123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.3389%2Ffphar.2013.00123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=24068999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FhsV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=123&author=C.+Stein&title=Targeting+pain+and+inflammation+by+peripherally+acting+opioids&doi=10.3389%2Ffphar.2013.00123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pain and inflammation by peripherally acting opioids</span></div><div class="casAuthors">Stein Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2CrTRODPZSxOk4JA3soTqfW6udTcc2eY5yccvndvSubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FhsV2huw%253D%253D&md5=0b64fd10bdac1329034c463688415d78</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00123%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26atitle%3DTargeting%2520pain%2520and%2520inflammation%2520by%2520peripherally%2520acting%2520opioids%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D123%26doi%3D10.3389%2Ffphar.2013.00123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Dubuisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, S. G.</span><span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine%2C+and+brain+stem+stimulation+in+rats+and+cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0liXj_g6_KmN_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%252C%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.neuropharm.2016.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26970017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Shsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=364-372&author=Z.+L.+Wangauthor=N.+Liauthor=P.+Wangauthor=H.+H.+Tangauthor=Z.+L.+Hanauthor=J.+J.+Songauthor=X.+H.+Liauthor=H.+P.+Yuauthor=T.+Zhangauthor=R.+Zhangauthor=B.+Xuauthor=M.+N.+Zhangauthor=Q.+Fangauthor=R.+Wang&title=Pharmacological+characterization+of+EN-9%2C+a+novel+chimeric+peptide+of+endomorphin-2+and+neuropeptide+FF+that+produces+potent+antinociceptive+activity+and+limited+tolerance&doi=10.1016%2Fj.neuropharm.2016.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance</span></div><div class="casAuthors">Wang, Zi-long; Li, Ning; Wang, Pei; Tang, Hong-hai; Han, Zheng-lan; Song, Jing-jing; Li, Xu-hui; Yu, Hong-ping; Zhang, Ting; Zhang, Run; Xu, Biao; Zhang, Meng-na; Fang, Quan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">364-372</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mounting evidences indicate the functional interactions between neuropeptide FF (NPFF) and opioids, including the endogenous opioids.  In the present work, EN-9, a chimeric peptide contg. the functional domains of the endogenous opioid endomorphin-2 (EM-2) and NPFF, was synthesized and pharmacol. characterized.  In vitro cAMP assay demonstrated that EN-9 was a multifunctional agonist of κ-opioid, NPFF1 and NPFF2 receptors.  In the mouse tail-flick test, intracerebroventricularly (i.c.v.) administration of EN-9 produced significant antinociception with an ED50 value of 13.44 nmol, which lasted longer than that of EM-2.  In addn., EN-9 induced potent antinociception after both i.v. (i.v.) and s.c. (s.c.) injection.  Furthermore, the expts. using the antagonists of opioid and NPFF receptors indicated that the central antinociception of EN-9 was mainly mediated by κ-opioid receptor, independently on NPFF receptors.  Notably, the central antinociception of EN-9 was not reduced over a period of 6 days repeated i.c.v. injection.  Repeated i.c.v. administration of EN-9 with the NPFF1 and NPFF2 receptors antagonist RF9 resulted in a progressive loss of analgesic potency, consistent with the development of tolerance.  Moreover, central administration of EN-9 induced the place conditioning aversion only at a high dose of 60 nmol, but not at low doses.  At supraspinal level, only high dose of EN-9 (60 nmol, i.c.v.) inhibited gastrointestinal transit via NPFF receptors.  Similarly, systemic administration of EN-9 also inhibited gastrointestinal transit at high doses (10 and 30 mg/kg, i.v.).  Taken together, the multifunctional agonist of κ-opioid and NPFF receptors EN-9 produced a potent, non-tolerance forming antinociception with limited side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoby4T7pGme6bVg90H21EOLACvtfcHk0ljm5t3hAGlU4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Shsbo%253D&md5=0b9dd9d2bdeba08a9b0248c7a0c68296</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DH.%2BH.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DYu%26aufirst%3DH.%2BP.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%2BN.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DPharmacological%2520characterization%2520of%2520EN-9%252C%2520a%2520novel%2520chimeric%2520peptide%2520of%2520endomorphin-2%2520and%2520neuropeptide%2520FF%2520that%2520produces%2520potent%2520antinociceptive%2520activity%2520and%2520limited%2520tolerance%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D108%26spage%3D364%26epage%3D372%26doi%3D10.1016%2Fj.neuropharm.2016.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e103773</span><span class="refDoi"> DOI: 10.1371/journal.pone.0103773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1371%2Fjournal.pone.0103773" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e103773&author=Z.+L.+Wangauthor=Q.+Fangauthor=Z.+L.+Hanauthor=J.+X.+Panauthor=X.+H.+Liauthor=N.+Liauthor=H.+H.+Tangauthor=P.+Wangauthor=T.+Zhengauthor=X.+M.+Changauthor=R.+Wang&title=Opposite+effects+of+neuropeptide+FF+on+central+antinociception+induced+by+endomorphin-1+and+endomorphin-2+in+mice&doi=10.1371%2Fjournal.pone.0103773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0103773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0103773%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%2BH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%2BM.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DOpposite%2520effects%2520of%2520neuropeptide%2520FF%2520on%2520central%2520antinociception%2520induced%2520by%2520endomorphin-1%2520and%2520endomorphin-2%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De103773%26doi%3D10.1371%2Fjournal.pone.0103773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">A new class of highly potent and selective endomorphin-1 analogues containing alpha-methylene-beta-aminopropanoic acids (map)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6224</span><span class="NLM_x">–</span> <span class="NLM_lpage">6236</span><span class="refDoi"> DOI: 10.1021/jm300664y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300664y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6224-6236&author=Y.+Wangauthor=Y.+Xingauthor=X.+Liuauthor=H.+Jiauthor=M.+Kaiauthor=Z.+Chenauthor=J.+Yuauthor=D.+Zhaoauthor=H.+Renauthor=R.+Wang&title=A+new+class+of+highly+potent+and+selective+endomorphin-1+analogues+containing+alpha-methylene-beta-aminopropanoic+acids+%28map%29&doi=10.1021%2Fjm300664y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm300664y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300664y%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DKai%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DA%2520new%2520class%2520of%2520highly%2520potent%2520and%2520selective%2520endomorphin-1%2520analogues%2520containing%2520alpha-methylene-beta-aminopropanoic%2520acids%2520%2528map%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6224%26epage%3D6236%26doi%3D10.1021%2Fjm300664y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mengna Zhang, Biao Xu, Ning Li, Hui Liu, Xuerui Shi, Qinqin Zhang, Yanbin Shi, Kangtai Xu, Jian Xiao, Dan Chen, Hanwen Zhu, Yulong Sun, Ting Zhang, Run Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Quan Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15709-15725. <a href="https://doi.org/10.1021/acs.jmedchem.0c01367" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BCharacterization%252Bof%252BCyclic%252BDisulfide-Containing%252BPeptide%252BAnalogs%252Bof%252Bthe%252BMultifunctional%252BOpioid%25252FNeuropeptide%252BFF%252BReceptor%252BAgonists%252BThat%252BProduce%252BLong-Lasting%252Band%252BNontolerant%252BAntinociception%26aulast%3DZhang%26aufirst%3DMengna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05082020%26date%3D03122020%26volume%3D63%26issue%3D24%26spage%3D15709%26epage%3D15725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thuy Nguyen, Julie Marusich, Jun-Xu Li, <span class="NLM_string-name hlFld-ContribAuthor">Yanan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12387-12402. <a href="https://doi.org/10.1021/acs.jmedchem.0c00643" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00643%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNeuropeptide%252BFF%252Band%252BIts%252BReceptors%25253A%252BTherapeutic%252BApplications%252Band%252BLigand%252BDevelopment%26aulast%3DNguyen%26aufirst%3DThuy%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19042020%26date%3D31072020%26date%3D16072020%26volume%3D63%26issue%3D21%26spage%3D12387%26epage%3D12402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junxian Yang, Wangsheng Sun, Zeyuan He, Changjun Yu, Guangjun Bao, Yiping Li, Yuyang Liu, Liang Hong, <span class="NLM_string-name hlFld-ContribAuthor">Rui Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Access to α,γ-Diamino Diacid Derivatives via Organocatalytic Asymmetric 1,4-Addition of Azlactones and Dehydroalanines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (22)
                                     , 7080-7084. <a href="https://doi.org/10.1021/acs.orglett.8b03020" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03020%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAccess%252Bto%252B%2525CE%2525B1%25252C%2525CE%2525B3-Diamino%252BDiacid%252BDerivatives%252Bvia%252BOrganocatalytic%252BAsymmetric%252B1%25252C4-Addition%252Bof%252BAzlactones%252Band%252BDehydroalanines%26aulast%3DYang%26aufirst%3DJunxian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20092018%26date%3D06112018%26volume%3D20%26issue%3D22%26spage%3D7080%26epage%3D7084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Matalińska</span>, <span class="hlFld-ContribAuthor ">Piotr F. J.  Lipiński</span>, <span class="hlFld-ContribAuthor ">Piotr  Kosson</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kosińska</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Misicka</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7738. <a href="https://doi.org/10.3390/ijms21207738" title="DOI URL">https://doi.org/10.3390/ijms21207738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207738%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIn%252BVivo%25252C%252BIn%252BVitro%252Band%252BIn%252BSilico%252BStudies%252Bof%252Bthe%252BHybrid%252BCompound%252BAA3266%25252C%252Ban%252BOpioid%252BAgonist%25252FNK1R%252BAntagonist%252Bwith%252BSelective%252BCytotoxicity%26aulast%3DMatali%25C5%2584ska%26aufirst%3DJoanna%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Kangtai  Xu</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Hanwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiandong  Niu</span>, <span class="hlFld-ContribAuthor ">Ting  Zheng</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>175 </em>, 108178. <a href="https://doi.org/10.1016/j.neuropharm.2020.108178" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108178%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DVF-13%25252C%252Ba%252Bchimeric%252Bpeptide%252Bof%252BVD-hemopressin%252528%2525CE%2525B1%252529%252Band%252Bneuropeptide%252BVF%25252C%252Bproduces%252Bpotent%252Bantinociception%252Bwith%252Breduced%252Bcannabinoid-related%252Bside%252Beffects%26aulast%3DXu%26aufirst%3DBiao%26date%3D2020%26volume%3D175%26spage%3D108178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Guanghai  Zhao</span>, <span class="hlFld-ContribAuthor ">Kangtai  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Hanwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiandong  Niu</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>880 </em>, 173169. <a href="https://doi.org/10.1016/j.ejphar.2020.173169" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173169%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DSpinal%252Badministration%252Bof%252Bthe%252Bmulti-functional%252Bopioid%25252Fneuropeptide%252BFF%252Bagonist%252BBN-9%252Bproduced%252Bpotent%252Bantinociception%252Bwithout%252Bdevelopment%252Bof%252Btolerance%252Band%252Bopioid-induced%252Bhyperalgesia%26aulast%3DZhang%26aufirst%3DRun%26date%3D2020%26volume%3D880%26spage%3D173169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Guo</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Kangtai  Xu</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Qiu</span>, <span class="hlFld-ContribAuthor ">Hanwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiandong  Niu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Central and peripheral modulation of gastrointestinal transit in mice by DN‐9, a multifunctional opioid/NPFF receptor agonist. </span><span class="cited-content_cbyCitation_journal-name">Neurogastroenterology & Motility</span><span> <strong>2020,</strong> <em>32 </em>
                                    (8)
                                     <a href="https://doi.org/10.1111/nmo.13848" title="DOI URL">https://doi.org/10.1111/nmo.13848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nmo.13848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnmo.13848%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurogastroenterology%2520%2526%2520Motility%26atitle%3DCentral%252Band%252Bperipheral%252Bmodulation%252Bof%252Bgastrointestinal%252Btransit%252Bin%252Bmice%252Bby%252BDN%2525E2%252580%2525909%25252C%252Ba%252Bmultifunctional%252Bopioid%25252FNPFF%252Breceptor%252Bagonist%26aulast%3DXu%26aufirst%3DBiao%26date%3D2020%26date%3D2020%26volume%3D32%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaomin  Yang</span>, <span class="hlFld-ContribAuthor ">Zhijian  Yu</span>, <span class="hlFld-ContribAuthor ">Wuping  Sun</span>, <span class="hlFld-ContribAuthor ">Changyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiyuan  Ba</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Donglin  Xiong</span>, <span class="hlFld-ContribAuthor ">Lizu  Xiao</span>, <span class="hlFld-ContribAuthor ">Qiwen  Deng</span>, <span class="hlFld-ContribAuthor ">Yue  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury. </span><span class="cited-content_cbyCitation_journal-name">Acta Neurologica Belgica</span><span> <strong>2020,</strong> <em>120 </em>
                                    (3)
                                     , 557-564. <a href="https://doi.org/10.1007/s13760-018-1006-9" title="DOI URL">https://doi.org/10.1007/s13760-018-1006-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13760-018-1006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13760-018-1006-9%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neurologica%2520Belgica%26atitle%3DThe%252Bantiviral%252Balkaloid%252Bberberine%252Bameliorates%252Bneuropathic%252Bpain%252Bin%252Brats%252Bwith%252Bperipheral%252Bnerve%252Binjury%26aulast%3DYang%26aufirst%3DShaomin%26date%3D2020%26date%3D2018%26volume%3D120%26issue%3D3%26spage%3D557%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Keyao  Luo</span>, <span class="hlFld-ContribAuthor ">Zhaojuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xianghui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dongxu  Yang</span>, <span class="hlFld-ContribAuthor ">Mengtao  Ma</span>, <span class="hlFld-ContribAuthor ">Jingjing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiaming  Cui</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Chao-zhen-yi  Han</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (9)
                                     , 115438. <a href="https://doi.org/10.1016/j.bmc.2020.115438" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115438%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bactivity%252Bof%252Bnew%252Bendomorphin%252Banalogs%252Bwith%252Bmulti-site%252Bmodifications%26aulast%3DZhao%26aufirst%3DLong%26date%3D2020%26volume%3D28%26issue%3D9%26spage%3D115438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilong  Wang</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Changyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Kangtai  Xu</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Pain</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3-4)
                                     , 477-493. <a href="https://doi.org/10.1016/j.jpain.2019.08.016" title="DOI URL">https://doi.org/10.1016/j.jpain.2019.08.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpain.2019.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpain.2019.08.016%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Pain%26atitle%3DSpinal%252BDN-9%25252C%252Ba%252BPeptidic%252BMultifunctional%252BOpioid%25252FNeuropeptide%252BFF%252BAgonist%252BProduced%252BPotent%252BNontolerance%252BForming%252BAnalgesia%252BWith%252BLimited%252BSide%252BEffects%26aulast%3DWang%26aufirst%3DZilong%26date%3D2020%26volume%3D21%26issue%3D3-4%26spage%3D477%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuerui  Shi</span>, <span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Zilong  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Qiu</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Kangtai  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Liedtke</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">The multifunctional peptide DN‐9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ‐ and κ‐opioid receptors. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (1)
                                     , 93-109. <a href="https://doi.org/10.1111/bph.14848" title="DOI URL">https://doi.org/10.1111/bph.14848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14848%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252Bmultifunctional%252Bpeptide%252BDN%2525E2%252580%2525909%252Bproduced%252Bperipherally%252Bacting%252Bantinociception%252Bin%252Binflammatory%252Band%252Bneuropathic%252Bpain%252Bvia%252B%2525CE%2525BC%2525E2%252580%252590%252Band%252B%2525CE%2525BA%2525E2%252580%252590opioid%252Breceptors%26aulast%3DXu%26aufirst%3DBiao%26date%3D2020%26date%3D2019%26volume%3D177%26issue%3D1%26spage%3D93%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Mohamed Fahad  AlAjmi</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Samira  Amir</span>, <span class="hlFld-ContribAuthor ">Fohad Mabood  Husain</span>, <span class="hlFld-ContribAuthor ">Ali  Alsalme</span>, <span class="hlFld-ContribAuthor ">Maqsood Ahmad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Abdulaziz A.  AlKhedhairy</span>, <span class="hlFld-ContribAuthor ">Rais Ahmad  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-41063-x" title="DOI URL">https://doi.org/10.1038/s41598-019-41063-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-41063-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-41063-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCopper%252528II%252529%252Bcomplexes%252Bas%252Bpotential%252Banticancer%252Band%252BNonsteroidal%252Banti-inflammatory%252Bagents%25253A%252BIn%252Bvitro%252Band%252Bin%252Bvivo%252Bstudies%26aulast%3DHussain%26aufirst%3DAfzal%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhui  Luo</span>, <span class="hlFld-ContribAuthor ">Wuping  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Feng</span>, <span class="hlFld-ContribAuthor ">Xiyuan  Ba</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lizu  Xiao</span>, <span class="hlFld-ContribAuthor ">Jin  Jiang</span>, <span class="hlFld-ContribAuthor ">Yue  Hao</span>, <span class="hlFld-ContribAuthor ">Donglin  Xiong</span>, <span class="hlFld-ContribAuthor ">Changyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">(−)-menthol increases excitatory transmission by activating both TRPM8 and TRPA1 channels in mouse spinal lamina II layer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2019,</strong> <em>516 </em>
                                    (3)
                                     , 825-830. <a href="https://doi.org/10.1016/j.bbrc.2019.06.135" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.06.135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.06.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.06.135%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3D%252528%2525E2%252588%252592%252529-menthol%252Bincreases%252Bexcitatory%252Btransmission%252Bby%252Bactivating%252Bboth%252BTRPM8%252Band%252BTRPA1%252Bchannels%252Bin%252Bmouse%252Bspinal%252Blamina%252BII%252Blayer%26aulast%3DLuo%26aufirst%3DYuhui%26date%3D2019%26volume%3D516%26issue%3D3%26spage%3D825%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunbo  He</span>, <span class="hlFld-ContribAuthor ">Hailan  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Lanxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Shouliang  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in vivo characterization of the bifunctional μ- and δ- opioid receptors ligand MCRT on mouse gastrointestinal motility. </span><span class="cited-content_cbyCitation_journal-name">Neuropeptides</span><span> <strong>2019,</strong> <em>74 </em>, 82-87. <a href="https://doi.org/10.1016/j.npep.2019.01.006" title="DOI URL">https://doi.org/10.1016/j.npep.2019.01.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.npep.2019.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.npep.2019.01.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropeptides%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252Bcharacterization%252Bof%252Bthe%252Bbifunctional%252B%2525CE%2525BC-%252Band%252B%2525CE%2525B4-%252Bopioid%252Breceptors%252Bligand%252BMCRT%252Bon%252Bmouse%252Bgastrointestinal%252Bmotility%26aulast%3DHe%26aufirst%3DChunbo%26date%3D2019%26volume%3D74%26spage%3D82%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenglan  Han</span>, <span class="hlFld-ContribAuthor ">Xuerui  Shi</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhao</span>, <span class="hlFld-ContribAuthor ">Zilong  Wang</span>, <span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Hanwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Ting  Zheng</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 630-643. <a href="https://doi.org/10.1016/j.bmc.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btwo%252Bnovel%252Bbranched%252Bpeptidomimetics%252Bcontaining%252Bendomorphin-2%252Band%252BRF9%252Bpharmacophores%25253A%252BSynthesis%252Band%252Bneuropharmacological%252Bevaluation%26aulast%3DZhang%26aufirst%3DTing%26date%3D2019%26volume%3D27%26issue%3D4%26spage%3D630%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhao</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Xuerui  Shi</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Guo</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Dan  Chen</span>, <span class="hlFld-ContribAuthor ">Ting  Zheng</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Analgesic activities of the mixed opioid and NPFF receptors agonist DN-9 in a mouse model of formalin-induced orofacial inflammatory pain. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2018,</strong> <em>110 </em>, 30-39. <a href="https://doi.org/10.1016/j.peptides.2018.10.010" title="DOI URL">https://doi.org/10.1016/j.peptides.2018.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2018.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2018.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DAnalgesic%252Bactivities%252Bof%252Bthe%252Bmixed%252Bopioid%252Band%252BNPFF%252Breceptors%252Bagonist%252BDN-9%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bformalin-induced%252Borofacial%252Binflammatory%252Bpain%26aulast%3DZhang%26aufirst%3DTing%26date%3D2018%26volume%3D110%26spage%3D30%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Zheng-Lan  Han</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Meng-Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue-Rui  Shi</span>, <span class="hlFld-ContribAuthor ">Wei-Dong  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guo</span>, <span class="hlFld-ContribAuthor ">Qin-Qin  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2018,</strong> <em>837 </em>, 53-63. <a href="https://doi.org/10.1016/j.ejphar.2018.08.039" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DSystemic%252Badministration%252Bof%252Bthe%252Bbifunctional%252Bopioid%25252Fneuropeptide%252BFF%252Breceptors%252Bagonist%252BBN-9%252Bproduced%252Bperipheral%252Bantinociception%252Bin%252Bpreclinical%252Bmouse%252Bmodels%252Bof%252Bpain%26aulast%3DLi%26aufirst%3DNing%26date%3D2018%26volume%3D837%26spage%3D53%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Xuerui  Shi</span>, <span class="hlFld-ContribAuthor ">Mengna  Zhang</span>, <span class="hlFld-ContribAuthor ">Qinqin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhao</span>, <span class="hlFld-ContribAuthor ">Run  Zhang</span>, <span class="hlFld-ContribAuthor ">Zilong  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Quan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">GpTx-1 and [Ala
              5
              , Phe
              6
              , Leu
              26
              , Arg
              28
              ]GpTx-1, two peptide Na
              V
              1.7 inhibitors: analgesic and tolerance properties at the spinal level. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2018,</strong> <em>175 </em>
                                    (20)
                                     , 3911-3927. <a href="https://doi.org/10.1111/bph.14461" title="DOI URL">https://doi.org/10.1111/bph.14461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14461%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DGpTx-1%252Band%252B%25255BAla%252B5%252B%25252C%252BPhe%252B6%252B%25252C%252BLeu%252B26%252B%25252C%252BArg%252B28%252B%25255DGpTx-1%25252C%252Btwo%252Bpeptide%252BNa%252BV%252B1.7%252Binhibitors%25253A%252Banalgesic%252Band%252Btolerance%252Bproperties%252Bat%252Bthe%252Bspinal%252Blevel%26aulast%3DChen%26aufirst%3DChao%26date%3D2018%26date%3D2018%26volume%3D175%26issue%3D20%26spage%3D3911%26epage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wuping  Sun</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiyuan  Ba</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Feng</span>, <span class="hlFld-ContribAuthor ">Xuexue  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoe  Cheng</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lizu  Xiao</span>, <span class="hlFld-ContribAuthor ">Jin  Jiang</span>, <span class="hlFld-ContribAuthor ">Donglin  Xiong</span>, <span class="hlFld-ContribAuthor ">Yue  Hao</span>, <span class="hlFld-ContribAuthor ">Zixian  Chen</span>, <span class="hlFld-ContribAuthor ">Changyu  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin Relieves Neuropathic Pain Through GABA Release and Presynaptic TRPV1 Inhibition in Spinal Cord. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2018,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnmol.2018.00248" title="DOI URL">https://doi.org/10.3389/fnmol.2018.00248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2018.00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2018.00248%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DOxytocin%252BRelieves%252BNeuropathic%252BPain%252BThrough%252BGABA%252BRelease%252Band%252BPresynaptic%252BTRPV1%252BInhibition%252Bin%252BSpinal%252BCord%26aulast%3DSun%26aufirst%3DWuping%26date%3D2018%26date%3D2018%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard J.  Bodnar</span>. </span><span class="cited-content_cbyCitation_article-title">Endogenous Opiates and Behavior: 2016. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2018,</strong> <em>101 </em>, 167-212. <a href="https://doi.org/10.1016/j.peptides.2018.01.011" title="DOI URL">https://doi.org/10.1016/j.peptides.2018.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2018.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2018.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DEndogenous%252BOpiates%252Band%252BBehavior%25253A%252B2016%26aulast%3DBodnar%26aufirst%3DRichard%2BJ.%26date%3D2018%26volume%3D101%26spage%3D167%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antinociceptive effect of <b>11</b> in the mouse tail-flick test after central administration. (A) Antinociceptive dose– and time–response curve for <b>11</b> after icv administration. (B) AUC date calculated from 0 to 60 min in the dose– and time–response curves. (C) Antinociceptive tolerance evaluation of <b>11</b> after 6 days of repeated icv administration. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared with the saline group according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of the involvement of opioid and NPFF receptors in the central antinociception of <b>11</b> in the mouse tail-flick test. (A) Effect of pretreatment with naloxone (5 nmol, icv) on the central antinociception of <b>11</b>. (B) Effect of icv administration of the selective opioid receptors antagonist β-FNA (10 nmol), nor-BNI (10 nmol), or naltrindole (10 nmol) on the central antinociception of <b>11</b>. (C) Effect of pretreatment with RF9 (10 nmol, icv) on the central antinociception of <b>11</b>. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared to the saline group, ###<i>P</i> < 0.001 indicates significant differences compared with the Saline + <b>11</b> group, according to one-way ANOVA, followed by Bonferroni’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antinociceptive effect of <b>11</b> in the mouse tail-flick test after systemic administration. (A) Antinociceptive dose– and time–response curve for <b>11</b> after ip administration. (B) AUC date calculated from 0 to 60 min based on the dose– and time–response curves. Each value represents the mean ± SEM. Group size is indicated in the figures. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 indicate significant differences compared with the saline group according to one-way ANOVA, followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antinociceptive effects of the icv injection of <b>11</b> in the mouse formalin test. Each value represents the mean ± SEM. Group size is indicated in the figure. *** <i>P</i> < 0.001 versus saline according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antinociceptive effect of the icv injection of <b>11</b> on CFA-induced chronic inflammatory pain. (A) Antinociceptive dose– and time–response curves for <b>11</b> in the CFA-induced chronic inflammatory pain. (B) Antinociceptive tolerance evaluation of <b>11</b> and morphine after 6 days of repeated icv administration in CFA-induced chronic inflammatory pain. Each value represents the mean ± SEM. Group size is indicated in the figures. ***<i>P</i> < 0.001 indicates significant differences compared with the saline group according to one-way ANOVA followed by Bonferroni’s post-hoc test; ###<i>P</i> < 0.001 indicates significant differences compared with day 1 according to one-way ANOVA followed by Tukey’s HSD post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/medium/jm-2016-01181q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of the icv (A) and ip (B) administrations of <b>11</b> on the motor performance of mice in the rota-rod test. Each value represents the mean ± SEM. Group size is indicated in the figure. No significant differences were observed according to one-way ANOVA followed by Dunnett’s post-hoc test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01181/20161118/images/large/jm-2016-01181q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01181&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Breivik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventafridda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallacher, D.</span><span> </span><span class="NLM_article-title">Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment</span> <span class="citation_source-journal">Eur. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1016/j.ejpain.2005.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.ejpain.2005.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16095934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BD287ntVWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=287-333&author=H.+Breivikauthor=B.+Collettauthor=V.+Ventafriddaauthor=R.+Cohenauthor=D.+Gallacher&title=Survey+of+chronic+pain+in+Europe%3A+prevalence%2C+impact+on+daily+life%2C+and+treatment&doi=10.1016%2Fj.ejpain.2005.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment</span></div><div class="casAuthors">Breivik Harald; Collett Beverly; Ventafridda Vittorio; Cohen Rob; Gallacher Derek</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pain (London, England)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-333</span>
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    </div><div class="casAbstract">UNLABELLED:  This large scale computer-assisted telephone survey was undertaken to explore the prevalence, severity, treatment and impact of chronic pain in 15 European countries and Israel.  Screening interviews identified respondents aged 18 years with chronic pain for in-depth interviews. 19% of 46,394 respondents willing to participate (refusal rate 46%) had suffered pain for 6 months, had experienced pain in the last month and several times during the last week.  Their pain intensity was 5 on a 10-point Numeric Rating Scale (NRS) (1 = no pain, 10 = worst pain imaginable) during last episode of pain.  In-depth interviews with 4839 respondents with chronic pain (about 300 per country) showed: 66% had moderate pain (NRS = 5-7), 34% had severe pain (NRS = 8-10), 46% had constant pain, 54% had intermittent pain. 59% had suffered with pain for two to 15 years, 21% had been diagnosed with depression because of their pain, 61% were less able or unable to work outside the home, 19% had lost their job and 13% had changed jobs because of their pain. 60% visited their doctor about their pain 2-9 times in the last six months.  Only 2% were currently treated by a pain management specialist.  One-third of the chronic pain sufferers were currently not being treated.  Two-thirds used non-medication treatments, e.g,. massage (30%), physical therapy (21%), acupuncture (13%).  Almost half were taking non-prescription analgesics; 'over the counter' (OTC) NSAIDs (55%), paracetamol (43%), weak opioids (13%).  Two-thirds were taking prescription medicines: NSAIDs (44%), weak opioids (23%), paracetamol (18%), COX-2 inhibitors (1-36%), and strong opioids (5%).  Forty percent had inadequate management of their pain.  Interesting differences between countries were observed, possibly reflecting differences in cultural background and local traditions in managing chronic pain.  CONCLUSIONS:  Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives.  Very few were managed by pain specialists and nearly half received inadequate pain management.  Although differences were observed between the 16 countries, we have documented that chronic pain is a major health care problem in Europe that needs to be taken more seriously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpPXuM7ASCakGy1nwu7K2mfW6udTcc2eY1s51mnSnO9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ntVWitQ%253D%253D&md5=bf092661c57858a462857ac057d03c48</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2005.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2005.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DBreivik%26aufirst%3DH.%26aulast%3DCollett%26aufirst%3DB.%26aulast%3DVentafridda%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DR.%26aulast%3DGallacher%26aufirst%3DD.%26atitle%3DSurvey%2520of%2520chronic%2520pain%2520in%2520Europe%253A%2520prevalence%252C%2520impact%2520on%2520daily%2520life%252C%2520and%2520treatment%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2006%26volume%3D10%26spage%3D287%26epage%3D333%26doi%3D10.1016%2Fj.ejpain.2005.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">McCarberg, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billington, R.</span><span> </span><span class="NLM_article-title">Consequences of neuropathic pain: quality-of-life issues and associated costs</span> <span class="citation_source-journal">Am. J. Manage. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">S263</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=S263-268&author=B.+H.+McCarbergauthor=R.+Billington&title=Consequences+of+neuropathic+pain%3A+quality-of-life+issues+and+associated+costs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarberg%26aufirst%3DB.%2BH.%26aulast%3DBillington%26aufirst%3DR.%26atitle%3DConsequences%2520of%2520neuropathic%2520pain%253A%2520quality-of-life%2520issues%2520and%2520associated%2520costs%26jtitle%3DAm.%2520J.%2520Manage.%2520Care%26date%3D2006%26volume%3D12%26spage%3DS263%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Inturrisi, C. E.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of opioids for pain</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1097/00002508-200207001-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1097%2F00002508-200207001-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=12479250" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=S3-13&author=C.+E.+Inturrisi&title=Clinical+pharmacology+of+opioids+for+pain&doi=10.1097%2F00002508-200207001-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00002508-200207001-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200207001-00002%26sid%3Dliteratum%253Aachs%26aulast%3DInturrisi%26aufirst%3DC.%2BE.%26atitle%3DClinical%2520pharmacology%2520of%2520opioids%2520for%2520pain%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2002%26volume%3D18%26spage%3DS3%26epage%3D13%26doi%3D10.1097%2F00002508-200207001-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zollner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, C.</span><span> </span><span class="NLM_article-title">Opioids</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=31-63&author=C.+Zollnerauthor=C.+Stein&title=Opioids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZollner%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DC.%26atitle%3DOpioids%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2007%26spage%3D31%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ji, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y. J.</span><span> </span><span class="NLM_article-title">Emerging targets in neuroinflammation-driven chronic pain</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/nrd4334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2Fnrd4334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=533-548&author=R.+R.+Jiauthor=Z.+Z.+Xuauthor=Y.+J.+Gao&title=Emerging+targets+in+neuroinflammation-driven+chronic+pain&doi=10.1038%2Fnrd4334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4334%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26aulast%3DXu%26aufirst%3DZ.%2BZ.%26aulast%3DGao%26aufirst%3DY.%2BJ.%26atitle%3DEmerging%2520targets%2520in%2520neuroinflammation-driven%2520chronic%2520pain%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D533%26epage%3D548%26doi%3D10.1038%2Fnrd4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basbaum, A. I.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of nociception</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">413</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1038/35093019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2F35093019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11557989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVyjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2001&pages=203-210&author=D.+Juliusauthor=A.+I.+Basbaum&title=Molecular+mechanisms+of+nociception&doi=10.1038%2F35093019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of nociception</span></div><div class="casAuthors">Julius, David; Basbaum, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue">6852</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with refs.  The sensation of pain alerts us to real or impending injury and triggers appropriate protective responses.  Unfortunately, pain often outlives its usefulness as a warning system and instead becomes chronic and debilitating.  This transition to a chronic phase involves changes within the spinal cord and brain, but there is also remarkable modulation where pain messages are initiated - at the level of the primary sensory neuron.  Efforts to det. how these neurons detect pain-producing stimuli of a thermal, mech. or chem. nature have revealed new signaling mechanisms and brought us closer to understanding the mol. events that facilitate transitions from acute to persistent pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5UN0IIQBxV7Vg90H21EOLACvtfcHk0lgDJpMpdBGLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVyjsr0%253D&md5=fae43aea6b2fb0691d651811972393cd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F35093019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35093019%26sid%3Dliteratum%253Aachs%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3DMolecular%2520mechanisms%2520of%2520nociception%26jtitle%3DNature%26date%3D2001%26volume%3D413%26spage%3D203%26epage%3D210%26doi%3D10.1038%2F35093019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Basbaum, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of pain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1016/j.cell.2009.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.cell.2009.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19837031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWht7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=267-284&author=A.+I.+Basbaumauthor=D.+M.+Bautistaauthor=G.+Scherrerauthor=D.+Julius&title=Cellular+and+molecular+mechanisms+of+pain&doi=10.1016%2Fj.cell.2009.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of pain</span></div><div class="casAuthors">Basbaum, Allan I.; Bautista, Diana M.; Scherrer, Gregory; Julius, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-284</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The nervous system detects and interprets a wide range of thermal and mech. stimuli, as well as environmental and endogenous chem. irritants.  When intense, these stimuli generate acute pain, and in the setting of persistent injury, both peripheral and central nervous system components of the pain transmission pathway exhibit tremendous plasticity, enhancing pain signals and producing hypersensitivity.  When plasticity facilitates protective reflexes, it can be beneficial, but when the changes persist, a chronic pain condition may result.  Genetic, electrophysiol., and pharmacol. studies are elucidating the mol. mechanisms that underlie detection, coding, and modulation of noxious stimuli that generate pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNLc2p-hLJLVg90H21EOLACvtfcHk0lgDJpMpdBGLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWht7zI&md5=afa43d19ea22a39b27952a2962df504b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DScherrer%26aufirst%3DG.%26aulast%3DJulius%26aufirst%3DD.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520pain%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D267%26epage%3D284%26doi%3D10.1016%2Fj.cell.2009.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Opioid-modulating peptides: mechanisms of action</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.2174/1568026053544515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F1568026053544515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=15857316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=341-355&author=C.+Mollereauauthor=M.+Roumyauthor=J.+M.+Zajac&title=Opioid-modulating+peptides%3A+mechanisms+of+action&doi=10.2174%2F1568026053544515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-modulating peptides: mechanisms of action</span></div><div class="casAuthors">Mollereau, Catherine; Roumy, Michel; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Opioids are involved in the physiol. control of numerous functions of the central nervous system, particularly nociception.  It appears that some endogenous neuropeptides, called anti-opioids, participate in an homeostatic system tending to reduce the effects of opioids.  Neuropeptide FF (NPFF) and cholecystokinin (CCK) possess these properties and, paradoxically, the opioid peptides nociceptin and dynorphin display some anti-opioid activity.  All these peptides exhibit complex properties as they are able to both counteract and potentiate opioid activity, acting rather as modulators of opioid functions.  The purpose of this review is to highlight that 2 different mechanisms are clearly involved in the control of opioid functions by opioid-modulating peptides: a circuitry-induced mechanism for nociceptin and dynorphin, and a cellular anti-opioid mechanism for NPFF and CCK.  The knowledge of these mechanisms has potential therapeutic interest in the control of opioid functions, notably for alleviating pain and(or) for the treatment of opioid abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZw2fMuWKMaLVg90H21EOLACvtfcHk0lgDJpMpdBGLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaqu70%253D&md5=f4a866b30e48dd49e4599405b8f1dab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568026053544515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053544515%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DRoumy%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DOpioid-modulating%2520peptides%253A%2520mechanisms%2520of%2520action%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D341%26epage%3D355%26doi%3D10.2174%2F1568026053544515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Welch, S. P.</span><span> </span><span class="NLM_article-title">Interaction of the cannabinoid and opioid systems in the modulation of nociception</span> <span class="citation_source-journal">Int. Rev. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1080/09540260902782794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1080%2F09540260902782794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19367508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BD1M3nsl2qsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=143-151&author=S.+P.+Welch&title=Interaction+of+the+cannabinoid+and+opioid+systems+in+the+modulation+of+nociception&doi=10.1080%2F09540260902782794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the cannabinoid and opioid systems in the modulation of nociception</span></div><div class="casAuthors">Welch Sandra P</div><div class="citationInfo"><span class="NLM_cas:title">International review of psychiatry (Abingdon, England)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cannabinoids and opioids produce antinociceptive synergy.  Cannabinoids such as Delta-9-tetrahydrocannabinol (THC) release endogenous opioids and endocannabinoids such as anandamide (AEA) also alter endogenous opioid tone.  Opioids and cannabinoids bind distinct receptors that co-localize in areas of the brain involved with the processing of pain signals.  Therefore, it is logical to look at interactions of these two systems in the modulation of both acute and chronic pain.  These drugs are often co-abused.  In addition, the lack of continued effectiveness of opioids due to tolerance development limits the use of such drugs.  The cost to society and patients in terms of dollars, loss of productivity, as well as quality of life, is staggering.  This review summarizes the data indicating that with cannabinoid/opioid therapy one may be able to produce long-term antinociceptive effects at doses devoid of substantial side effects, while preventing the neuronal biochemical changes that accompany tolerance.  The clinical utility of modulators of the endocannabinoid system as a potential mimic for THC-like drugs in analgesia and tolerance-sparing effects of opioids is a critical future direction also addressed in the review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxqa50ZJHHcIxhnOQkIHOxfW6udTcc2ebTPcTTxTrQPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3nsl2qsw%253D%253D&md5=5c9c0f1480176202e3de9dd1bdc954fa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F09540260902782794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09540260902782794%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DS.%2BP.%26atitle%3DInteraction%2520of%2520the%2520cannabinoid%2520and%2520opioid%2520systems%2520in%2520the%2520modulation%2520of%2520nociception%26jtitle%3DInt.%2520Rev.%2520Psychiatry%26date%3D2009%26volume%3D21%26spage%3D143%26epage%3D151%26doi%3D10.1080%2F09540260902782794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Bi- or multifunctional opioid peptide drugs</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span><span class="refDoi"> DOI: 10.1016/j.lfs.2009.02.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.lfs.2009.02.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19285088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlChs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=598-603&author=P.+W.+Schiller&title=Bi-+or+multifunctional+opioid+peptide+drugs&doi=10.1016%2Fj.lfs.2009.02.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bi- or multifunctional opioid peptide drugs</span></div><div class="casAuthors">Schiller, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">598-603</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Strategies for the design of bi- or multifunctional drugs are reviewed.  A distinction is made between bifunctional drugs interacting in a monovalent fashion with two targets and ligands contg. two distinct pharmacophores binding in a bivalent mode to the two binding sites in a receptor heterodimer.  Arguments are presented to indicate that some of the so-called "bivalent" ligands reported in the literature are unlikely to simultaneously interact with two binding sites.  Aspects related to the development of bi- or multifunctional drugs are illustrated with examples from the field of opioid analgesics.  The drug-like properties of the tetrapeptide Dmt1[DALDA] with triple action as a μ opioid agonist, norepinephrine uptake inhibitor and releaser of endogenous opioid peptides to produce potent spinal analgesia are reviewed.  Rationales for the development of opioid peptides with mixed agonist/antagonist profiles as analgesics with reduced side effects are presented.  Progress in the development of mixed μ opioid agonist/δ opioid antagonists with low propensity to produce tolerance and phys. dependence is reviewed.  Efforts to develop bifunctional peptides contg. a μ opioid agonist and a cholecystokinin antagonist or an NK1 receptor antagonist as analgesics expected to produce less tolerance and dependence are also reviewed.  A strategy to improve the drug-like properties of bifunctional opioid peptide analgesics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51QVXgJVx6LVg90H21EOLACvtfcHk0lgJA2mRWF2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlChs7o%253D&md5=6bb5b32b59f9d2bbd12763c1c32cd641</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2009.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2009.02.025%26sid%3Dliteratum%253Aachs%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DBi-%2520or%2520multifunctional%2520opioid%2520peptide%2520drugs%26jtitle%3DLife%2520Sci.%26date%3D2010%26volume%3D86%26spage%3D598%26epage%3D603%26doi%3D10.1016%2Fj.lfs.2009.02.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span> </span><span class="NLM_article-title">Hybrid opioid/non-opioid ligands in pain research</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7435</span><span class="NLM_x">–</span> <span class="NLM_lpage">7450</span><span class="refDoi"> DOI: 10.2174/138161281942140105165646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F138161281942140105165646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23448481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7435-7450&author=P.+Kleczkowskaauthor=A.+W.+Lipkowskiauthor=D.+Tourweauthor=S.+Ballet&title=Hybrid+opioid%2Fnon-opioid+ligands+in+pain+research&doi=10.2174%2F138161281942140105165646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid Opioid/Non-Opioid Ligands in Pain Research</span></div><div class="casAuthors">Kleczkowska, Patrycja; Lipkowski, Andrzej W.; Tourwe, Dirk; Ballet, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">7435-7450</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To address the different types of pain (e.g. acute, chronic, neuropathic) different classes of medications, mainly non-steroidal anti-inflammatory drugs and narcotics (opioids), are used.  More specifically, the alleviation or treatment of moderate to severe pain states commonly invokes the use of opioids.  Unfortunately, their chronic administration induces various undesirable side effects, such as for example phys. dependence and tolerance.  One strategy to overcome these major side effects and to prolong the antinociceptive efficiency of the applied drugs involves the creation of multifunctional compds. which contain hybridized structures.  Combination of opioid agonist and antagonist pharmacophores in a single chem. entity has been considered and extensively investigated, but opioids have also been combined with other bioactive neurotransmitters and peptide hormones that are involved in pain perception (e.g. substance P, neurotensin, cholecystokinin, cannabinoids, melanocortin ligands, etc.).  Such novel chimeras (also called designed multiple ligands or twin/triplet drugs), may interact independently with their resp. receptors and potentially result in more effective antinociceptive properties.  The designed multiple ligands presented in this work include opioid-non-opioid peptide dimer analogs, mixed peptidic- non-peptidic bifunctional ligands and dual non-peptidic dimers.  The main focus herein is placed on the design and biol. evaluation of these multiple opioid compds., rather than the synthetic approach and prepn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRD8bJ077blrVg90H21EOLACvtfcHk0lgJA2mRWF2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFyrsg%253D%253D&md5=ffb0df5135c1b9461124b86d47c86531</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161281942140105165646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161281942140105165646%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DBallet%26aufirst%3DS.%26atitle%3DHybrid%2520opioid%252Fnon-opioid%2520ligands%2520in%2520pain%2520research%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D7435%26epage%3D7450%26doi%3D10.2174%2F138161281942140105165646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Turnaturi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronsisvalle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinucci, L.</span><span> </span><span class="NLM_article-title">Multitarget opioid ligands in pain relief: New players in an old game</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.11.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.ejmech.2015.11.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26656913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=211-228&author=R.+Turnaturiauthor=G.+Aricoauthor=G.+Ronsisvalleauthor=C.+Parentiauthor=L.+Pasquinucci&title=Multitarget+opioid+ligands+in+pain+relief%3A+New+players+in+an+old+game&doi=10.1016%2Fj.ejmech.2015.11.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget opioid ligands in pain relief: New players in an old game</span></div><div class="casAuthors">Turnaturi, Rita; Arico, Giuseppina; Ronsisvalle, Giuseppe; Parenti, Carmela; Pasquinucci, Lorella</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-228</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Still nowadays pain is one of the most common disabling conditions and yet it remains too often unsolved.  Analgesic opioid drugs, and mainly MOR agonists such as morphine, are broadly employed for pain management.  MOR activation, however, has been seen to cause not only analgesia but also undesired side effects.  A potential pain treatment option is represented by the simultaneous targeting of different opioid receptors.  In fact, ligands possessing multitarget capabilities led to an improved pharmacol. fingerprint.  This review focuses on the examn. of multitarget opioid ligands which have been distinguished in peptide and non-peptide and further listed as bivalent and bifunctional ligands.  Moreover, the potential of these compds., both as analgesic drugs and pharmacol. tools to explore heteromer receptors, has been stressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1KgfVHTj67Vg90H21EOLACvtfcHk0lgJA2mRWF2d4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmsrrN&md5=49fa91877cdaa733f7ec58d5e80a3869</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.11.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.11.028%26sid%3Dliteratum%253Aachs%26aulast%3DTurnaturi%26aufirst%3DR.%26aulast%3DArico%26aufirst%3DG.%26aulast%3DRonsisvalle%26aufirst%3DG.%26aulast%3DParenti%26aufirst%3DC.%26aulast%3DPasquinucci%26aufirst%3DL.%26atitle%3DMultitarget%2520opioid%2520ligands%2520in%2520pain%2520relief%253A%2520New%2520players%2520in%2520an%2520old%2520game%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D211%26epage%3D228%26doi%3D10.1016%2Fj.ejmech.2015.11.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bihel, F.</span><span> </span><span class="NLM_article-title">Opioid adjuvant strategy: improving opioid effectiveness</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.4155/fmc.15.186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.4155%2Ffmc.15.186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26898358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=339-354&author=F.+Bihel&title=Opioid+adjuvant+strategy%3A+improving+opioid+effectiveness&doi=10.4155%2Ffmc.15.186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid adjuvant strategy: improving opioid effectiveness</span></div><div class="casAuthors">Bihel, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">339-354</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Opioid analgesics continue to be the mainstay of pharmacol. treatment of moderate to severe pain.  Many patients, particularly those suffering from chronic pain, require chronic high-dose analgesic therapy.  Achieving clin. efficacy and tolerability of such treatment regimens is hampered by the appearance of opioid-induced side effects such as tolerance, hyperalgesia and withdrawal syndrome.  Among the therapeutic options to improve the opioid effectiveness, this current review focuses on strategies combining opioids to other drugs that can modulate opioid-mediated effects.  We will discuss about exptl. evidences reported for several potential opioid adjuvants, including N-methyl-D-aspartate receptor antagonists, 5-HT7 agonists, sigma-1 antagonists, I2-R ligands, cholecystokinin antagonists, neuropeptide FF-R antagonists and toll-like receptor 4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJF8bC0s0lxbVg90H21EOLACvtfcHk0li9J2WLJelSCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjs70%253D&md5=13f51430ab11eb649db0afda5676dea0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.186%26sid%3Dliteratum%253Aachs%26aulast%3DBihel%26aufirst%3DF.%26atitle%3DOpioid%2520adjuvant%2520strategy%253A%2520improving%2520opioid%2520effectiveness%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D339%26epage%3D354%26doi%3D10.4155%2Ffmc.15.186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Salat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1036985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1517%2F13543784.2015.1036985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=837-844&author=K.+Salatauthor=A.+Jakubowskaauthor=K.+Kulig&title=Cebranopadol%3A+a+first-in-class+potent+analgesic+agent+with+agonistic+activity+at+nociceptin%2Forphanin+FQ+and+opioid+receptors&doi=10.1517%2F13543784.2015.1036985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1036985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1036985%26sid%3Dliteratum%253Aachs%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DJakubowska%26aufirst%3DA.%26aulast%3DKulig%26aufirst%3DK.%26atitle%3DCebranopadol%253A%2520a%2520first-in-class%2520potent%2520analgesic%2520agent%2520with%2520agonistic%2520activity%2520at%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D837%26epage%3D844%26doi%3D10.1517%2F13543784.2015.1036985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00824.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1111%2Fj.1476-5381.2010.00824.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20977451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2ms7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=986-1001&author=T.+M.+Largent-Milnesauthor=T.+Yamamotoauthor=P.+Nairauthor=J.+W.+Moultonauthor=V.+J.+Hrubyauthor=J.+Laiauthor=F.+Porrecaauthor=T.+W.+Vanderah&title=Spinal+or+systemic+TY005%2C+a+peptidic+opioid+agonist%2Fneurokinin+1+antagonist%2C+attenuates+pain+with+reduced+tolerance&doi=10.1111%2Fj.1476-5381.2010.00824.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance</span></div><div class="casAuthors">Largent-Milnes, T. M.; Yamamoto, T.; Nair, P.; Moulton, J. W.; Hruby, V. J.; Lai, J.; Porreca, F.; Vanderah, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">986-1001</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The use of opioids in treating pain is limited due to significant side effects including somnolence, constipation, analgesic tolerance, addiction and respiratory depression.  Pre-clin. studies have shown that neurokinin 1 (NK1) receptor antagonists block opioid-induced antinociceptive tolerance and may inhibit opioid-induced rewarding behaviors.  Here, we have characterized a bifunctional peptide with both opioid agonist and NK1 antagonist pharmacophores in a rodent model of neuropathic pain.  Rats were evaluated for behavioral responses to both tactile and thermal stimuli in either an uninjured, sham- or nerve-injured state.  TY005 (Tyr-DAla-Gly-Phe-Met-Pro-Leu-Trp-O-3,5-Bn(CF3)2) was delivered spinally or systemically to assess the antinociceptive effects after acute exposure.  Motor skills were evaluated using the rotarod test to det. potential sedative effects.  Spinal TY005 was given chronically to sham- or nerve-injured animals to det. the development of tolerance.  Bolus injections of TY005 produced dose-dependent antinociception in non-injured animals and alleviated nerve injury-induced thermal and tactile hypersensitivities (i.e. antihyperalgesia) more effectively than morphine.  Sedative effects were not evident from the rotarod test at doses that were antihyperalgesic, nor at doses 3-fold higher.  Repeated administration of TY005 did not lead to the development of antihyperalgesic tolerance or alter sensory thresholds.  Collectively, the data suggest that opioid agonist/NK1 antagonist bifunctional peptides represent a promising novel approach to the management of chronic pain without the development of tolerance, reducing the need for escalation of doses and unwanted side effects assocd. with opiates alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIZV-rESBFrVg90H21EOLACvtfcHk0li9J2WLJelSCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2ms7jN&md5=5ea51d658f8678e93d8e19a5f20802c1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00824.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00824.x%26sid%3Dliteratum%253Aachs%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DMoulton%26aufirst%3DJ.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DSpinal%2520or%2520systemic%2520TY005%252C%2520a%2520peptidic%2520opioid%2520agonist%252Fneurokinin%25201%2520antagonist%252C%2520attenuates%2520pain%2520with%2520reduced%2520tolerance%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D986%26epage%3D1001%26doi%3D10.1111%2Fj.1476-5381.2010.00824.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Le Naour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekkirala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyuzhny, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span><span class="refDoi"> DOI: 10.1021/jm4005219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5505-5513&author=M.+Le+Naourauthor=E.+Akgunauthor=A.+Yekkiralaauthor=M.+M.+Lunzerauthor=M.+D.+Powersauthor=A.+E.+Kalyuzhnyauthor=P.+S.+Portoghese&title=Bivalent+ligands+that+target+mu+opioid+%28MOP%29+and+cannabinoid1+%28CB1%29+receptors+are+potent+analgesics+devoid+of+tolerance&doi=10.1021%2Fjm4005219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm4005219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005219%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNaour%26aufirst%3DM.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DYekkirala%26aufirst%3DA.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DPowers%26aufirst%3DM.%2BD.%26aulast%3DKalyuzhny%26aufirst%3DA.%2BE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DBivalent%2520ligands%2520that%2520target%2520mu%2520opioid%2520%2528MOP%2529%2520and%2520cannabinoid1%2520%2528CB1%2529%2520receptors%2520are%2520potent%2520analgesics%2520devoid%2520of%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5505%26epage%3D5513%26doi%3D10.1021%2Fjm4005219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnatt, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Hage, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dever, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimers: binding affinity versus functional activities</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1039/c3md00080j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1039%2Fc3md00080j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23682308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=847-851&author=Y.+Yuanauthor=C.+K.+Arnattauthor=N.+El-Hageauthor=S.+M.+Deverauthor=J.+C.+Jacobauthor=D.+E.+Selleyauthor=K.+F.+Hauserauthor=Y.+Zhang&title=A+bivalent+ligand+targeting+the+putative+mu+opioid+receptor+and+chemokine+receptor+CCR5+heterodimers%3A+binding+affinity+versus+functional+activities&doi=10.1039%2Fc3md00080j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities</span></div><div class="casAuthors">Yuan, Yunyun; Arnatt, Christopher K.; El-Hage, Nazira; Dever, Seth M.; Jacob, Joanna C.; Selley, Dana E.; Hauser, Kurt F.; Zhang, Yan</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">847-851</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Opioid substitution and antiretroviral therapies have steadily increased the life spans of AIDS patients with opioid addiction, while the adverse drug-drug interactions and persistence of HIV-assocd. neurocognitive disorders still require new strategies to target opioid abuse and HIV-1 comorbidities.  A bivalent ligand 1 with a 21-atom spacer was thus synthesized and explicitly characterized as a novel pharmacol. probe to study the underlying mechanism of opioid-enhanced NeuroAIDS.  The steric hindrance generated from the spacer affected the binding affinity and Ca2+ flux inhibition functional activity of bivalent ligand 1 at the chemokine receptor CCR5 more profoundly than it did at the mu opioid receptor (MOR).  However, the CCR5 radioligand binding affinity and the Ca2+ flux inhibition function of the ligand seemed not necessarily to correlate with its antiviral activity given that it was at least two times more potent than maraviroc alone in reducing Tat expression upon HIV-1 infection in human astrocytes.  Furthermore, the ligand was also about two times more potent than the simple mixt. of maraviroc and naltrexone in the same viral entry inhibition assay.  Therefore bivalent ligand 1 seemed to function more effectively by targeting specifically the putative MOR-CCR5 heterodimer in the viral invasion process.  The results reported here suggest that a properly designed bivalent ligand may serve as a useful chem. probe to study the potential MOR-CCR5 interaction during the progression of NeuroAIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc2twZlWfnf7Vg90H21EOLACvtfcHk0ljxez-YAhd2_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVyhu7g%253D&md5=74444181b5c9d456600a745c066f67d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3md00080j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00080j%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DArnatt%26aufirst%3DC.%2BK.%26aulast%3DEl-Hage%26aufirst%3DN.%26aulast%3DDever%26aufirst%3DS.%2BM.%26aulast%3DJacob%26aufirst%3DJ.%2BC.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DHauser%26aufirst%3DK.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DA%2520bivalent%2520ligand%2520targeting%2520the%2520putative%2520mu%2520opioid%2520receptor%2520and%2520chemokine%2520receptor%2520CCR5%2520heterodimers%253A%2520binding%2520affinity%2520versus%2520functional%2520activities%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D847%26epage%3D851%26doi%3D10.1039%2Fc3md00080j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Harikumar, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. J.</span><span> </span><span class="NLM_article-title">Modulation of cell surface expression of nonactivated cholecystokinin receptors using bivalent ligand-induced internalization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span><span class="refDoi"> DOI: 10.1021/jm100135g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100135g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2836-2842&author=K.+G.+Harikumarauthor=E.+Akgunauthor=P.+S.+Portogheseauthor=L.+J.+Miller&title=Modulation+of+cell+surface+expression+of+nonactivated+cholecystokinin+receptors+using+bivalent+ligand-induced+internalization&doi=10.1021%2Fjm100135g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100135g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100135g%26sid%3Dliteratum%253Aachs%26aulast%3DHarikumar%26aufirst%3DK.%2BG.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26atitle%3DModulation%2520of%2520cell%2520surface%2520expression%2520of%2520nonactivated%2520cholecystokinin%2520receptors%2520using%2520bivalent%2520ligand-induced%2520internalization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2836%26epage%3D2842%26doi%3D10.1021%2Fjm100135g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Akgun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javed, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeester, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beitz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">11595</span><span class="NLM_x">–</span> <span class="NLM_lpage">11599</span><span class="refDoi"> DOI: 10.1073/pnas.1305461110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.1305461110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=23798416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Gls73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11595-11599&author=E.+Akgunauthor=M.+I.+Javedauthor=M.+M.+Lunzerauthor=B.+A.+Smeesterauthor=A.+J.+Beitzauthor=P.+S.+Portoghese&title=Ligands+that+interact+with+putative+MOR-mGluR5+heteromer+in+mice+with+inflammatory+pain+produce+potent+antinociception&doi=10.1073%2Fpnas.1305461110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception</span></div><div class="casAuthors">Akgun, Eyup; Javed, Muhammad I.; Lunzer, Mary M.; Smeester, Branden A.; Beitz, Al J.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11595-11599, S11595/1-S11595/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The low effectiveness of morphine and related mu opioid analgesics for the treatment of chronic inflammatory pain is a result of opioid-induced release of proinflammatory cytokines and glutamate that lower the pain threshold.  In this regard, the use of opioids with metabotropic glutamate-5 receptor (mGluR5) antagonist has been reported to increase the efficacy of morphine and prevent the establishment of adverse effects during chronic use.  Given the presence of opioid receptors (MORs) and mGluR5 in glia and neurons, together with reports that suggest coexpressed MOR/mGluR5 receptors in cultured cells assoc. as a heteromer, the possibility that such a heteromer could be a target in vivo was addressed by the design and synthesis of a series of bivalent ligands that contain mu opioid agonist and mGluR5 antagonist pharmacophores linked through spacers of varying length (10-24 atoms).  The series was evaluated for antinociception using the tail-flick and von Frey assays in mice pretreated with lipopolysaccharide (LPS) or in mice with bone cancer.  In LPS-pretreated mice, MMG22, I (22-atom spacer), was the most potent member of the series (intrathecal ED50 ∼ 9 fmol per mouse), whereas in untreated mice its ED50 was more than three orders of magnitude higher.  As members of the series with shorter or longer spacers have ≥500-fold higher ED50s in LPS-treated mice, the exceptional potency of MMG22 may be a result of the optimal bridging of protomers in a putative MOR-mGluR5 heteromer.  The finding that MMG22 possesses a >106 therapeutic ratio suggests that it may be an excellent candidate for treatment of chronic, intractable pain via spinal administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sHkH4sok2bVg90H21EOLACvtfcHk0ljQKa-fUcpcDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Gls73N&md5=ced95f48600b2217e402a5cf794f0784</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1305461110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1305461110%26sid%3Dliteratum%253Aachs%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DJaved%26aufirst%3DM.%2BI.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DSmeester%26aufirst%3DB.%2BA.%26aulast%3DBeitz%26aufirst%3DA.%2BJ.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DLigands%2520that%2520interact%2520with%2520putative%2520MOR-mGluR5%2520heteromer%2520in%2520mice%2520with%2520inflammatory%2520pain%2520produce%2520potent%2520antinociception%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11595%26epage%3D11599%26doi%3D10.1073%2Fpnas.1305461110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Guillemyn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyniewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojewska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mika, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arranz-Gibert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megarbane, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span> </span><span class="NLM_article-title">Bifunctional peptide-based opioid agonist-nociceptin antagonist ligands for dual treatment of acute and neuropathic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3792</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01976</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlOntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3777-3792&author=K.+Guillemynauthor=J.+Starnowskaauthor=C.+Lagardauthor=J.+Dyniewiczauthor=E.+Rojewskaauthor=J.+Mikaauthor=N.+N.+Chungauthor=V.+Utardauthor=P.+Kossonauthor=A.+W.+Lipkowskiauthor=L.+Chevillardauthor=P.+Arranz-Gibertauthor=M.+Teixidoauthor=B.+Megarbaneauthor=D.+Tourweauthor=F.+Simoninauthor=B.+Przewlockaauthor=P.+W.+Schillerauthor=S.+Ballet&title=Bifunctional+peptide-based+opioid+agonist-nociceptin+antagonist+ligands+for+dual+treatment+of+acute+and+neuropathic+pain&doi=10.1021%2Facs.jmedchem.5b01976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain</span></div><div class="casAuthors">Guillemyn, Karel; Starnowska, Joanna; Lagard, Camille; Dyniewicz, Jolanta; Rojewska, Ewelina; Mika, Joanna; Chung, Nga N.; Utard, Valerie; Kosson, Piotr; Lipkowski, Andrzej W.; Chevillard, Lucie; Arranz-Gibert, Pol; Teixido, Meritxell; Megarbane, Bruno; Tourwe, Dirk; Simonin, Frederic; Przewlocka, Barbara; Schiller, Peter W.; Ballet, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3777-3792</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the opioid pharmacophore H-Dmt-D-Arg-Aba-β-Ala-NH2 (7) was linked to peptide ligands for the nociceptin receptor.  Combination of 7 and NOP ligands (e.g., H-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2) led to binding affinities in the low nanomolar domain.  In vitro, the hybrids behaved as agonists at the opioid receptors and antagonists at the nociceptin receptor.  I.v. administration of hybrid 13a (H-Dmt-D-Arg-Aba-β-Ala-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2) to mice resulted in potent and long lasting antinociception in the tail-flick test, indicating that 13a was able to permeate the BBB.  This was further supported by a cell-based BBB model.  All hybrids alleviated allodynia and hyperalgesia in neuropathic pain models.  Esp. with respect to hyperalgesia, they showed to be more effective than the parent compds.  Hybrid 13a did not result in significant respiratory depression, in contrast to an equipotent analgesic dose of morphine.  These hybrids hence represent a promising avenue toward analgesics for the dual treatment of acute and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMjKi5JZ8AVbVg90H21EOLACvtfcHk0ljQKa-fUcpcDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlOntL4%253D&md5=fa45a9594bfe7d25d9729aabf85d3b85</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01976%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemyn%26aufirst%3DK.%26aulast%3DStarnowska%26aufirst%3DJ.%26aulast%3DLagard%26aufirst%3DC.%26aulast%3DDyniewicz%26aufirst%3DJ.%26aulast%3DRojewska%26aufirst%3DE.%26aulast%3DMika%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DUtard%26aufirst%3DV.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26aulast%3DChevillard%26aufirst%3DL.%26aulast%3DArranz-Gibert%26aufirst%3DP.%26aulast%3DTeixido%26aufirst%3DM.%26aulast%3DMegarbane%26aufirst%3DB.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DSimonin%26aufirst%3DF.%26aulast%3DPrzewlocka%26aufirst%3DB.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBallet%26aufirst%3DS.%26atitle%3DBifunctional%2520peptide-based%2520opioid%2520agonist-nociceptin%2520antagonist%2520ligands%2520for%2520dual%2520treatment%2520of%2520acute%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3777%26epage%3D3792%26doi%3D10.1021%2Facs.jmedchem.5b01976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnes, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1016/S0024-3205(03)00390-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2FS0024-3205%2803%2900390-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=699-704&author=V.+J.+Hrubyauthor=R.+S.+Agnesauthor=P.+Davisauthor=S.+W.+Maauthor=Y.+S.+Leeauthor=T.+W.+Vanderahauthor=J.+Laiauthor=F.+Porreca&title=Design+of+novel+peptide+ligands+which+have+opioid+agonist+activity+and+CCK+antagonist+activity+for+the+treatment+of+pain&doi=10.1016%2FS0024-3205%2803%2900390-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900390-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900390-4%26sid%3Dliteratum%253Aachs%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DAgnes%26aufirst%3DR.%2BS.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DDesign%2520of%2520novel%2520peptide%2520ligands%2520which%2520have%2520opioid%2520agonist%2520activity%2520and%2520CCK%2520antagonist%2520activity%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D699%26epage%3D704%26doi%3D10.1016%2FS0024-3205%2803%2900390-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orduna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/mu receptor agonists in the sciatic nerve ligation chronic pain model in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1124/jpet.111.184663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1124%2Fjpet.111.184663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21859931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=687-693&author=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=J.+Ordunaauthor=J.+Montenegroauthor=F.+Jiangauthor=N.+T.+Zaveriauthor=L.+Toll&title=Differential+effects+of+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+agonists+in+acute+versus+chronic+pain%3A+studies+with+bifunctional+NOP%2Fmu+receptor+agonists+in+the+sciatic+nerve+ligation+chronic+pain+model+in+mice&doi=10.1124%2Fjpet.111.184663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice</span></div><div class="casAuthors">Khroyan, Taline V.; Polgar, Willma E.; Orduna, Juan; Montenegro, Jose; Jiang, Faming; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150) and 1-(1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidinl-4-yl)-indolin-2-one (SR16835) are moderately selective nociceptin/orphanin FQ (NOP) receptor agonists.  In the [35S]guanosine 5'-O-(3-thiotriphosphate) assay in vitro, SR14150 is a partial agonist at both the NOP and μ-opioid receptors, whereas SR16835 is a full agonist at the NOP receptor and has low efficacy at μ receptors.  These compds. were tested for antinociceptive and antiallodynic activity, using mice in chronic pain, subsequent to spinal nerve ligation (SNL) surgery.  When administered s.c. to mice after SNL surgery, SR14150 but not SR16835 increased tail-flick latency, which was blocked by the opioid antagonist naloxone, but not by the NOP receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).  In contrast, both SR14150 and SR16835 had antiallodynic activity when mech. allodynia was measured with von Frey monofilaments.  This effect was completely blocked by SB-612111 but not by naloxone.  On the other hand, morphine antinociception and antiallodynia were both blocked by naloxone and potentiated by SB-612111.  These results indicate that, in mice, circuitry mediating antinociceptive activity in acute and chronic pain states is different.  It is possible that during a chronic pain state, an up-regulated NOP system in the spinal cord leads to NOP receptor-mediated antiallodynia, which is blocked by NOP antagonists.  However, supraspinal up-regulation could lead to an attenuation of morphine antinociception and antiallodynia, which can be alleviated by an NOP receptor antagonist.  Thus, although neither NOP agonists nor antagonists are effective as analgesics in acute pain, they may have efficacy as analgesics, either alone or in combination with morphine, for treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0K9DfQCAq7Vg90H21EOLACvtfcHk0liTfbblDRO3Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL&md5=d5e03c7d72ac9feab468aa8cdc8ba89d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184663%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DOrduna%26aufirst%3DJ.%26aulast%3DMontenegro%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDifferential%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520agonists%2520in%2520acute%2520versus%2520chronic%2520pain%253A%2520studies%2520with%2520bifunctional%2520NOP%252Fmu%2520receptor%2520agonists%2520in%2520the%2520sciatic%2520nerve%2520ligation%2520chronic%2520pain%2520model%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D687%26epage%3D693%26doi%3D10.1124%2Fjpet.111.184663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3308</span><span class="NLM_x">–</span> <span class="NLM_lpage">3313</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmcl.2013.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3308-3313&author=N.+T.+Zaveriauthor=F.+Jiangauthor=C.+Olsenauthor=W.+E.+Polgarauthor=L.+Toll&title=Designing+bifunctional+NOP+receptor-mu+opioid+receptor+ligands+from+NOP+receptor-selective+scaffolds.+Part+I&doi=10.1016%2Fj.bmcl.2013.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDesigning%2520bifunctional%2520NOP%2520receptor-mu%2520opioid%2520receptor%2520ligands%2520from%2520NOP%2520receptor-selective%2520scaffolds.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3308%26epage%3D3313%26doi%3D10.1016%2Fj.bmcl.2013.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Blair Journigan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2508</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmc.2014.02.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2508-2516&author=V.+Blair+Journiganauthor=W.+E.+Polgarauthor=T.+V.+Khroyanauthor=N.+T.+Zaveri&title=Designing+bifunctional+NOP+receptor-mu+opioid+receptor+ligands+from+NOP-receptor+selective+scaffolds.+Part+II&doi=10.1016%2Fj.bmc.2014.02.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%2BJournigan%26aufirst%3DV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DDesigning%2520bifunctional%2520NOP%2520receptor-mu%2520opioid%2520receptor%2520ligands%2520from%2520NOP-receptor%2520selective%2520scaffolds.%2520Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2508%26epage%3D2516%26doi%3D10.1016%2Fj.bmc.2014.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7337</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmc.2009.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=19762245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ais7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7337-7343&author=T.+Yamamotoauthor=P.+Nairauthor=S.+W.+Maauthor=P.+Davisauthor=H.+I.+Yamamuraauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=The+biological+activity+and+metabolic+stability+of+peptidic+bifunctional+compounds+that+are+opioid+receptor+agonists+and+neurokinin-1+receptor+antagonists+with+a+cystine+moiety&doi=10.1016%2Fj.bmc.2009.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety</span></div><div class="casAuthors">Yamamoto, Takashi; Nair, Padma; Ma, Shou-wu; Davis, Peg; Yamamura, Henry I.; Vanderah, Todd W.; Porreca, Frank; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7337-7343</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to improve metabolic stability, a ring structure with a cystine moiety was introduced into TY027 (Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-[3',5'-(CF3)2Bzl]), which is a lead compd. of our developing bifunctional peptide possessing opioid agonist and NK1 antagonist activities.  TY038 (Tyr-cyclo[D-Cys-Gly-Phe-Met-Pro-D-Cys]-Trp-NH-[3',5'-(CF3)2Bzl]) was found as a highly selective δ opioid agonist over μ receptor in conventional tissue-based assays, together with an effective NK1 antagonist activity and good metabolic stability with more than 24 h half life in rat plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparHxQyFibhbVg90H21EOLACvtfcHk0liTfbblDRO3Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ais7nL&md5=61567a71476cf64f45d354d7be6cec53</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DThe%2520biological%2520activity%2520and%2520metabolic%2520stability%2520of%2520peptidic%2520bifunctional%2520compounds%2520that%2520are%2520opioid%2520receptor%2520agonists%2520and%2520neurokinin-1%2520receptor%2520antagonists%2520with%2520a%2520cystine%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7337%26epage%3D7343%26doi%3D10.1016%2Fj.bmc.2009.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Nair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratilova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span> </span><span class="NLM_article-title">Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4975</span><span class="NLM_x">–</span> <span class="NLM_lpage">4978</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bmcl.2013.06.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4975-4978&author=P.+Nairauthor=T.+Yamamotoauthor=T.+M.+Largent-Milnesauthor=S.+Cowellauthor=V.+Kulkarniauthor=S.+Moyeauthor=E.+Navratilovaauthor=P.+Davisauthor=S.+W.+Maauthor=T.+W.+Vanderahauthor=J.+Laiauthor=F.+Porrecaauthor=V.+J.+Hruby&title=Truncation+of+the+peptide+sequence+in+bifunctional+ligands+with+mu+and+delta+opioid+receptor+agonist+and+neurokinin+1+receptor+antagonist+activities&doi=10.1016%2Fj.bmcl.2013.06.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DP.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DCowell%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DMoye%26aufirst%3DS.%26aulast%3DNavratilova%26aufirst%3DE.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.%2BW.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DTruncation%2520of%2520the%2520peptide%2520sequence%2520in%2520bifunctional%2520ligands%2520with%2520mu%2520and%2520delta%2520opioid%2520receptor%2520agonist%2520and%2520neurokinin%25201%2520receptor%2520antagonist%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4975%26epage%3D4978%26doi%3D10.1016%2Fj.bmcl.2013.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesniak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojnik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowicka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujalska-Zadrozny, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misicka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span> </span><span class="NLM_article-title">Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile(9)]PK20 in an acute pain treatment in rodents</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1648</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/j.brainres.2016.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.brainres.2016.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1648&publication_year=2016&pages=172-180&author=P.+Kleczkowskaauthor=E.+Hermansauthor=P.+Kossonauthor=A.+Kowalczykauthor=A.+Lesniakauthor=K.+Pawlikauthor=E.+Bojnikauthor=S.+Benyheauthor=B.+Nowickaauthor=M.+Bujalska-Zadroznyauthor=A.+Misickaauthor=A.+W.+Lipkowski&title=Antinociceptive+effect+induced+by+a+combination+of+opioid+and+neurotensin+moieties+vs.+their+hybrid+peptide+%5BIle%289%29%5DPK20+in+an+acute+pain+treatment+in+rodents&doi=10.1016%2Fj.brainres.2016.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile9]PK20 in an acute pain treatment in rodents</span></div><div class="casAuthors">Kleczkowska, Patrycja; Hermans, Emmanuel; Kosson, Piotr; Kowalczyk, Agnieszka; Lesniak, Anna; Pawlik, Karolina; Bojnik, Engin; Benyhe, Sandor; Nowicka, Barbara; Bujalska-Zadrozny, Magdalena; Misicka, Aleksandra; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1648</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">172-180</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hybrid compds. are suggested to be a more effective remedy for treatment of various diseases than combination therapy, since the attenuation or total disappearance of side effects, typically induced by a single moiety, can be obsd.  This is of great importance, esp. when we consider problems resulting from the use of opioid analgesics.  However, although it seems that such compds. can be valuable therapeutic tools, the lack of conviction among the public as to the appropriateness of their use still remains; therefore patients are commonly treated with polypharmacy.  Thus, in the presented paper we show a comparison of the antinociceptive effect between a novel opioid-neurotensin chimera called [Ile9]PK20 and a mixt. of its structural elements, delivered intrathecally and systemically.  Addnl., motor coordination was assessed in the rotarod test.  The results clearly indicate that spinal administration of the examd. compds., resulted in a long-lasting, dose- and time-dependent antinociceptive effect.  Although the mixt. of both pharmacophores was found to be more active than [Ile9]PK20, motor impairments surfaced as a side effect.  This in turn illustrates the advantageous use of hybrid structures over drug cocktails.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpYBf-wrNJbVg90H21EOLACvtfcHk0liIwvRNFspRqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgsLfO&md5=73edaf5ea34e262e8adb6f3108823844</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2016.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2016.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DHermans%26aufirst%3DE.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DLesniak%26aufirst%3DA.%26aulast%3DPawlik%26aufirst%3DK.%26aulast%3DBojnik%26aufirst%3DE.%26aulast%3DBenyhe%26aufirst%3DS.%26aulast%3DNowicka%26aufirst%3DB.%26aulast%3DBujalska-Zadrozny%26aufirst%3DM.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DAntinociceptive%2520effect%2520induced%2520by%2520a%2520combination%2520of%2520opioid%2520and%2520neurotensin%2520moieties%2520vs.%2520their%2520hybrid%2520peptide%2520%255BIle%25289%2529%255DPK20%2520in%2520an%2520acute%2520pain%2520treatment%2520in%2520rodents%26jtitle%3DBrain%2520Res.%26date%3D2016%26volume%3D1648%26spage%3D172%26epage%3D180%26doi%3D10.1016%2Fj.brainres.2016.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kleczkowska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipkowski, A. W.</span><span> </span><span class="NLM_article-title">PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1186/1744-8069-6-86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1186%2F1744-8069-6-86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=86&author=P.+Kleczkowskaauthor=P.+Kossonauthor=S.+Balletauthor=I.+Van+den+Eyndeauthor=Y.+Tsudaauthor=D.+Tourweauthor=A.+W.+Lipkowski&title=PK20%2C+a+new+opioid-neurotensin+hybrid+peptide+that+exhibits+central+and+peripheral+antinociceptive+effects&doi=10.1186%2F1744-8069-6-86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects</span></div><div class="casAuthors">Kleczkowska, Patrycja; Kosson, Piotr; Ballet, Steven; Van den Eynde, Isabelle; Tsuda, Yuko; Tourwe, Dirk; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>CODEN:
                <span class="NLM_cas:coden">MPOAC5</span>;
        ISSN:<span class="NLM_cas:issn">1744-8069</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The clin. treatment of various types of pain relies upon the use of opioid analgesics.  However most of them produce, in addn. to the analgesic effect, several side effects such as the development of dependence and addiction as well as sedation, dysphoria, and constipation.  One soln. to these problems are chimeric compds. in which the opioid pharmacophore is hybridized with another type of compd. to increase antinociceptive effects.  Neurotensin-induced antinociception is not mediated through the opioid system.  Therefore, hybridizing neurotensin with opioid elements may result in a potent synergistic antinociceptor.  Results: Using the known structure-activity relationships of neurotensin we have synthesized a new chimeric opioid-neurotensin compd. PK20 which is characterized by a very strong antinociceptive potency.  The observation that the opioid antagonist naltrexone did not completely reverse the antinociceptive effect, indicates the partial involvement of the nonopioid component in PK20 in the produced analgesia.  Conclusions: The opioid-neurotensin hybrid analog PK20, in which opioid and neurotensin pharmacophores overlap partially, expresses high antinociceptive tail-flick effects after central as well as peripheral applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoYplSz0cuXLVg90H21EOLACvtfcHk0liIwvRNFspRqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrvM&md5=cf7bc30203a46b1087061d84a028259e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-6-86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-6-86%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DI.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DTourwe%26aufirst%3DD.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DPK20%252C%2520a%2520new%2520opioid-neurotensin%2520hybrid%2520peptide%2520that%2520exhibits%2520central%2520and%2520peripheral%2520antinociceptive%2520effects%26jtitle%3DMol.%2520Pain%26date%3D2010%26volume%3D6%26spage%3D86%26doi%3D10.1186%2F1744-8069-6-86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mouledous, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Opioid-modulating properties of the neuropeptide FF system</span> <span class="citation_source-journal">Biofactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1002/biof.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fbiof.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20803521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1eitrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=423-429&author=L.+Mouledousauthor=C.+Mollereauauthor=J.+M.+Zajac&title=Opioid-modulating+properties+of+the+neuropeptide+FF+system&doi=10.1002%2Fbiof.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid-modulating properties of the neuropeptide FF system</span></div><div class="casAuthors">Mouledous, Lionel; Mollereau, Catherine; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">BioFactors</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-429</span>CODEN:
                <span class="NLM_cas:coden">BIFAEU</span>;
        ISSN:<span class="NLM_cas:issn">1872-8081</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Opioid receptors are involved in the control of pain perception in the central nervous system together with endogenous neuropeptides, termed opioid-modulating peptides, participating in a homeostatic system.  Neuropeptide FF (NPFF) and related peptides possess anti-opioid properties, the cellular mechanisms of which are still unclear.  The purpose of this review is to detail the phenomenon of cross-talk taking place between opioid and NPFF systems at the in vivo pharmacol. level and to propose cellular and mol. models of functioning.  A better knowledge of the mechanisms underlying opioid-modulating properties of NPFF has potential therapeutic interest for the control of opioid functions, notably for alleviating pain and/or for the treatment of opioid abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoMvNllQW4rVg90H21EOLACvtfcHk0ljV4PwGQIxCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1eitrbM&md5=c489980c318bc15aae70b2f1285ee281</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbiof.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbiof.116%26sid%3Dliteratum%253Aachs%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DOpioid-modulating%2520properties%2520of%2520the%2520neuropeptide%2520FF%2520system%26jtitle%3DBiofactors%26date%3D2010%26volume%3D36%26spage%3D423%26epage%3D429%26doi%3D10.1002%2Fbiof.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Yang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iadarola, M. J.</span><span> </span><span class="NLM_article-title">Modulatory role of neuropeptide FF system in nociception and opiate analgesia</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.npep.2007.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.npep.2007.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=17854890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=1-18&author=H.+Y.+Yangauthor=T.+Taoauthor=M.+J.+Iadarola&title=Modulatory+role+of+neuropeptide+FF+system+in+nociception+and+opiate+analgesia&doi=10.1016%2Fj.npep.2007.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modulatory role of neuropeptide FF system in nociception and opiate analgesia</span></div><div class="casAuthors">Yang, Hsiu-Ying T.; Tao, Tao; Iadarola, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tetra-peptide FMRF-NH2 is a cardioexcitatory peptide in the clam.  Using the antibody against this peptide, FMRF-NH2-like immunoreactive material was detected in mammalian CNS.  Subsequently, mammalian FMRF-NH2 immunoreactive peptides were isolated from bovine brain and characterized to be FLFQPQRF-NH2 (NPFF) and AGEGLSSPFWSLAAPQRF-NH2 (NPAF).  The genes encoding NPFF precursor proteins and NPFF receptors 1 and 2 are expressed in all vertebrate species examd. to date and are highly conserved.  Among many biol. roles suggested for the NPFF system, the possible modulatory role of NPFF in nociception and opiate analgesia has been most widely investigated.  Pharmacol., NPFF-related peptides were found to exhibit analgesia and also potentiate the analgesic activity of opiates when administered intrathecally but attenuate the opiate induced analgesia when administered intracerebroventricularly.  RF-NH2 peptides including NPFF-related peptides were found to delay the rate of acid sensing ion channels (ASIC) desensitization resulting in enhancing acid gated currents, raising the possibility that NPFF also may have a pain modulatory role through ASIC.  The genes for NPFF as well as NPFF-R2, preferred receptor for NPFF, are highly unevenly expressed in the rat CNS with the highest levels localized to the superficial layers of the dorsal spinal cord.  These two genes are also present in the dorsal root ganglia (DRG), though at low levels in normal rats.  NPFF and NPFF-R2 mRNAs were found to be coordinately up-regulated in spinal cord and DRG of rats with peripheral inflammation.  In addn., NPFF-R2 immunoreactivity in the primary afferents was increased by peripheral inflammation.  The findings from the early studies on the analgesic and morphine modulating activities suggested a role for NPFF in pain modulation and this possibility is further supported by the distribution of NPFF and its receptor and the regulation of the NPFF system in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ3E7lCwQWnLVg90H21EOLACvtfcHk0ljV4PwGQIxCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVylsrg%253D&md5=ef433f74a8ebc21e349e22e1f960680b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2007.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2007.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DTao%26aufirst%3DT.%26aulast%3DIadarola%26aufirst%3DM.%2BJ.%26atitle%3DModulatory%2520role%2520of%2520neuropeptide%2520FF%2520system%2520in%2520nociception%2520and%2520opiate%2520analgesia%26jtitle%3DNeuropeptides%26date%3D2008%26volume%3D42%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.npep.2007.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Quillet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bihel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elhabazi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilien, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonin, F.</span><span> </span><span class="NLM_article-title">RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.pharmthera.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26896564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=84-132&author=R.+Quilletauthor=S.+Ayachiauthor=F.+Bihelauthor=K.+Elhabaziauthor=B.+Ilienauthor=F.+Simonin&title=RF-amide+neuropeptides+and+their+receptors+in+Mammals%3A+Pharmacological+properties%2C+drug+development+and+main+physiological+functions&doi=10.1016%2Fj.pharmthera.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions</span></div><div class="casAuthors">Quillet, Raphaelle; Ayachi, Safia; Bihel, Frederic; Elhabazi, Khadija; Ilien, Brigitte; Simonin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-132</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  RF-amide neuropeptides, with their typical Arg-Phe-NH2 signature at their carboxyl C-termini, belong to a lineage of peptides that spans almost the entire life tree.  Throughout evolution, RF-amide peptides and their receptors preserved fundamental roles in reprodn. and feeding, both in Vertebrates and Invertebrates.  The scope of this review is to summarize the current knowledge on the RF-amide systems in Mammals from historical aspects to therapeutic opportunities.  Taking advantage of the most recent findings in the field, special focus will be given on mol. and pharmacol. properties of RF-amide peptides and their receptors as well as on their implication in the control of different physiol. functions including feeding, reprodn. and pain.  Recent progress on the development of drugs that target RF-amide receptors will also be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNuBEfA0vxh7Vg90H21EOLACvtfcHk0ljV4PwGQIxCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCgt7g%253D&md5=47630823d26f5794a3a7b669c06ae18e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DQuillet%26aufirst%3DR.%26aulast%3DAyachi%26aufirst%3DS.%26aulast%3DBihel%26aufirst%3DF.%26aulast%3DElhabazi%26aufirst%3DK.%26aulast%3DIlien%26aufirst%3DB.%26aulast%3DSimonin%26aufirst%3DF.%26atitle%3DRF-amide%2520neuropeptides%2520and%2520their%2520receptors%2520in%2520Mammals%253A%2520Pharmacological%2520properties%252C%2520drug%2520development%2520and%2520main%2520physiological%2520functions%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D160%26spage%3D84%26epage%3D132%26doi%3D10.1016%2Fj.pharmthera.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.2174/092986611794654012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F092986611794654012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21121889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtlSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=403-409&author=Q.+Fangauthor=T.+N.+Jiangauthor=N.+Liauthor=Z.+L.+Hanauthor=R.+Wang&title=Central+administration+of+neuropeptide+FF+and+related+peptides+attenuate+systemic+morphine+analgesia+in+mice&doi=10.2174%2F092986611794654012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice</span></div><div class="casAuthors">Fang, Quan; Jiang, Tian-nan; Li, Ning; Han, Zheng-lan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-409</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) belongs to an opioid-modulating peptide family.  NPFF has been reported to play important roles in the control of pain and analgesia through interactions with the opioid system.  However, very few studies examd. the effect of supraspinal NPFF system on analgesia induced by opiates administered at the peripheral level.  In the present study, intracerebroventricular (i.c.v.) injection of NPFF (1, 3 and 10 nmol) dose-dependently inhibited systemic morphine (0.12 mg, i.p.) analgesia in the mouse tail flick test.  Similarly, i.c.v. administration of dNPA and NPVF, two agonists highly selective for NPFF2 and NPFF1 receptors, resp., decreased analgesia induced by i.p. morphine in mice.  Furthermore, these anti-opioid activities of NPFF and related peptides were blocked by pretreatment with the NPFF receptors selective antagonist RF 9 (10 nmol, i.c.v.).  These results demonstrate that activation of central NPFF1 and NPFF2 receptors has the similar anti-opioid actions on the antinociceptive effect of systemic morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQRM265cpFbVg90H21EOLACvtfcHk0ljV4PwGQIxCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtlSnurs%253D&md5=52f5901722a3f7a8779a012d477058dc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F092986611794654012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986611794654012%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DT.%2BN.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DCentral%2520administration%2520of%2520neuropeptide%2520FF%2520and%2520related%2520peptides%2520attenuate%2520systemic%2520morphine%2520analgesia%2520in%2520mice%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2011%26volume%3D18%26spage%3D403%26epage%3D409%26doi%3D10.2174%2F092986611794654012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fratta, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majane, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, E.</span><span> </span><span class="NLM_article-title">Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">7757</span><span class="NLM_x">–</span> <span class="NLM_lpage">7761</span><span class="refDoi"> DOI: 10.1073/pnas.82.22.7757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.82.22.7757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=3865193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL28XhsFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=7757-7761&author=H.+Y.+Yangauthor=W.+Frattaauthor=E.+A.+Majaneauthor=E.+Costa&title=Isolation%2C+sequencing%2C+synthesis%2C+and+pharmacological+characterization+of+two+brain+neuropeptides+that+modulate+the+action+of+morphine&doi=10.1073%2Fpnas.82.22.7757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine</span></div><div class="casAuthors">Yang, H. Y. T.; Fratta, W.; Majane, E. A.; Costa, E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7757-61</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Two peptides that crossreact with an antiserum raised against Phe-Met-Arg-Phe-NH2 were purified from bovine brain ext.  Their structures were Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2  [99588-52-0] and Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2  [99566-27-5].  The sequences were detd. by gas-phase sequencing, except for the COOH-terminal phenylalaninamides.  These were assigned on the basis of the reactivity of the peptides with the anti-Phe-Met-Arg-Phe-NH2 antiserum, which appears to recognize the detd. -Arg-Phe-NH2.  Both peptides were synthesized, and the synthetic peptides have the same HPLC retention times as the endogenous Phe-Met-Arg-Phe-NH2 immunoreactive peptides, thus confirming the assignment of phenylalaninamide to the COOH-terminal positions.  Both of the synthetic peptides decreased tail-flick latency in rats, and the octapeptide was more active than the octadecapeptide.  The octapeptide also attenuated the prolongation of the tail-flick latency induced by morphine  [57-27-2].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrrSLMcu4RF7Vg90H21EOLACvtfcHk0liqpT8-L6eTfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsFamuw%253D%253D&md5=545596b16b26ea9f5e6612bc1f4b306b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.22.7757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.22.7757%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DFratta%26aufirst%3DW.%26aulast%3DMajane%26aufirst%3DE.%2BA.%26aulast%3DCosta%26aufirst%3DE.%26atitle%3DIsolation%252C%2520sequencing%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520two%2520brain%2520neuropeptides%2520that%2520modulate%2520the%2520action%2520of%2520morphine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D7757%26epage%3D7761%26doi%3D10.1073%2Fpnas.82.22.7757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gouarderes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamandas, K.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/0014-2999(93)90095-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2893%2990095-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=8102975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1993&pages=73-81&author=C.+Gouarderesauthor=M.+Sutakauthor=J.+M.+Zajacauthor=K.+Jhamandas&title=Antinociceptive+effects+of+intrathecally+administered+F8Famide+and+FMRFamide+in+the+rat&doi=10.1016%2F0014-2999%2893%2990095-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat</span></div><div class="casAuthors">Gouarderes, Christine; Sutak, Maaja; Zajac, Jean Marie; Jhamandas, Khem</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of intrathecal injections of F8Famide (Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2, 0.05-17.5 nmol) and FMRFamide (Phe-Met-Arg-Phe-NH2, 0.002-25 nmol), known as anti-opioid agents, were investigated by using noxious thermal (tail flick) and mech. (paw pressure) tests in the rat.  Both peptides produced significant long-lasting (24-48 h) analgesia in both tests without causing detectable motor dysfunction.  Pretreatment with systemic naloxone (5.5 μmol/kg i.p.) attenuated the initial antinociceptive effects (first hour) induced by both peptides (8.8 nmol) in the tail flick test and only by FMRFamide in the paw pressure test.  A subeffective dose of F8Famide (0.05 nmol) enhanced both the intensity and the duration of spinal morphine (6.6 nmol) analgesia in both tests.  In contrast, a subanalgesic dose of FMRFamide (0.002 nmol) decreased the intensity and enhanced the duration of the effect of morphine.  These results show that, besides acting as antinociceptive agents in the spinal cord, F8Famide and FMRFamide could differentially modulate spinal opioid functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf1qTi_F38LVg90H21EOLACvtfcHk0liqpT8-L6eTfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFaguro%253D&md5=fd912d83d08e5853d0e304e1ae9e9084</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990095-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990095-Y%26sid%3Dliteratum%253Aachs%26aulast%3DGouarderes%26aufirst%3DC.%26aulast%3DSutak%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26aulast%3DJhamandas%26aufirst%3DK.%26atitle%3DAntinociceptive%2520effects%2520of%2520intrathecally%2520administered%2520F8Famide%2520and%2520FMRFamide%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D237%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0014-2999%2893%2990095-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kontinen, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E. A.</span><span> </span><span class="NLM_article-title">Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">977</span><span class="refDoi"> DOI: 10.1016/0196-9781(95)00068-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0196-9781%2895%2900068-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=7479344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK2MXntFSnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=973-977&author=V.+K.+Kontinenauthor=E.+A.+Kalso&title=Differential+modulation+of+alpha+2-adrenergic+and+mu-opioid+spinal+antinociception+by+neuropeptide+FF&doi=10.1016%2F0196-9781%2895%2900068-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Differential modulation of α2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF</span></div><div class="casAuthors">Kontinen, Vesa K.; Kalso, Eija A.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Tarrytown, New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">973-7</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) has been found to act as an antiopioid peptide.  However, intrathecal NPFF has recently been shown to potentiate the antinociceptive effects of intrathecal morphine and to produce antinociception on its own.  The aim of this study was to find out whether pretreatment with NPFF causes a comparable potentiation of dexmedetomidine-induced antinociception.  NPFF (0.05-10.0 nmol) produced no antinociceptive effects in the rat tail flick test.  NPFF potentiated the antinociceptive effect of intrathecal morphine (7.8 nmol).  This potentiation was prevented by intrathecal naltrindole (28 nmol), which did not attenuate the antinociceptive effect of morphine.  Dexmedetomidine (1.6-6.4 nmol) produced a dose-dependent antinociceptive effect, which was not potentiated by NPFF.  Activation of the endogenous β-opioid system due to the antiopioid effect of intrathecal NPFF is proposed as an explanation to the reported differential action of NPFF on the μ-opioid and the α2-adrenergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXB-DrpZNe-7Vg90H21EOLACvtfcHk0liqpT8-L6eTfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFSnsr0%253D&md5=ea5d38d9c81d68eec6337cfdca8e3b53</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2895%2900068-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252895%252900068-U%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BK.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26atitle%3DDifferential%2520modulation%2520of%2520alpha%25202-adrenergic%2520and%2520mu-opioid%2520spinal%2520antinociception%2520by%2520neuropeptide%2520FF%26jtitle%3DPeptides%26date%3D1995%26volume%3D16%26spage%3D973%26epage%3D977%26doi%3D10.1016%2F0196-9781%2895%2900068-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Simonin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laulin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laboureyras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhamandas, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacTavish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matifas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonnet, G.</span><span> </span><span class="NLM_article-title">RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1073/pnas.0502090103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1073%2Fpnas.0502090103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16407169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=466-471&author=F.+Simoninauthor=M.+Schmittauthor=J.+P.+Laulinauthor=E.+Laboureyrasauthor=J.+H.+Jhamandasauthor=D.+MacTavishauthor=A.+Matifasauthor=C.+Mollereauauthor=P.+Laurentauthor=M.+Parmentierauthor=B.+L.+Kiefferauthor=J.+J.+Bourguignonauthor=G.+Simonnet&title=RF9%2C+a+potent+and+selective+neuropeptide+FF+receptor+antagonist%2C+prevents+opioid-induced+tolerance+associated+with+hyperalgesia&doi=10.1073%2Fpnas.0502090103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia</span></div><div class="casAuthors">Simonin, Frederic; Schmitt, Martine; Laulin, Jean-Paul; Laboureyras, Emilie; Jhamandas, Jack H.; MacTavish, David; Matifas, Audrey; Mollereau, Catherine; Laurent, Patrick; Parmentier, Marc; Kieffer, Brigitte L.; Bourguignon, Jean-Jacques; Simonnet, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neuropeptide FF (NPFF) has been proposed to play a role in pain modulation, opioid tolerance, and several other physiol. processes.  However, pharmacol. agents that would help define physiol. roles for this peptide are still missing.  Here we report the discovery of a potent and selective NPFF receptor antagonist, RF9, that can be administered systemically.  This compd. does not show any effects by itself but can block efficiently the increase in blood pressure and heart rate evoked by NPFF.  When chronically coinjected with heroin, RF9 completely blocks the delayed and long-lasting paradoxical opioid-induced hyperalgesia and prevents the development of assocd. tolerance.  Our data indicate that NPFF receptors are part of a bona fide antiopioid system and that selective antagonists of these receptors could represent useful therapeutic agents for improving the efficacy of opioids in chronic pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mP_bY_LIv7Vg90H21EOLACvtfcHk0liJqp7QDjgbkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVSksQ%253D%253D&md5=16892ae9708b76e0bd11860c3e444879</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502090103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502090103%26sid%3Dliteratum%253Aachs%26aulast%3DSimonin%26aufirst%3DF.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DLaulin%26aufirst%3DJ.%2BP.%26aulast%3DLaboureyras%26aufirst%3DE.%26aulast%3DJhamandas%26aufirst%3DJ.%2BH.%26aulast%3DMacTavish%26aufirst%3DD.%26aulast%3DMatifas%26aufirst%3DA.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DP.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DBourguignon%26aufirst%3DJ.%2BJ.%26aulast%3DSimonnet%26aufirst%3DG.%26atitle%3DRF9%252C%2520a%2520potent%2520and%2520selective%2520neuropeptide%2520FF%2520receptor%2520antagonist%252C%2520prevents%2520opioid-induced%2520tolerance%2520associated%2520with%2520hyperalgesia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D466%26epage%3D471%26doi%3D10.1073%2Fpnas.0502090103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pineda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Galiano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Garrido, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Pino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijcks, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomenrohr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Noort, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tena-Sempere, M.</span><span> </span><span class="NLM_article-title">Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1902</span><span class="NLM_x">–</span> <span class="NLM_lpage">1913</span><span class="refDoi"> DOI: 10.1210/en.2009-1259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1210%2Fen.2009-1259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=20160130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1CmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=1902-1913&author=R.+Pinedaauthor=D.+Garcia-Galianoauthor=M.+A.+Sanchez-Garridoauthor=M.+Romeroauthor=F.+Ruiz-Pinoauthor=E.+Aguilarauthor=F.+A.+Dijcksauthor=M.+Blomenrohrauthor=L.+Pinillaauthor=P.+I.+van+Noortauthor=M.+Tena-Sempere&title=Characterization+of+the+potent+gonadotropin-releasing+activity+of+RF9%2C+a+selective+antagonist+of+RF-amide-related+peptides+and+neuropeptide+FF+receptors%3A+physiological+and+pharmacological+implications&doi=10.1210%2Fen.2009-1259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications</span></div><div class="casAuthors">Pineda, R.; Garcia-Galiano, D.; Sanchez-Garrido, M. A.; Romero, M.; Ruiz-Pino, F.; Aguilar, E.; Dijcks, F. A.; Blomenrohr, M.; Pinilla, L.; van Noort, P. I.; Tena-Sempere, M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1902-1913</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Identification of RF-amide-related peptides (RFRP), as putative mammalian orthologs of the avian gonadotropin-inhibitory hormone, has drawn considerable interest on its potential effects and mechanisms of action in the control of gonadotropin secretion in higher vertebrates.  Yet, these analyses have so far relied mostly on indirect approaches, while direct assessment of their physiol. roles has been hampered by the lack of suitable antagonists.  RF9 was recently reported as a selective and potent antagonist of the receptors for RFRP (RFRPR) and the related neuropeptides, neuropeptide FF (NPFF) and neuropeptide AF (NPFF receptor).  We show here that RF9 possesses very strong gonadotropin-releasing activities in vivo.  Central administration of RF9 evoked a dose-dependent increase of LH and FSH levels in adult male and female rats.  Similarly, male and female mice responded to intracerebroventricular injection of RF9 with robust LH secretory bursts.  In rats, administration of RF9 further augmented the gonadotropin-releasing effects of kisspeptin, and its stimulatory effects were detected despite the prevailing suppression of gonadotropin secretion by testosterone or estradiol.  In fact, blockade of estrogen receptor-α partially attenuated gonadotropin responses to RF9.  Finally, systemic administration of RF9 modestly stimulated LH secretion in vivo, although no direct effects in terms of gonadotropin secretion were detected at the pituitary in vitro.  Although, these data are the first to disclose the potent gonadotropin-releasing activity of RF9, a selective antagonist of RFRP (and NPFF) receptors.  Our findings support a putative role of the RFRP/gonadotropin-inhibitory hormone system in the central control of gonadotropin secretion in mammals and have interesting implications concerning the potential therapeutic indications and pharmacol. effects of RF9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocbncTm_LSjrVg90H21EOLACvtfcHk0liJqp7QDjgbkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1CmurY%253D&md5=472c43660da33a416ecee90042b9aca2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1210%2Fen.2009-1259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2009-1259%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%26aufirst%3DR.%26aulast%3DGarcia-Galiano%26aufirst%3DD.%26aulast%3DSanchez-Garrido%26aufirst%3DM.%2BA.%26aulast%3DRomero%26aufirst%3DM.%26aulast%3DRuiz-Pino%26aufirst%3DF.%26aulast%3DAguilar%26aufirst%3DE.%26aulast%3DDijcks%26aufirst%3DF.%2BA.%26aulast%3DBlomenrohr%26aufirst%3DM.%26aulast%3DPinilla%26aufirst%3DL.%26aulast%3Dvan%2BNoort%26aufirst%3DP.%2BI.%26aulast%3DTena-Sempere%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520potent%2520gonadotropin-releasing%2520activity%2520of%2520RF9%252C%2520a%2520selective%2520antagonist%2520of%2520RF-amide-related%2520peptides%2520and%2520neuropeptide%2520FF%2520receptors%253A%2520physiological%2520and%2520pharmacological%2520implications%26jtitle%3DEndocrinology%26date%3D2010%26volume%3D151%26spage%3D1902%26epage%3D1913%26doi%3D10.1210%2Fen.2009-1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Marchand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betourne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marty, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daumas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frances, B.</span><span> </span><span class="NLM_article-title">A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span><span class="refDoi"> DOI: 10.1016/j.peptides.2005.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.peptides.2005.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=16494968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=964-972&author=S.+Marchandauthor=A.+Betourneauthor=V.+Martyauthor=S.+Daumasauthor=H.+Halleyauthor=J.+M.+Lassalleauthor=J.+M.+Zajacauthor=B.+Frances&title=A+neuropeptide+FF+agonist+blocks+the+acquisition+of+conditioned+place+preference+to+morphine+in+C57Bl%2F6J+mice&doi=10.1016%2Fj.peptides.2005.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice</span></div><div class="casAuthors">Marchand, Stephane; Betourne, Alexandre; Marty, Virginie; Daumas, Stephanie; Halley, Helene; Lassalle, Jean-Michel; Zajac, Jean-Marie; Frances, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-972</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neuropeptide FF behaves as an opioid-modulating peptide that seems to be involved in morphine tolerance and phys. dependence.  Nevertheless, the effects of neuropeptide FF agonists on the rewarding properties of morphine remain unknown.  C57BL6 mice were conditioned in an unbiased balanced paradigm of conditioned place preference to study the effect of i.c.v. injections of 1DMe ([D-Tyr1,(NMe)Phe3]-neuropeptide FF), a stable agonist of the neuropeptide FF system, on the acquisition of place conditioning by morphine or alc. (ethanol).  Morphine (10 mg/kg, i.p.) or ethanol (2 g/kg, i.p.) induced a significant place preference.  Injection of 1DMe (1-20 nmol), given 10 min before the i.p. injection of the reinforcing drug during conditioning, inhibited the rewarding effect of morphine but had no effect on the rewarding effect of ethanol.  However, a single injection of 1DMe given just before place preference testing was unable to inhibit the rewarding effects of morphine.  By itself, 1DMe was inactive but an aversive effect of this agonist could be evidenced if the exptl. procedure was biased.  These results suggest that neuropeptide FF, injected during conditioning, should influence the development of rewarding effects of morphine and reinforce the hypothesis of strong inhibitory interactions between neuropeptide FF and opioids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWobhvneEwrLVg90H21EOLACvtfcHk0liJqp7QDjgbkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVeitb4%253D&md5=b1ef3824383885ae0c952de0e9c574b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DS.%26aulast%3DBetourne%26aufirst%3DA.%26aulast%3DMarty%26aufirst%3DV.%26aulast%3DDaumas%26aufirst%3DS.%26aulast%3DHalley%26aufirst%3DH.%26aulast%3DLassalle%26aufirst%3DJ.%2BM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26aulast%3DFrances%26aufirst%3DB.%26atitle%3DA%2520neuropeptide%2520FF%2520agonist%2520blocks%2520the%2520acquisition%2520of%2520conditioned%2520place%2520preference%2520to%2520morphine%2520in%2520C57Bl%252F6J%2520mice%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D964%26epage%3D972%26doi%3D10.1016%2Fj.peptides.2005.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.bbr.2013.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.bbr.2013.03.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2013&pages=51-56&author=Z.+L.+Hanauthor=Z.+L.+Wangauthor=H.+Z.+Tangauthor=N.+Liauthor=Q.+Fangauthor=X.+H.+Liauthor=X.+L.+Yangauthor=X.+Y.+Zhangauthor=R.+Wang&title=Neuropeptide+FF+attenuates+the+acquisition+and+the+expression+of+conditioned+place+aversion+to+endomorphin-2+in+mice&doi=10.1016%2Fj.bbr.2013.03.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DTang%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DNeuropeptide%2520FF%2520attenuates%2520the%2520acquisition%2520and%2520the%2520expression%2520of%2520conditioned%2520place%2520aversion%2520to%2520endomorphin-2%2520in%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D248%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.bbr.2013.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1880</span><span class="refDoi"> DOI: 10.1111/bph.13489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1111%2Fbph.13489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=27018797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmtlenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=1864-1880&author=N.+Liauthor=Z.+L.+Hanauthor=Z.+L.+Wangauthor=Y.+H.+Xingauthor=Y.+L.+Sunauthor=X.+H.+Liauthor=J.+J.+Songauthor=T.+Zhangauthor=R.+Zhangauthor=M.+N.+Zhangauthor=B.+Xuauthor=Q.+Fangauthor=R.+Wang&title=BN-9%2C+a+chimeric+peptide+with+mixed+opioid+and+neuropeptide+FF+receptor+agonistic+properties%2C+produces+nontolerance-forming+antinociception+in+mice&doi=10.1111%2Fbph.13489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice</span></div><div class="casAuthors">Li, Ning; Han, Zheng-lan; Wang, Zi-long; Xing, Yan-hong; Sun, Yu-long; Li, Xu-hui; Song, Jing-jing; Zhang, Ting; Zhang, Run; Zhang, Meng-na; Xu, Biao; Fang, Quan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1864-1880</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Neuropeptide FF (NPFF) behaves as an endogenous opioid-modulating peptide.  In the present study, the opioid and NPFF pharmacophore-contg. chimeric peptide BN-9 was synthesized and pharmacol. characterized.  Exptl. Approach : Agonist activities of BN-9 at opioid and NPFF receptors were characterized in in vitro cAMP assays.  Antinociceptive activities of BN-9 were evaluated in the mouse tail-flick and formalin tests.  Furthermore, its side effects were investigated in rotarod, antinociceptive tolerance, reward and gastrointestinal transit tests.  Key Results : BN-9 acted as a novel multifunctional agonist at μ, δ, κ, NPFF1 and NPFF2 receptors in cAMP assays.  In the tail-flick test, BN-9 produced dose-related antinociception and was approx. equipotent to morphine; this antinociception was blocked by μ and κ receptor antagonists, but not by the δ receptor antagonist.  In the formalin test, supraspinal administration of BN-9 produced significant analgesia.  Notably, repeated administration of BN-9 produced analgesia without loss of potency over 8 days.  In contrast, repeated i.c.v. co-administration of BN-9 with the NPFF receptor antagonist RF9 produced significant antinociceptive tolerance.  Furthermore, i.c.v.  BN-9 induced conditioned place preference.  When given by the same routes, BN-9 had a more than eightfold higher ED50 value for gastrointestinal transit inhibition compared with the ED50 values for antinociception.  Conclusions and Implications : BN-9 produced a robust, nontolerance-forming analgesia with limited inhibition of gastrointestinal transit.  As BN-9 is able to activate both opioid and NPFF systems, this provides an interesting approach for the development of novel analgesics with minimal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpicXFgT8DcO7Vg90H21EOLACvtfcHk0lhu0-qb0nNTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmtlenu7Y%253D&md5=90dce7f015555e141e30a0e82d8bdfd7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fbph.13489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13489%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DXing%26aufirst%3DY.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%2BN.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DBN-9%252C%2520a%2520chimeric%2520peptide%2520with%2520mixed%2520opioid%2520and%2520neuropeptide%2520FF%2520receptor%2520agonistic%2520properties%252C%2520produces%2520nontolerance-forming%2520antinociception%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D1864%26epage%3D1880%26doi%3D10.1111%2Fbph.13489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrig, C. A.</span><span> </span><span class="NLM_article-title">Recent developments in the design of receptor specific opioid peptides</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1002/med.2610090306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fmed.2610090306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=2547125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=343-401&author=V.+J.+Hrubyauthor=C.+A.+Gehrig&title=Recent+developments+in+the+design+of+receptor+specific+opioid+peptides&doi=10.1002%2Fmed.2610090306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of receptor-specific opioid peptides</span></div><div class="casAuthors">Hruby, Victor; Gehrig, Catherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-401</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 179 refs., describing the design of peptides with specificity for the μ-, δ-, and κ-opioid receptors.  Opioid antagonists of a peptide nature are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYb3tCrcYC7Vg90H21EOLACvtfcHk0lhu0-qb0nNTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSiurc%253D&md5=a8feef3e6753c2bb9c25d33176bda87a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610090306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610090306%26sid%3Dliteratum%253Aachs%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DGehrig%26aufirst%3DC.%2BA.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520receptor%2520specific%2520opioid%2520peptides%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1989%26volume%3D9%26spage%3D343%26epage%3D401%26doi%3D10.1002%2Fmed.2610090306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Liu, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1002/med.20222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1002%2Fmed.20222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=536-580&author=W.+X.+Liuauthor=R.+Wang&title=Endomorphins%3A+potential+roles+and+therapeutic+indications+in+the+development+of+opioid+peptide+analgesic+drugs&doi=10.1002%2Fmed.20222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs</span></div><div class="casAuthors">Liu, Wei X.; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">536-580</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The application of endomorphins as clin. available analgesic drugs has been impeded by their relatively poor receptor selectivity compared with alkaloid analgesics, rapid degrdn. in vivo, inefficient to penetrate the blood-brain barrier (BBB), and undesirable or toxic effects, such as acute tolerance and phys. dependence, respiratory depression, and inhibition of gastrointestinal motility.  Extensive studies have been performed so far striving to conquer these problems.  In this article we review and discuss conformational and topog. modifications of the peptide amide bond and amino acid side groups to attain the most appropriate receptor binding affinity and high receptor selectivity; diverse strategies such as insertion of unnatural amino acids, covalent or noncovalent constraints as well as cyclization of linear peptides to enhance the enzymic stability; designing of peptidomimetic ligands, glycopeptides, and N-terminal amidinationed analogs (such as incorporating guanidine into endomorphins) to penetrate the BBB.  Also, several pertinent examples of bivalent and/or multivalent (such as mixed μ-agonist/δ-antagonist profile) compds. are discussed based on the existing literature and current data intending to give an insight into the development of opioid peptides expressing low tendency to produce acute tolerance and phys. dependence. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 32, No. 3, 536-580, 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHdETrlLSOH7Vg90H21EOLACvtfcHk0lhu0-qb0nNTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWnsr8%253D&md5=5a5183b1c9059cc3ea55ed9154cc6907</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fmed.20222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20222%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEndomorphins%253A%2520potential%2520roles%2520and%2520therapeutic%2520indications%2520in%2520the%2520development%2520of%2520opioid%2520peptide%2520analgesic%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D536%26epage%3D580%26doi%3D10.1002%2Fmed.20222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Vyas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheve, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span><span class="refDoi"> DOI: 10.1016/j.peptides.2005.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.peptides.2005.07.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=990-996&author=N.+Vyasauthor=C.+Mollereauauthor=G.+Cheveauthor=C.+R.+McCurdy&title=Structure-activity+relationships+of+neuropeptide+FF+and+related+peptidic+and+non-peptidic+derivatives&doi=10.1016%2Fj.peptides.2005.07.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DVyas%26aufirst%3DN.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DCheve%26aufirst%3DG.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DStructure-activity%2520relationships%2520of%2520neuropeptide%2520FF%2520and%2520related%2520peptidic%2520and%2520non-peptidic%2520derivatives%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D990%26epage%3D996%26doi%3D10.1016%2Fj.peptides.2005.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Summers, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, R. J.</span><span> </span><span class="NLM_article-title">The interaction of N alpha-alkylenkephalins with opiate receptors. Tissue-dependent shifts in the opiate activity of methionine-enkephalin following N alpha-alkylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1981&pages=4951-4956&author=M.+C.+Summersauthor=R.+J.+Hayes&title=The+interaction+of+N+alpha-alkylenkephalins+with+opiate+receptors.+Tissue-dependent+shifts+in+the+opiate+activity+of+methionine-enkephalin+following+N+alpha-alkylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DM.%2BC.%26aulast%3DHayes%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520interaction%2520of%2520N%2520alpha-alkylenkephalins%2520with%2520opiate%2520receptors.%2520Tissue-dependent%2520shifts%2520in%2520the%2520opiate%2520activity%2520of%2520methionine-enkephalin%2520following%2520N%2520alpha-alkylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26volume%3D256%26spage%3D4951%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Audigier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gout, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cros, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0014-2999(80)90114-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2880%2990114-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=6247160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL3cXktF2ksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1980&pages=35-46&author=Y.+Audigierauthor=H.+Mazarguilauthor=R.+Goutauthor=J.+Cros&title=Structure-activity+relationships+of+enkephalin+analogs+at+opiate+and+enkephalin+receptors%3A+correlation+with+analgesia&doi=10.1016%2F0014-2999%2880%2990114-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors:  correlation with analgesia</span></div><div class="casAuthors">Audigier, Y.; Mazarguil, H.; Gout, R.; Cros, J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The influences of physico-chem. parameters (chem. structure and lipophilicity), biochem. properties (catabolism, affinity for etorphine binding sites and (D-Ala)2-Leu5-enkephalinamide binding sites), and biol. activities in isolated organs (guinea pig ileum and mouse vas deferens) on the regulation of analgesia induced after intracerebroventricular injection of various enkephalin analogs were detd.  The selectivity of these metabolically stable analogs for μ- and δ-receptors, present in guinea pig ileum and mouse vas deferens, resp., depended on the C-terminal amino acid and also on the nature of the 2nd D-amino acid.  A strong correlation existed between activity in guinea pig ileum and affinity for etorphine binding sites, suggesting that these sites in rat brain have properties identical to those of μ-receptors characterized in guinea pig ileum.  Similarly, the affinity for (D-Ala)2-Leu5-enkephalinamide binding sites in mouse brain correlated with the activity in mouse vas deferens and suggested that central δ-receptors are not different from peripheral δ-receptors.  Considering morphine-like drugs and enkephalin analogs contg. the same C-terminal amino acid as the enkephalins, there was a good correlation between activity on μ-receptors (affinity for etorphine binding sites and activity in guinea pig ileum) and the antinociceptive activity.  This supports the hypothesis that μ-receptors are strongly involved in the analgesic effect.  However, when proline was the C-terminal amino acid, the antinociceptive activity was enhanced without any concomitant increase in the affinity.  This activity enhancement was the same for each analog and a similar correlation (identical to what was found with other opioid peptides and opiates) could still be established.  The reason for such a potentiation of the activity remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6jjF8XqMzt7Vg90H21EOLACvtfcHk0lgDZSAyBQhD9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktF2ksr8%253D&md5=554ff23f80e7c142e4c077c11f36b8a3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2880%2990114-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252880%252990114-4%26sid%3Dliteratum%253Aachs%26aulast%3DAudigier%26aufirst%3DY.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DGout%26aufirst%3DR.%26aulast%3DCros%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationships%2520of%2520enkephalin%2520analogs%2520at%2520opiate%2520and%2520enkephalin%2520receptors%253A%2520correlation%2520with%2520analgesia%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1980%26volume%3D63%26spage%3D35%26epage%3D46%26doi%3D10.1016%2F0014-2999%2880%2990114-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shaw, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, M. J.</span><span> </span><span class="NLM_article-title">In vitro profile of some opioid pentapeptide analogues</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1016/0014-2999(78)90109-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2878%2990109-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaE1cXlsFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1978&pages=313-317&author=J.+S.+Shawauthor=M.+J.+Turnbull&title=In+vitro+profile+of+some+opioid+pentapeptide+analogues&doi=10.1016%2F0014-2999%2878%2990109-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro profile of some opioid pentapeptide analogs</span></div><div class="casAuthors">Shaw, John S.; Turnbull, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-17</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The opiate agonist potency of 13 synthetic enkephalin pentapeptides was examd. on the elec.-stimulated guinea pig ileum and mouse vas deferens prepns. in comparison with Met-enkephalin  [58569-55-4], Leu-enkephalin  [58822-25-6], β-endorphin  [60617-12-1], and normorphine  [466-97-7].  Their antagonism by naloxone was also assessed on each prepn.  The findings are compatible with, and are discussed in the context of, the presence of at least 2 populations of receptors in these prepns..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUD_wveHlrgLVg90H21EOLACvtfcHk0lgDZSAyBQhD9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXlsFOksb8%253D&md5=f8ec859f9a2298f9b67969a0dba05338</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2878%2990109-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252878%252990109-7%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DJ.%2BS.%26aulast%3DTurnbull%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vitro%2520profile%2520of%2520some%2520opioid%2520pentapeptide%2520analogues%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1978%26volume%3D49%26spage%3D313%26epage%3D317%26doi%3D10.1016%2F0014-2999%2878%2990109-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Wuster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, R.</span><span> </span><span class="NLM_article-title">The preference of putative pro-enkephalins for different types of opiate receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90226-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0024-3205%2881%2990226-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=1219-1227&author=M.+Wusterauthor=P.+Rubiniauthor=R.+Schulz&title=The+preference+of+putative+pro-enkephalins+for+different+types+of+opiate+receptors&doi=10.1016%2F0024-3205%2881%2990226-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990226-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990226-5%26sid%3Dliteratum%253Aachs%26aulast%3DWuster%26aufirst%3DM.%26aulast%3DRubini%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DR.%26atitle%3DThe%2520preference%2520of%2520putative%2520pro-enkephalins%2520for%2520different%2520types%2520of%2520opiate%2520receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D29%26spage%3D1219%26epage%3D1227%26doi%3D10.1016%2F0024-3205%2881%2990226-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Handa, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. F.</span><span> </span><span class="NLM_article-title">Analogues of beta-LPH61–64 possessing selective agonist activity at mu-opiate receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span><span class="refDoi"> DOI: 10.1016/0014-2999(81)90364-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0014-2999%2881%2990364-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=6263640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaL3MXksFGhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1981&pages=531-540&author=B.+K.+Handaauthor=A.+C.+Laneauthor=J.+A.+Lordauthor=B.+A.+Morganauthor=M.+J.+Ranceauthor=C.+F.+Smith&title=Analogues+of+beta-LPH61%E2%80%9364+possessing+selective+agonist+activity+at+mu-opiate+receptors&doi=10.1016%2F0014-2999%2881%2990364-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of β-LPH61-64 possessing selective agonist activity at μ-opiate receptors</span></div><div class="casAuthors">Handa, Balraj K.; Lane, Anthony C.; Lord, John A. H.; Morgan, Barry A.; Rance, Michael J.; Smith, Colin F. C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-40</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Peptides based on the stabilized tetrapeptide HTyr-D-Ala-Gly-MePheOH were synthesized (M. et al. 1977) and shown to have substantial opioid activity both in vitro and in vivo.  The selectivity of these compds. for different receptor populations was investigated using both isolated tissue assays and binding studies.  Results suggest that the compds. are potent agonists at μ-receptors with little or no affinity for the δ-receptor population.  One of the compds., RX 783006 (Tyr-D-Ala-Gly-MePhe-NH(CH2)2OH)  [78123-71-4], was tritiated to high specific radioactivity and may prove to be a useful probe in the elucidation of the function of the heterogeneous opiate receptor population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp14h_RQou3fLVg90H21EOLACvtfcHk0lizvWhDNojkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFGhtbY%253D&md5=6dc5006ca4ee4e384466f421cd23425d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2881%2990364-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252881%252990364-2%26sid%3Dliteratum%253Aachs%26aulast%3DHanda%26aufirst%3DB.%2BK.%26aulast%3DLane%26aufirst%3DA.%2BC.%26aulast%3DLord%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DRance%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BF.%26atitle%3DAnalogues%2520of%2520beta-LPH61%25E2%2580%259364%2520possessing%2520selective%2520agonist%2520activity%2520at%2520mu-opiate%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D70%26spage%3D531%26epage%3D540%26doi%3D10.1016%2F0014-2999%2881%2990364-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouarderes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tafani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of neuropeptide FF: role of C-terminal regions</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1016/S0196-9781(01)00468-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2FS0196-9781%2801%2900468-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11514031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=1471-1478&author=H.+Mazarguilauthor=C.+Gouarderesauthor=J.+A.+Tafaniauthor=D.+Marcusauthor=M.+Kotaniauthor=C.+Mollereauauthor=M.+Roumyauthor=J.+M.+Zajac&title=Structure-activity+relationships+of+neuropeptide+FF%3A+role+of+C-terminal+regions&doi=10.1016%2FS0196-9781%2801%2900468-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of neuropeptide FF: role of C-terminal regions</span></div><div class="casAuthors">Mazarguil, H.; Gouarderes, C.; Tafani, J.-A. M.; Marcus, D.; Kotani, M.; Mollereau, C.; Roumy, M.; Zajac, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1471-1478</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A structure-activity study was carried out to det. the importance of the C-terminal amino acids of the octapeptide Neuropeptide FF (NPFF) in binding and agonistic activity.  Affinities of NPFF analogs were tested toward NPFF receptors of the rat spinal cord and the human NPFF2 receptors transfected in CHO cells.  The activities of these analogs were evaluated by their ability to both inhibit adenylate cyclase in NPFF2 receptor transfected CHO cells and to reverse the effect of nociceptin on acutely dissocd. rat dorsal raphe neurons.  The substitutions of Phenylalanine8 by a tyrosine, phenylglycine or homophenylalanine were deleterious for high affinity.  Similarly, the replacement of Arginine7 by a lysine or D-Arginine induces a loss in affinity.  The pharmacol. characterization showed that the presence of the amidated Phe8 and Arg7 residues are also extremely crit. for activation of anti-opioid effects on dorsal raphe neurons.  The sequence of the C-terminal dipeptide seems also to be responsible for the high affinity and the activity on human NPFF2 receptors.  The results support the view that a code messaging the mol. interaction toward NPFF-receptors is expressed in the C-terminal region of these peptides but the N-terminal segment is important to gain very high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqJrQWywXEbVg90H21EOLACvtfcHk0lizvWhDNojkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksLc%253D&md5=a5527ccb1b91887b8f821a9af783cada</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900468-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900468-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DGouarderes%26aufirst%3DC.%26aulast%3DTafani%26aufirst%3DJ.%2BA.%26aulast%3DMarcus%26aufirst%3DD.%26aulast%3DKotani%26aufirst%3DM.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DRoumy%26aufirst%3DM.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520relationships%2520of%2520neuropeptide%2520FF%253A%2520role%2520of%2520C-terminal%2520regions%26jtitle%3DPeptides%26date%3D2001%26volume%3D22%26spage%3D1471%26epage%3D1478%26doi%3D10.1016%2FS0196-9781%2801%2900468-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Gicquel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desprat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devillers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonnet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. M.</span><span> </span><span class="NLM_article-title">Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3477</span><span class="NLM_x">–</span> <span class="NLM_lpage">3481</span><span class="refDoi"> DOI: 10.1021/jm00047a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00047a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFKitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3477-3481&author=S.+Gicquelauthor=H.+Mazarguilauthor=C.+Despratauthor=M.+Allardauthor=J.+P.+Devillersauthor=G.+Simonnetauthor=J.+M.+Zajac&title=Structure-activity+study+of+neuropeptide+FF%3A+contribution+of+N-terminal+regions+to+affinity+and+activity&doi=10.1021%2Fjm00047a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Study of Neuropeptide FF: Contribution of N-Terminal Regions to Affinity and Activity</span></div><div class="casAuthors">Gicquel, Sophie; Mazarguil, Honore; Desprat, Corinne; Allard, Michele; Devillers, Jean-Philippe; Simonnet, Guy; Zajac, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3477-81</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Twenty neuropeptide FF (NPFF) analogs having various lengths were synthesized by solid-phase peptide synthesis to gain more information on the role of N-terminal residues for the NPFF receptor affinity.  The affinities were evaluated in the rat spinal cord membrane prepns., and the biol. activities were measured on morphine analgesia in the mouse tail-flick test.  Shortening of the NPFF sequence from the N-terminus produced only a moderate decrease in affinity until NPFF(4-8) was reached.  In the same way, NPFF(3-8) significantly decreased morphine analgesia, while NPFF(4-8) had no significant effect at a dose of 22 nmol.  The introduction in the N-terminal part of NPFF of a D-enantiomer at positions 2 and 1 or the presence of an N-Me group on position 3 did not modify affinity and activity.  Substitution of proline5 by the D-isomer decreased the affinity of NPFF analogs whatever their length, and [Tyr1,D-Pro5]NPFF(1-8) was 2.5-fold less potent than [Tyr1]NPFF(1-8) in reversing morphine-induced analgesia.  In contrast, the presence of a glycine residue in position 5 did not influence the affinity toward NPFF receptors.  Data provide evidence that the N-terminal segment of neuropeptide FF is responsible for high-affinity binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr890at16DLTLVg90H21EOLACvtfcHk0lizvWhDNojkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFKitrs%253D&md5=215b2957aa0393eeb0d0d935150de4a5</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm00047a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00047a005%26sid%3Dliteratum%253Aachs%26aulast%3DGicquel%26aufirst%3DS.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DDesprat%26aufirst%3DC.%26aulast%3DAllard%26aufirst%3DM.%26aulast%3DDevillers%26aufirst%3DJ.%2BP.%26aulast%3DSimonnet%26aufirst%3DG.%26aulast%3DZajac%26aufirst%3DJ.%2BM.%26atitle%3DStructure-activity%2520study%2520of%2520neuropeptide%2520FF%253A%2520contribution%2520of%2520N-terminal%2520regions%2520to%2520affinity%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3477%26epage%3D3481%26doi%3D10.1021%2Fjm00047a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Raehal, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span> </span><span class="NLM_article-title">Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1124/pr.111.004598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1124%2Fpr.111.004598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=21873412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1001-1019&author=K.+M.+Raehalauthor=C.+L.+Schmidauthor=C.+E.+Groerauthor=L.+M.+Bohn&title=Functional+selectivity+at+the+mu-opioid+receptor%3A+implications+for+understanding+opioid+analgesia+and+tolerance&doi=10.1124%2Fpr.111.004598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance</span></div><div class="casAuthors">Raehal, Kirsten M.; Schmid, Cullen L.; Groer, Chad E.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1001-1019</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Opioids are the most effective analgesic drugs for the management of moderate or severe pain, yet their clin. use is often limited because of the onset of adverse side effects.  Drugs in this class produce most of their physiol. effects through activation of the μ opioid receptor; however, an increasing no. of studies demonstrate that different opioids, while presumably acting at this single receptor, can activate distinct downstream responses, a phenomenon termed functional selectivity.  Functional selectivity of receptor-mediated events can manifest as a function of the drug used, the cellular or neuronal environment examd., or the signaling or behavioral measure recorded.  This review summarizes both in vitro and in vivo work demonstrating functional selectivity at the μ opioid receptor in terms of G protein coupling, receptor phosphorylation, interactions with β-arrestins, receptor desensitization, internalization and signaling, and details on how these differences may relate to the progression of analgesic tolerance after their extended use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2I02i0h7f87Vg90H21EOLACvtfcHk0lhO0GAgNSzVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ksb0%253D&md5=ad63762316c6f136fbbd3155d0364199</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004598%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DSchmid%26aufirst%3DC.%2BL.%26aulast%3DGroer%26aufirst%3DC.%2BE.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DFunctional%2520selectivity%2520at%2520the%2520mu-opioid%2520receptor%253A%2520implications%2520for%2520understanding%2520opioid%2520analgesia%2520and%2520tolerance%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D1001%26epage%3D1019%26doi%3D10.1124%2Fpr.111.004598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/35047086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1038%2F35047086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=11130073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=720-723&author=L.+M.+Bohnauthor=R.+R.+Gainetdinovauthor=F.+T.+Linauthor=R.+J.+Lefkowitzauthor=M.+G.+Caron&title=Mu-opioid+receptor+desensitization+by+beta-arrestin-2+determines+morphine+tolerance+but+not+dependence&doi=10.1038%2F35047086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence</span></div><div class="casAuthors">Bohn, Laura M.; Gainetdinov, Raul R.; Lin, Fang-Tsyr; Lefkowitz, Robert J.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">720-723</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence.  The development of opiate tolerance occurs on continued use of the drug such that the amt. of drug required to elicit pain relief must be increased to compensate for diminished responsiveness.  In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors.  In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called β-arrestins.  Using a knockout mouse lacking β-arrestin-2 (βarr2-/-), we have assessed the contribution of desensitization of the μ-opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of phys. dependence.  Here we show that in mice lacking β-arrestin-2, desensitization of the μ-opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance.  However, the deletion of β-arrestin-2 does not prevent the chronic morphine-induced up-regulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become phys. dependent on the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOyilKuNxt7Vg90H21EOLACvtfcHk0lhO0GAgNSzVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCrs7c%253D&md5=6c54b96c15fec1c9620d1fd90d24a1eb</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2F35047086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047086%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DMu-opioid%2520receptor%2520desensitization%2520by%2520beta-arrestin-2%2520determines%2520morphine%2520tolerance%2520but%2520not%2520dependence%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D720%26epage%3D723%26doi%3D10.1038%2F35047086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">DeHaven-Hudkins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolle, R. E.</span><span> </span><span class="NLM_article-title">Peripherally restricted opioid agonists as novel analgesic agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.2174/1381612043453036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.2174%2F1381612043453036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=15032700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=743-757&author=D.+L.+DeHaven-Hudkinsauthor=R.+E.+Dolle&title=Peripherally+restricted+opioid+agonists+as+novel+analgesic+agents&doi=10.2174%2F1381612043453036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally restricted opioid agonists as novel analgesic agents</span></div><div class="casAuthors">DeHaven-Hudkins, D. L.; Dolle, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mediation of antinociception via opioid receptors located in the periphery is a viable strategy to produce analgesia without the occurrence of side effects assocd. with stimulation of opioid receptors located in the central nervous system.  Peripheral opioid receptors are particularly important in inflammatory pain states and in the responses to pruritogenic stimuli, and have been implicated in the transmission of visceral pain.  Medicinal chem. approaches to achieve peripheralization of opioid agonists have started with a centrally acting opioid agonist as a template, and introduced features of lipophilicity, hydrophilicity, or combined lipophilicity and hydrophilicity to achieve amphiphilicity.  Quaternarization of centrally acting opioid agonists or identification of compds. that serve as substrates for the mdr transporter to achieve transport out of the brain has also been employed.  The in vivo assays used to identify peripherally selective compds. have measured a variety of behavioral and pharmacokinetic endpoints, with varying degrees of predictability.  This review focuses on a discussion of these methods, as well as a review of those compds. where sufficient data exist to support a claim of peripheralization in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooc-Vny_w6QrVg90H21EOLACvtfcHk0lhO0GAgNSzVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFOktbc%253D&md5=f3168a79c9798ca1fed846744baa1a41</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F1381612043453036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043453036%26sid%3Dliteratum%253Aachs%26aulast%3DDeHaven-Hudkins%26aufirst%3DD.%2BL.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26atitle%3DPeripherally%2520restricted%2520opioid%2520agonists%2520as%2520novel%2520analgesic%2520agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D743%26epage%3D757%26doi%3D10.2174%2F1381612043453036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Smith, H. S.</span><span> </span><span class="NLM_article-title">Peripherally-acting opioids</span> <span class="citation_source-journal">Pain Physician</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=S121-S132&author=H.+S.+Smith&title=Peripherally-acting+opioids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DH.%2BS.%26atitle%3DPeripherally-acting%2520opioids%26jtitle%3DPain%2520Physician%26date%3D2008%26volume%3D11%26spage%3DS121%26epage%3DS132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Stein, C.</span><span> </span><span class="NLM_article-title">Targeting pain and inflammation by peripherally acting opioids</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="refDoi"> DOI: 10.3389/fphar.2013.00123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.3389%2Ffphar.2013.00123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=24068999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FhsV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=123&author=C.+Stein&title=Targeting+pain+and+inflammation+by+peripherally+acting+opioids&doi=10.3389%2Ffphar.2013.00123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting pain and inflammation by peripherally acting opioids</span></div><div class="casAuthors">Stein Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2CrTRODPZSxOk4JA3soTqfW6udTcc2eb11vgwld0-_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FhsV2huw%253D%253D&md5=0b64fd10bdac1329034c463688415d78</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00123%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26atitle%3DTargeting%2520pain%2520and%2520inflammation%2520by%2520peripherally%2520acting%2520opioids%26jtitle%3DFront.%2520Pharmacol.%26date%3D2013%26volume%3D4%26spage%3D123%26doi%3D10.3389%2Ffphar.2013.00123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Dubuisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, S. G.</span><span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine%2C+and+brain+stem+stimulation+in+rats+and+cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lgat_isRzBDZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%252C%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1016%2Fj.neuropharm.2016.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=26970017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1Shsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=364-372&author=Z.+L.+Wangauthor=N.+Liauthor=P.+Wangauthor=H.+H.+Tangauthor=Z.+L.+Hanauthor=J.+J.+Songauthor=X.+H.+Liauthor=H.+P.+Yuauthor=T.+Zhangauthor=R.+Zhangauthor=B.+Xuauthor=M.+N.+Zhangauthor=Q.+Fangauthor=R.+Wang&title=Pharmacological+characterization+of+EN-9%2C+a+novel+chimeric+peptide+of+endomorphin-2+and+neuropeptide+FF+that+produces+potent+antinociceptive+activity+and+limited+tolerance&doi=10.1016%2Fj.neuropharm.2016.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance</span></div><div class="casAuthors">Wang, Zi-long; Li, Ning; Wang, Pei; Tang, Hong-hai; Han, Zheng-lan; Song, Jing-jing; Li, Xu-hui; Yu, Hong-ping; Zhang, Ting; Zhang, Run; Xu, Biao; Zhang, Meng-na; Fang, Quan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">364-372</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mounting evidences indicate the functional interactions between neuropeptide FF (NPFF) and opioids, including the endogenous opioids.  In the present work, EN-9, a chimeric peptide contg. the functional domains of the endogenous opioid endomorphin-2 (EM-2) and NPFF, was synthesized and pharmacol. characterized.  In vitro cAMP assay demonstrated that EN-9 was a multifunctional agonist of κ-opioid, NPFF1 and NPFF2 receptors.  In the mouse tail-flick test, intracerebroventricularly (i.c.v.) administration of EN-9 produced significant antinociception with an ED50 value of 13.44 nmol, which lasted longer than that of EM-2.  In addn., EN-9 induced potent antinociception after both i.v. (i.v.) and s.c. (s.c.) injection.  Furthermore, the expts. using the antagonists of opioid and NPFF receptors indicated that the central antinociception of EN-9 was mainly mediated by κ-opioid receptor, independently on NPFF receptors.  Notably, the central antinociception of EN-9 was not reduced over a period of 6 days repeated i.c.v. injection.  Repeated i.c.v. administration of EN-9 with the NPFF1 and NPFF2 receptors antagonist RF9 resulted in a progressive loss of analgesic potency, consistent with the development of tolerance.  Moreover, central administration of EN-9 induced the place conditioning aversion only at a high dose of 60 nmol, but not at low doses.  At supraspinal level, only high dose of EN-9 (60 nmol, i.c.v.) inhibited gastrointestinal transit via NPFF receptors.  Similarly, systemic administration of EN-9 also inhibited gastrointestinal transit at high doses (10 and 30 mg/kg, i.v.).  Taken together, the multifunctional agonist of κ-opioid and NPFF receptors EN-9 produced a potent, non-tolerance forming antinociception with limited side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoby4T7pGme6bVg90H21EOLACvtfcHk0lgat_isRzBDZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1Shsbo%253D&md5=0b9dd9d2bdeba08a9b0248c7a0c68296</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DH.%2BH.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DSong%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DYu%26aufirst%3DH.%2BP.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%2BN.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DPharmacological%2520characterization%2520of%2520EN-9%252C%2520a%2520novel%2520chimeric%2520peptide%2520of%2520endomorphin-2%2520and%2520neuropeptide%2520FF%2520that%2520produces%2520potent%2520antinociceptive%2520activity%2520and%2520limited%2520tolerance%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D108%26spage%3D364%26epage%3D372%26doi%3D10.1016%2Fj.neuropharm.2016.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Wang, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e103773</span><span class="refDoi"> DOI: 10.1371/journal.pone.0103773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;key=10.1371%2Fjournal.pone.0103773" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e103773&author=Z.+L.+Wangauthor=Q.+Fangauthor=Z.+L.+Hanauthor=J.+X.+Panauthor=X.+H.+Liauthor=N.+Liauthor=H.+H.+Tangauthor=P.+Wangauthor=T.+Zhengauthor=X.+M.+Changauthor=R.+Wang&title=Opposite+effects+of+neuropeptide+FF+on+central+antinociception+induced+by+endomorphin-1+and+endomorphin-2+in+mice&doi=10.1371%2Fjournal.pone.0103773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0103773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0103773%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BL.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DZ.%2BL.%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DH.%2BH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DX.%2BM.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DOpposite%2520effects%2520of%2520neuropeptide%2520FF%2520on%2520central%2520antinociception%2520induced%2520by%2520endomorphin-1%2520and%2520endomorphin-2%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De103773%26doi%3D10.1371%2Fjournal.pone.0103773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span> </span><span class="NLM_article-title">A new class of highly potent and selective endomorphin-1 analogues containing alpha-methylene-beta-aminopropanoic acids (map)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6224</span><span class="NLM_x">–</span> <span class="NLM_lpage">6236</span><span class="refDoi"> DOI: 10.1021/jm300664y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300664y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6224-6236&author=Y.+Wangauthor=Y.+Xingauthor=X.+Liuauthor=H.+Jiauthor=M.+Kaiauthor=Z.+Chenauthor=J.+Yuauthor=D.+Zhaoauthor=H.+Renauthor=R.+Wang&title=A+new+class+of+highly+potent+and+selective+endomorphin-1+analogues+containing+alpha-methylene-beta-aminopropanoic+acids+%28map%29&doi=10.1021%2Fjm300664y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm300664y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300664y%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DKai%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DA%2520new%2520class%2520of%2520highly%2520potent%2520and%2520selective%2520endomorphin-1%2520analogues%2520containing%2520alpha-methylene-beta-aminopropanoic%2520acids%2520%2528map%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6224%26epage%3D6236%26doi%3D10.1021%2Fjm300664y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01181">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64754"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01181">10.1021/acs.jmedchem.6b01181</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Details of the antinociceptive dose– and time–response curve and tolerance evaluation for the icv administration of the new analogues of <b>0</b> in the mouse tail-flick test; antinociceptive tolerance evalution of morphine and <b>0</b> analogues after 6 days of repeated icv administration in the mouse tail-flick test (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01181/suppl_file/jm6b01181_si_001.pdf">jm6b01181_si_001.pdf (142.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01181&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01181%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01181" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679936d9df1b3c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
